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1.INTRODUCTION 
The siddha system of medicine is considered to be one of the most antiquated 
traditional medical system. The Siddha system is largely therapeutic in nature and is 
based on the relationship between man and nature. The objective of siddha system is 
to attain a fullest survival and to overcome the handicaps of nature and age .   
Siddhars, the spiritual scientists are the founding fathers of this scientific 
system. Siddha system believes that all objects in the universe including human body 
are composed of five basic primordial elements namely earth, water, fire, air and 
space called as “panchaboothams”. 
Siddhars  were of the concept that a healthy soul can only be developed 
through a healthy body. Siddhars practiced intense yogic practices,  including years of 
periodic fasting and meditation and gained the supreme wisdom and overall 
immortality. Through this spiritually attained supreme knowledge, they wrote 
scriptures on all aspects of life, from arts to science and truth of life to miracle  cure 
for diseases. So they developed methods and medication that are believed to 
strengthen their physical body and thereby their souls . They explored the nature and 
use the natural resources for the sake of humanity. Their boundless knowledge on the 
properties drugs, purification, processing, heat application, fixing dosage, toxicity, 
antidote and clinical application is astonishing the modern scientific world. 
Eczema is an universally encountered mostly acute,less frequently chronic, 
recurrent skin disease, characterized by pleomorphism of the morphological lesions; it 
occurs at any age.  The Greek word  “ekzein” means “to boil out” or “to effervesce”. 
The important thing to realize is that it is a symptom only, and in no sense of 
the word a disease. As a symptom, it is an indispensable word. 
It is now accepted that the eczema process as a result of the effect of a 
complex of neuroallergic, endocrine,  metabolic ,emotional factors, psychologic stress 
and exogenous factors.The exogenic irritants include chemical and biological 
agents,bacterial agents,physical factors, drugs ,foodstuffs, cosmetics etc.., 
            It is estimated that 10% people have some of eczema at any one time and upto 
40% of population will have an episode of eczema during their lifetime. In India 
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eczematous diseases are very common with an estimated prevalence of more than 
10% in the general population.  According to statistics 15 to 25% of all 
dermatological patients suffer from eczema. 
           Current treatments include emollient based creams after a lukewarm water 
bath. Mild, medium or high potency corticosteroid creams are being used to reduce 
inflammatory reactions based on the severity of symptoms. Oral antihistamines are 
used in case of severe itching. Short course of oral corticosteroids  is prescribed to 
control acute outbreak of eczema. Ultraviolet light therapy is also another option for 
people with eczema. 
          Prolonged use of topical corticosteroids is thought to increase the risk of side 
effects, the most common of which is the skin becoming thin and fragile(atrophy). 
Short term side effects of light treatment include sunburn- like reactions and potential 
longterm side effects include premature skin ageing and skin cancer. 
         Since the above said allopathic treatment seems to have many adverse 
reactions, a search for the safe herbal drug for skin disease particularly eczema leads 
me to select the plant Karunchembai (Sesbania sesban) from the literature, which is 
a promising drug for the above cure. 
        “ Skin is the index of health” 
  Since the skin reflects the healthy condition of the body, for the maintenance 
and glow of a healthy skin, the above said medicine Karunchembai leaves proves to 
be a better medicine. 
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2. AIM AND OBJECTIVES 
Aim: 
The main aim of this dissertation is to prove the efficacy of Karunchembai Ilai 
Chooranam for treating Karappan (Eczema). 
Objective: 
 The skin is considered as the body’s largest immunological organ. Most of the 
Inflammatory reactions occurring in the skin  are based on the disturbance in the 
normal protective mechanism, conditions affecting the skin cause unfold misery and 
millions of people face such problems. In Siddha system , many drugs have been 
effective for skin diseases. Many of Siddha literatures have mentioned about 
Karunchembai for the treatment of Eczema. So I have taken this work with intense. 
 The main objective of the present study is to establish herbal based medicine 
to the following method. To highlight the efficacy of the medicines for Karappan 
diseases, the following methods are adopted. 
              Establishing the identity of the drug through literature evidences and 
pharmacognostical         studies.  
• Collection of various literatures about the plant in Gunapadam and botanical 
aspects. 
• To analyse the drug in Bio-chemical analysis. 
• Anti-Microbial study. 
• Establishing the Anti-histamine, Anti-inflammatory activities of the test drug 
through pharmacological studies. 
• To have clinical study on Eczema with trial medicine. 
• To find the statistical analysis of the clinical study.  
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3.REVIEW OF LITERATURE 
3.1 BOTANICAL ASPECT: 
Sesbania sesban (Karunchembai) 
Bentham and Hooker classification: 
     Kingdom          : Plantae  
           Phylum            : Magnaliophyta  
           Class                : Angiospermae  
           Order               : Fabales  
           Family             : Leguminosae  
           Genus              : Sesbania  
            Species           : sesban  
           Binomial name: Sesbania sesban 
Synonyms: 
                 Aeschynomene sesban 
                 Emerus sesban 
                 Sesbania aegyptiaca 
                 Sesbania confaloniana 
                 Sesbania pubescens  
Vernacular names: 
                English- Common sesban, Egyptian Rattle pod 
                Tamil –  Chittagathi , Karunchembai, Champai 
                Sanskrit –  Jayantika , Jayanti  
                Hindi –  Jainti , Jait, Rawasan 
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                Bengali –  Jainti, Jayant 
                Marathi –  Shewarie , Jayat, Jarjan 
                Gujarati -  Jayati , Raishingin  
                Telugu –  Samintha , Suminta 
                 Kannada –  Arisina , Jeenangi Karijeenangimare 
                Malayalam – Sempa , Nellithalai, Kedangi 
Description of the plant: 
A soft – wooded, quick growing short – lived shrub. 1.8 – 6m high, found 
cultivated throughout the plains of  India upto an altitude of 1200 m. Leaves 7.5 – 15 
m long , paripinnate, leaflets 8 – 20 pairs, linear oblong , glabrous , entire, mucronate 
to acuminate, 6.0 – 2.5 mm x 2.5 – 6.0 mm, flowers yellow or yellow apotted red to 
purple or with standard petals coloured purple or brown from outside , in 8 – 10 
flowered , lax , axillary racemes , 2.5 – 14.0 cm long, poda 12.5 – 22.5 cm x 0.25 – 
0.37 cm , pendulous, weak , distinctly torulose, twisted , sharply beaked , 20 – 30 
seeded and septate. 
Cultivation: 
The plant is extensively cultivated as a shade tree for turmeric, tea , sweet 
orange and mandarin in south – west India and for cotton raised during summer in 
Tamilnadu. It is grown as a hedge in North India and as Paddy field – bunds in 
Tamilnadu . Sesban is valued as a wind – break for betel – wines and grape – wines in 
Baroda and Assam . Ragi, Paddy and Sugarcane are manured with sesban.  
Uses: 
Sesban can grow under widely different conditions and can provide large 
quantities of green manure. However, it is recommended suitable for cultivation in 
region liable to periodic inundation. It can also be grown under water logged 
conditions and acid soils. It withstands salt concentration of 0.4 – 1.0 percent in 
seeding stage and 0.9 – 1.4 % towards maturity. The leaves and pods dry up as a 
result of frost. 
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            Well grown plants of Sesbania sesban yield fairly good quantity of green 
leaves as this plant has a great capacity to regenerate quickly after pruning. 
             The plant is especially rich in Nitrogen (4%) and exceeds the minimum of 2 
% over which organic nitrogen materials render nitrogen available for plant growth. It 
nitrifies soil easily. 
            Sesban is classed under famine foods because of its seeds which are rich in 
protein. ( In Bihar the flowers are eaten as vegetable).  
            Leaves collected from plants in Jammu is analysed gave the following values 
(on dry wt), protein, 26.6, ether extr. 5.8, fibre 8.4, N- free extr, 49.5 , ash 10.0 g/ 
100g, calcium 32.50 mg and phosphorous, 340 mg / 100 g. They are a good source of 
protein, calcium & phosphorous. 
               Sesban is a common cottage ornament. The leaves and flowers are used in 
religious offerings. The plant yields an insecticide & is also in making ink.The plant is 
credited with galactagogue properties. The root is hot and bitter; carminative, 
alterative and anthelmintic; removes “kapha”, biliousness, inflammation; cures 
tuberculous glands, fevers, ulcers, diabetes, leucoderma relieves throat troubles; an 
excellent cure for scorpion-sting 
 The leaves are purgative, anthelmintic, maturant, demulcent useful for 
hydrocele and all pains and inflammations. 
              In Dacca, the juice of fresh leaves is given as an anthelmintic. 
              Pigments isolated from the flowers include a complex of cyaniding and 
delphinidin glycoside acylated with gallic and an unidentified acid. Atleast six 
flavanols, magnesium and traces of iron are present.  
Bark is the source of a fibre used for making ropes. Analysis of the fibre gave 
the following values; moisture 5%; cellulose 65.9; lignin and pectin 24.3; extract 
2.5% 
            Charcoal obtained from the wood is used for gunpowder. Sesban wood is 
employed as fuel to boil jiggery. Sesban is grown in Deccan to furnish poles as a 
substitute for bamboo and for roofing huts. 
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Seeds are stimulant, emmenagogue and astringent and useful in checking 
diarrhoea and reducing enlargement of the spleen. In the form of ointment, the seeds 
are used to cure itches and various other skin eruptions. For the same troubles juice of 
the bark given internally is found effective. A poultice of seeds is reported to be a 
suppuration of boils and abcesses and absorption of  inflammatory rheumatic 
swellings. 
3.2 MATERIA MEDICA (GUNAPADAM ASPECT) 
 Karunchembai (sesbania sesban) 
Synonyms:  
chithagathi,chembai 
Habit: 
It is a small tree cultivated in almost all parts of  India.There are three types of                        
chempai namely karunchembai,manjal chembai and chenchembai. 
 Parts used:   Leaves,flowers,seeds and root. 
          Suvai  :    kaippu,thuvarppu 
         Thanmai   :    veppam 
         Pirivu        :    kaarppu 
         Action      :    Stimulant 
                          :  Emmenagogue 
                          :  Astringent 
                          :  Anthelmintic 
                          :  Diuretic 
                          :  Resolvent 
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General Characters 
                         “விப்புருதிப் புண்ணாறும் வ றுகரப் பானும்ேபாந் 
              தப்பாமல் ேமகந் தணியுங்காண்-ெவப்பாƫ 
              கபேராக ேமகுஞ் கருஞ்ெசம்ைப ெயான்றுக் 
              கிபமா முைலமாேத!எண்.” 
                                    -அகத்தியƫ குணவாகடம் 
The leaves cures leucorrhoea, boils, ulcers and eczema. This cures common 
cold. 
                           
                           தைலக்குத்த ைலயஞ் சலேதாடம் வாதம் 
              உைலப்பீ னிசமுமிந்த வூƫக்குள்-நிைலக்கா 
              தருஞ்சண் பகநாசி யாயிைழேய சுத்தக் 
              கருஞ்ெசம்ைபப் பூவிருக்குங் கால் 
                                   .-அகத்தியƫ குணவாகடம் 
The flowers cures headache, common cold, sinusitis and vadha disease. 
 
                        கட்டி ெயாடுவ க்கங் காயத்துள் நேரற்றம் 
            ஒட்டிவரு வாதகபம் ஓட்டுவது-ெதாட்டுவிடும் 
            அம்ைபயிைல ேவைலெவன்ற வங்கண் மடமாேத! 
            ெசம்ைபயிைல ேவைலெயனத் ேதƫ. 
                                   -அகத்தியƫ குணவாகடம் 
Heated leaves are applied externally for oedema. It absorbs water in case of 
ulcers and inflammation.The leaf extract eradicates the intestinal worms. 
            Leaves along with common salt and Acalypha indica are made into a paste and 
this is used as external application for eczema, but the bark paste also should be taken 
internally. 
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            The flower oil cures migraines and headache.The paste of the seeds if taken 
internally it checks diarrhoea and menorrhagia.  The powdered root mixed with 
vinegar is applied on the spot where scorpion has stung. It relieves pain immediately. 
Drugs and other processes which contains Karunchembai: 
நயன வாயுவுக்குத் ‘ைதலம்’ 
         ெநல்லி ெசம்ைபப் ெபாற்கண்ணிச்சாறுடேனƫ 
              பசும்பால் விளக்ெகண்ெணய் நல்ெலண்ெணய் 
         நல்ல ெநய்யுஞ் சமங்கூட்டிதிற்சாறு 
              நாடும் பாதியிட்டுக் காய்ச்சிசரீகம் 
         ெமல்லைரத் திட்டுப் பக்குவத்திெலr 
              ேமல்வடித்து முழுகிடும்ேபாது ேகள் 
         ெவல்லு ேநத்திர வாயுவிட்ேடாடிேய 
               ெவளிச்சமாகிடு ேமற்குணேமவியேத.  
                                    -சரேபந்திரƫ ைவத்திய முைறகள்  
Ingredients: 
       Juice of amla-1.3 lit 
       Juice of sessile plant-1.3 lit 
       Juice of sesban-1.3 lit 
        Castor oil-2.6 lit 
        Gingelly oil-2.6 lit  
        Cow’s milk-1.3 lit 
        Cumin seeds-350 gms 
Preparation: 
The paste should be prepared with cumin seeds and milk and then we have to 
add the above said juices and oil and stir well. Boil the above said mixture and filter 
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it. The filtered solution should be used for head bath. This cures naethiravayu and this 
will also result in brightening the eyes. 
                                      Chittagathi thailam 
Ingredients: 
       Gingelly oil-1.3 lit 
      Flowers of sesbania sesban-1.3 lit 
      Vettiveria zizanioides-1/2 ounce 
       Plectranthus vettiveroides-1/2 ounce 
       Samutra pachai-1/2 ounce 
       Poolangilangu-1/2 ounce 
       Curcuma aromatica-1/2 ounce 
       Senbagapoo-1/2 ounce 
       Sandal wood powder-1 ounce 
        Betle leaf-35 gms 
        Ginger-35 gms 
        Pepper-1/2 ounce 
        Cumin seeds-1/2 ounce 
        Puzhukappattai-1/2 ounce 
         Rose buds-1 ounce 
Preparation: 
 Cut the betle leaf and ginger into  small pieces and have  the other ingredients 
in powdered form. Add the powder, juice of chittagathi and ginger betle leaf pieces in 
boiling oil and raise the flame, wait until the oil bubbles get settled down and also 
when chittagathi flowers and betle pieces are in crispy stage, stop heating it anymore. 
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Filter the solution when it’s hot. Leave it to get cool and keep it in airtight container. 
Headache, sneezing, heaviness of the head and cold complaints can be cured by 
applying (once or twice in a week) the solution on head and taking  headbat 
                                         Aathandai ennai 
Ingredients: 
           Root of Capparis zeylenica-140 gms 
           Flowers of Sesbania sesban-70 gms 
           Styrax benzoin-70 gms 
          Allium sativum-70 gms 
           Betle leaf-70gms 
           Flowers of Leucas aspera-35 gms 
           Curcuma aromatica-35 gms 
           Sandal wood powder-35 gms 
           Papaver somniferum-2.1 gms 
           Pepper-8.4 gms 
 Preparation: 
The abovesaid contents are grinded into a paste with milk. Then add 650 ml of 
milk and 1400 gms of gingelly oil and it is allowed to heat in the flame and then 
filtered. 
Uses:  
 Used as bath oil twice in a week and it cures all types of headache. 
Honey (Adjuvant) : 
Honey is a food tastes sweet made by bees collecting nectar from flowers. 
Honey bees changes nectar into honey by a process reabsorption and evaporation. 
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The viscosity of honey varies greatly by both temperature and water content. 
The flow of honey directly depends on the humidity of honey. Water has little effect 
on viscosity, when it crosses its melting point.  
The average pH of honey is 3.9. It  ranges from 3.4 to 6.1. Honey contains 
many kinds of  organic and amino acids. Honey contains about 18 of the 20 amino 
acids. However, amino acid content is much negligible in honey, i.e. only 0.05–0.1% 
of the composition. The main amino acid is proline. Amino acids are derived from the 
bodies of the bees. 
 Honey (Thaen) is one of the five elixirs of immortality (Panchamritam). 
Ancient literature mention the use of honey as a great medicinal and health food. 
Typical honey analysis : 
 Fructose   : 38.2% 
 Glucose   : 31.3% 
 Maltose   : 7.1% 
 Sucrose   : 1.3% 
 Water    : 17.2% 
 Higher sugars   : 1.5% 
 Ash    : 0.2% 
 Other/undetermined  : 3.2% 
Its glycemic index ranges from 31 to 78, depending on the variety.  
Honey has a density of about 1.36 kilograms per litre (36% denser than water) 
 
                                    3.3 Siddha aspect of the disease 
                                           Karappan 
 Definition: 
  Karappan  is characterized by erythema, papules, vesicles and crusting with 
lichenification followed by scaling of healthy skin without scars. This skin disease 
called as ‘karappan’ sometimes occur without itching complaint. 
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Aetiology: 
Though the exact causes for the ‘karappan noi’ are unknown, it has been said 
the ‘kirumi’(parasites) could not cause the karappan noi. But, the ‘kirumi’ may be 
seen in the surface of the karappan skin lesions. 
The friction of the known allergic things or wool like foreign allergic materials 
and the psychosomatic disorders may cause ‘karappan noi’. Generally the ‘karappan’ 
in children caused by some kinds of food allergy. These allergic food substances have 
been well defined by our ancestors as ‘karappan pandangal’. These substances cause 
the allergic reaction in the body which may be the reasons for the ‘Karappan’. 
  Most cases of eczema especially in infants are really food allergies, they are 
the reaction of the skin, at a particular time to particular foods. The treatment of such 
cases is prevention, discovery and avoidance of particular food. 
The allergic substances or the karappan substances are known by the 
following verse 
                
                “ெபருகுஞ் ேசாள மிறுங்கும் ெபரும்கம்பு 
                         வரகு காருடன் வாைழயின் காெயாடு 
                          உைரெகாள் பாகற் ெகளிற்றுமீன் உண்டிடில் 
                          விrவ தாய்க்கரப் பானுமிகுந்தேத”. 
Maize(pear millet), (Pennisetum typhoideum) Italian millet(Setaria italica), 
varagu(paspalum scrobiculatum i.e.kodo millet),samai(little millet Panicum 
sumatrense), unripe fruit of Musa sapientum(Plantain fruit), Bitter gourd(Momordica 
charantia), ‘Kelitru’ variety of fish are the ‘Karappan’ substances according to the 
above poem. But Yuhimuni says, eating of non-vegetarian foods, maize, millet, kodi 
millet, little millet, tubers, unhygienic foods and sexual contact with elder women are 
the reasons for the ‘Karappan noi’. Besides these, Guava(Psidium guava 
fruit),Egg,dried and salted fish(Karuvadu), Brinjal and white pumpkin(Cucurbita 
pepo) are also considered as karappan substances. 
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  As karappan is caused by allergic substance it is also called as allergic 
diseases. The ‘Karappan noi’ which are caused by the substances said above, allergic 
diseases. But we could not say these allergic substances to the all persons in always. 
 Some known allergic substances which are allergic to some persons was not 
allergic to other persons. Some other substances which have not been said above may 
be allergic to some other persons. And some substances which could allergic to some 
persons in sometime, may not allergic to the same persons in another time. 
Classifications: 
 Yuhi muni classified this karappan noi into seven types. These are 
1.vathakarappan, 2.Kanda karappan, 3.Varatchi karappan, 4.Thimir vadha 
karappan, 5.Kapala karappan, 6.pitha karappan, 7.Setthuma karappan. But in 
‘Pathinen siddhar palavagadam thirattu’, the karappan classification had been said 
18 types.These are  
       1.Vadha karappan, 2.Pitha karappan, 3.Kapha karappan, 4.Ari karappan, 
5.Oothu karappan, 6.Soolai karappan, 7.Veengu karappan, 8.Vedi karappan, 
9.Mandai karappan, 10.Pori karappan, 11.Sattai karappan, 12.Odu karappan, 
13.Karun karappan, 14.Sen karappan, 15.Kolli karappan, 16.Thoda karappan, 
17.Valai karappan, 18.varal karappan. 
       These types occur in children and is described in ‘Bala vagada thirattu’. Now we 
see the Yuhi muni’s classification. 
General symptoms: 
 Itching, scratching is followed by the ‘Erythema, papules,vesicles, oedema, 
weeping, crushing, scabbing and the healthy skin without scars. The colour of the skin 
occurs inbetween the stages of papules with oedema and scabbing. 
            In some karappan types, weeping may not occur. Oozing of blood occur in 
some types. The clotted blood forms the crust and gives foetid odour. 
1.Vadha karappan 
 According to the Yuhi muni, the symptoms of the vadha karappan are; 
general malaise, popular lesions with Oedema, weeping and crusting, in the affected 
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skin areas, ankylosis of the joints and immobility of fingers, enlargement of the vein 
and the dryness of the skin. 
 2.Kanda karappan  
  Burning sensation, thickening of the skin in the head and ears. Rigor, 
shivering are followed by the appearance of the ‘sori’ skin lesion(hyperkeratosis), 
chillness of the body, tingling sensation, dazzling of the eyes and thorns sensation in 
the skin are the symptoms of the “Kanda Karappan” disease. 
3.Varatchi karappan  
Dropsy, tingling sensation and itching, fatigue, drowsiness, dryness of the 
skin(emaciation), weight loss, unmeaningful talks, weeping in the oedematous areas 
and foetid odour are the symptoms and signs of the varatchi karappan. 
 
4.Thimir vadha karappan 
Pain in the joints especially while standing up, ankylosis of the legs, arms, hip, 
and knee joints.Oedema all over the body(dropsy), weeping and the crust formation in 
the fissures.Excessive urination(polyuria), burning sensation all over the body and 
tremor(rigor) are the symptoms of the Thimir vadha karappan. 
           Itching and oedematous swelling in the inter digital areas of the foot, weeping 
and ulcer formation, malaise, emaciation of the body.Crust formation and prutitis may 
also be the symptoms of the Thimir vadha karappan. 
5.Kabala karappan 
 Burning sensation and itching in the ear lobes, eyes, hoarseness of the voice, 
gummy excretions from the eyes, lacrimal secretion, rhinorrhoea, itching in the head, 
sneezing, fluttering of the forehead, uvula inflammation(uvulitis) are the symptoms of 
the kabala karappan. 
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6.Pitha karappan 
 Drooping of the eyelids, loosening of the hells, burning sensation and 
increased temperature, vertigo, weakness, yellowish discolouration, loss of appetite, 
anorexia and creeping sensationare the symptoms of the pitha karappan. 
7.Sethuma karappan 
Pallor, hoarse of the voice, low pitch tone, tachypnoea, cough and asthma are 
the symptoms seen in sethuma karappan.Patient expects the help from others in all the 
things. 
Diseases which are accompanied by the ‘Karappan noi’ 
Karappan noi sometimes accompany with pitha noi and pramega noi. 
Karappan in Pitha Rogam 
Itching all over the body and ‘sori’ skin lesions, lumps formation, itching, 
burning sensations, pallor, diarrhea, barborygoms, convulsions, weakness of the legs 
and painful hip joint are the symptoms seen in the pitha rogam accompanied with 
karappan. 
Karappan in pramega rogam 
           Colic pain, barborycoms, pallor, defecation, dysuria(burning sensation) with 
colour urine,  micturition with ulceration of the urethra of  UTI, pyrexia, weakness of 
the upper and lower limbs and larger skin lesions(sori) are seen. 
Prognosis  
       Vadha karappan, Pitha karappan, Varatchi karappan and Kabala karappan are 
the four curable karappan types. Others are incurable. 
General restrictions 
        Patient is advised to have sound sleep, rest, good ventilation and to do some mild 
exercises. He has to take nourished vegetable diet, milk and milky products. Cooked 
meat also be given.Spicy items, aromatics, chilly items(pungent taste), karappan 
substances and narcotics should be avoided.For children limited food only be given. 
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       If the ‘kudal kirumi’(helminthiasis) is accompanied by ‘Karappan noi’ the 
disease can be cured, by treating the kirumi noi(helminthiasis) first followed by the 
treatment of  karappan. 
      To clean the vesicles, ‘Kaluvu neer’ is used. For the inflammation, 
emolliated(skin lesions) are used. 
     In ulcerated skin lesions, ointment or cream is used. The varied potencies of 
external medicines are used, according to the nature of the skin. The crusted skin 
lesions are applied with emollients. Use warm water for bathing purposes. 
          Dried and powder of Acacia cancinna pods and(fuller’s earth) soaps, should not 
be used. 
     The powdered phaseolus mungo(green gram) or Nalangu podi(The mixture of 
neem leaves, turmeric, sandal and others) may be used to clean the body while taking 
bath. 
     Patient should avoid contact with the allergens which caused this disease. If the 
disease is occupationally related, he should change his job. Dye factory 
workers,Building workers are more prone to this disease. 
      Doctors and the nurse are also susceptible to this disease as they are practicing 
streptomycin which is one of the known allergen. 
3.4 Modern aspect of the disease 
Eczema 
Definition: 
              Eczema is an inflammatory skin reaction characterized histologically by 
spongiosis with varying degrees of acanthosis, and a superficial perivascular  
lymphohistiocytic infiltrate.The term ‘dermatitis’ and ‘eczema’ are nowadays 
generally regarded as synonymous. Eczema is a specific type of allergic cutaneous 
manifestation of antigen-antibody reaction. 
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Etiology: 
The exact cause of eczema is unknown, but it's thought to be linked to an 
overactive response by the body's immune system to an irritant. It is this response that 
causes the symptoms of eczema. 
  In addition, eczema is commonly found in families with a history of other 
allergies or asthma. 
             Some people may suffer "flare-ups" of the itchy rash in response to certain 
substances or conditions. For some, coming into contact with rough or coarse 
materials may cause the skin to become itchy. For others, feeling too hot or too cold, 
exposure to certain household products like soap or detergent, or coming into contact 
with animal dander may cause an outbreak. Upper respiratory infections or colds may 
also be triggers. Stress may cause the condition to worsen. 
Predisposing factors: 
  Eczema sometimes occurs in infancy, at puberty and at the time of 
menopause. 
 Familial sensitiveness is an important factor.There is usually a personal 
or family history of allergy, viz.,asthma, eczema, hay fever, etc 
  Genetic predisposition is responsible for the preponderance of 
eczemas in certain families and their absence in others.               
 General physical debility predisposes to eczemas by lowering the 
resistance of the individual and hence the threshold.                        
Climatic extremes like heat, dampness and severe cold and also 
psychological stresses, promote the development of eczema.  
 Besides the above mentioned conditions, local factors like xeroderma 
or ichthyosis, a greasy skin, hyperhidrosis, varicose veins causing 
congestion and focus of lowered resistance, hypostasis or chilblains 
predispose to eczema development. 
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Classification of Eczemas: 
Exogenous eczemas: 
 Irritant dermatitis 
 Allergic contact dermatitis 
   Photo-allergic contact dermatitis 
    Dermatophytide 
 Post- traumatic eczema 
Endogenous eczemas: 
 Atopic dermatitis 
 Seborrhoeic dermatitis 
 Asteatotic eczema 
 Discoid eczema 
 Pityriasis alba 
 Hand eczema 
 Gravitational eczema 
 Juvenile plantar dermatosis 
 Eczema associated with systemic disease 
 Eczematous drug eruptions 
Pathogenesis: 
            Two different pathogenetic mechanisms appear  to be involved in irritant 
contact dermatitis. Chronic irritant dermatitis seems to be related to disturbed barrier 
function and increased epidermal cell turnover leading to lichenification, whereas 
acute irritant contact dermatitis is characterized by an inflammatory  reaction which 
mimics allergic contact dermatitis, with release of inflammatory mediators and 
cytokines. 
           In allergic contact dermatitis, an antigen is presented to T lymphocytes by 
Langerhans’ cells or by keratinocytes, leading to release of cytokines such as 
interferon- (IFN- ), tumour necrosis factor-α(TNF-α), or interleukin 1(IL-1). IFN- 
promotes expression of HLA-DR, up-regulation of intercellular adhesion molecule 
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1(ICAM-1) and CD36 on keratinocytes, whereas TNF-α induces only ICAM-1 
expression.The expression of these antigens permits adhesion of leukocytes to the 
epidermis and the subsequent development of inflammation. 
        Although very similar, acute irritant contact dermatitis differs by not expressing 
HLA-DR or CD36 on keratinocytes. Thus, ICAM-1 expression may predominate in 
irritant contact dermatitis as a consequence of TNF-α release, or by direct action of 
the irritant on the keratinocyte. 
Exogenous eczemas: 
Irritant contact dermatitis: 
         Contact irritants are the commonest exogenous cause of hand eczema. It is 
estimated that irritant contact dermatitis causes one third of hand eczema. The 
majority of occupational hand eczemas are irritant in nature. They often become 
chronic. 
 Clinical features: 
          The skin is dry and later there is chapping, cracking and fissuring seen on the 
palms, palmar aspects of fingers and sometimes on the knuckles. The skin is red, 
shiny, and even glistening. The complaints are burning and pain rather than itching. 
Allergic contact dermatitis: 
          The commonest allergens were vegetables(21%), nickel(20%), and 
chromium(20%). In adolescents, a significant association is found between hand 
eczema and nickel allergy acquired by ear piercing by a nickel needle or from nickel 
coated dental braces. 
Photo-allergic dermatitis: 
           The common causes of photodermatitis are: 
1. Drugs like sulphonamides, chlorpromazine, promethazine, declamycin, 
terramycin, chlorthiazide diuretic, different hypotensive and anti-diabetic 
drugs, quindexin in animal feeding stuff. 
2. Foods like figs, buckwheat. 
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3. External application of bithionol, tetrachlorsalicylanilide etc. 
4. Plants and their products-like parsnips, cow parsnips, meadow grass, 
mustards, lime oil, psoralea, celery, bur clover, bergamot oil etc.Vit.B 
complex deficiency, porphyrinuria, seborrhoeic diathesis and liver disorders 
predispose to photodermatitis. 
Infective dermatitis: 
         This results from sensitization to certain organisms like streptococci, 
staphylococci, dermatophytes and yeast organisms. Infective eczemas are very 
common in tropical countries. 
Post-traumatic eczema: 
         The rash is comprised of reddish brown, slightly crusted and scaly patches, with 
occasional papulovesicles. Histology shows subacute spongiotic dermatitis. The 
condition responds to topical corticosteroids, but tends to relapse when the treatment 
is stopped. 
Endogenous eczemas  
Atopic dermatitis: 
        Atopic dermatitis is the major cause of hand and foot eczema. The most common 
site of atopic dermatitis is the hand in adults; sometimes the hands alone are involved. 
Atopic adolescents and young adults develop hand eczema when they are exposed to 
schoolwork, hobbies, or occupational contacts. 
        Important predisposing factors in the development of hand dermatitis in atopics 
are atopic dermatitis of the hands in childhood; history of widespread dermatitis in 
childhood; persistent, diffuse atopic dermatitis; and dry itchy skin. Less important 
factors are female sex, family history of eczema, and presence of other atopic 
disorders.The atopic diathesis may also predispose to discoid eczema and pompholyx. 
Seborrheic dermatitis:  
       Seborrheic dermatitis is biphasic, being seen in early infancy(within the first three 
months of life) and later in adult life.In adults it usually does not start before the third 
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decade but may occur upto the sixth decade. In infancy, there is an equal incidence in 
both sexes, but in adults, it is more frequently seen in males. 
Infantile seborrheic dermatitis: 
       The cause of infantile seborrheic dermatitis is not fully known. Studies have 
linked it to the influence of maternal hormones on sebum production. It has been 
suggested that Malassezia furfur is involved in the development of infantile 
seborrheic dermatitis. 
      Spongiosis is the main feature of seborrheic dermatitis. Spongiotic foci are 
accentuated around hair follicles, whose ostii are surrounded by parakeratotic scales. 
The stratum corneum shows parakeratosis. The epidermis shows mild inflammatory 
lymphohistiocytic infiltrate. 
    Infantile seborrheic dermatitis is usually seen during the first three months of life, 
usually between the third and eighth week.Infants having  this dermatitis are 
comparatively calm and unperturbed and are not irritated. The scalp and diaper areas 
are the first to be involved, followed by the face, retroauricular fold, neck and axillary 
folds.  
Adults: 
      The lesions originate in hairy skin, are brownish in colour and are covered with 
greasy scales. They involve the scalp, face, presternal,interscapular regions and 
flexures. Their distribution is the hallmark of SD and is helpful in diagnosis. 
Asteatotic eczema:(Winter eczema, Eczema craquele, Senile eczema) 
        The term asteatotic eczema means eczema due to decreased surface skin lipids. 
        Asteatotic eczema is basically because of dry skin, xerosis, which precedes it. A 
decrease in natural lipids, derived from keratohyaline granules, may cause the dryess 
of old age. Malnutrition, particularly zinc deficiency, may be a contributory factor. 
Diuretics can affect the hydration of the skin in the elderly. Myxedema should always 
be ruled out, as asteatosis may be the presenting sign. 
Nummular dermatitis: 
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(Discoid eczema) 
       Nummular(meaning coin-shaped) dermatitis is characterized by round 
eczematous lesions, papulovesicular and oozing or scaly erythematous, with a clearly 
demarcated edge, usually on the extensors of the limbs. It is more common in adults 
over the age of 50 years. 
Stasis dermatitis 
(Gravitational eczema, Varicose eczema) 
          The primary cause of stasis dermatitis is venous insufficiency.Chronic venous 
insufficiency of the lower extremities is the cause of stasis syndrome. The venous 
flow up from the feet against gravity is made possible physiologically by the action of 
calf muscles and competence of valves in the veins. This mechanism is defective in 
chronic venous insufficiency because of damage to the veins by thrombophlebitis or 
due to structural weakness of veins in the form of an incompetent valvular system. 
Because of incompetent valves, there is blood reflux from the deep to the superficial 
veins, causing venous hypertension. 
          Other causes are related to the obstruction of one of the major veins, 
particularly the ileofemoral, due to external pressure caused by neoplastic invasion, 
hemangioma or arteriovenous fistula. 
Juvenile plantar dermatosis 
        It is a condition seen as dry, glistening and sometimes fissured skin on the 
forefeet of children aged 3 to 14 years. 
Pityriasis alba 
       It is commonly seen as asymptomatic scaly hypopigmented patches generally on 
the face. 
       It is considered as one of the minor diagnostic signs of atopic dermatitis, but it is 
common in nonatopics too. 
 
 
                                                                                                               PG Gunapadam 
 
24 
 
Lichen simplex 
(Lichen simplex chronicus, Circumscribed neurodermatitis) 
        It is an intensely itchy disorder manifesting as a lichenified 
plaque.Lichenification refers to thickening of the skin with accentuation of skin 
markings because of rubbing. It is common in patients with atopic diathesis. 
       Lichenification can develop on normal skin by persistent rubbing and scratching, 
but not everyone develops it. Atopics are more prone and a significant number of 
lichen simplex patients have a history of atopic disorders. In predisposed patients, 
psychological factors play an important role in the development and perpetuation of 
lichen simplex. Anxiety or more importantly depression may be the primary cause. 
Metabolic eczema 
(Eczemas associated with systemic diseases) 
        Intestinal malabsorption  can be the cause of or the result of widespread eczema. 
Severe inflammatory skin disease can cause malabsorption known as dermatogenic 
enteropathy. Malabsorption improves rapidly as the skin condition is treated. 
      Atopic dermatitis-like eczema is associated with hypogamma-globulinemia and 
Wiskott-Aldrich syndrome. HyperIgE syndrome too is associated with dermatitis.A 
photosensitive dermatitis is a diagnostic featureof pellagra and Hartnup disease. 
Phenylketonuria is characterized by eczema in some cases. 
Eczematous drug eruptions 
    Though rare, eczematous drug reactions can be caused by many drugs. 
     A systemic drug to which a patient has developed an allergic contact dermatitis by 
prior topical usage can cause intractable recurrent eczema. 
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Pompholyx 
(Dyshydrotic eczema) 
       This form of eczema is characterized by vesicles and bullae on the palms and 
soles. When it involves the palms it is called cheiropompholyx and when on the soles, 
podopompholyx. 
        The direct contact allergens implicated are primin, isopropyl-para-
phenylenediamine, benzoiso-thiazolones and dichromates, perfumes, fragrances and 
balsam ingredients. They cause palmar vesicles. 
       Nickel sulphate was the commonest allergen(14%) followed by potassium 
dichromate, phenylenediamine and nitrofurazone(8% each),fragrance mix(6%) and 
cobalt chloride(4%). 
Investigations: 
¾ Prick tests 
¾ Patch tests 
¾ Immunoglobulin E 
¾ RAST 
¾ ELISA 
3.5 Lateral research 
Antidiabetic Activity of Aqueous Leaves Extract of Sesbania sesban (L) Merr.in 
Streptozotocin Induced Diabetic Rats 
Ramdas B. Pandhare 1,2*, B. Sangameswaran 3, Popat B. Mohite 1, Shantaram G. 
Khanage  
1. MES College of Pharmacy, Sonai, Newasa, Ahmednagar, Maharashtra, India 
2. Research Scholar Department of Pharmacy, Suresh Gyan Vihar University, Jaipur, 
Rajasthan, India 
3. Department of Pharmacognosy, TIT-Pharmacy, Bhopal, India 
The aqueous leaves extract of Sesbania sesban (L) Merr. (Family: Fabaceae) 
was evaluated for its antidiabetic potential on normal and streptozotocin (STZ)-
induced diabetic rats. In the chronic model, the aqueous extract was administered to 
normal and STZ- induced diabetic rats at the doses of 250 and 500 mg/kg body 
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weight (b.w.) p.o. per day for 30 days. The fasting Blood Glucose Levels (BGL), 
serum insulin level and biochemical data such as glycosylated hemoglobin, Total 
Cholesterol (TC), Triglycerides (TG), High Density Lipoproteins (HDL) and Low 
Density Lipoproteins (LDL) were evaluated and all were compared to that of the 
known anti-diabetic drug glibenclamide (0.25 mg/kg b.w.). The statistical data 
indicated significant increase in the body weight, liver glycogen, serum insulin and 
HDL levels and decrease in blood glucose, glycosylated hemoglobin, total cholesterol 
and serumtriglycerides when compared with glibenclamide. Thus the aqueous leaves 
extract of Sesbania sesban had beneficial effects in reducing the elevated blood 
glucose level and lipid profile of STZ-induced diabetic rats. 
Antinociceptive activity of Sesbania sesban(Linn)Wood extracts, a preliminary 
study 
Indian Journal of Experimental Biology 
Volume.50, Jan 2012, pp.61-64 
                   The wood of the plant sesbania sesban is reported to have antinociceptive 
activity. To validate its folk use in the treatment of pain, wood was extracted 
successively with petroleum ether, chloroform, ethyl acetate, ethanol and water to 
produce respective extracts. The extracts(50 and100mg/kg,ip) were screened for 
antinociceptive activity using hot plate test and acetic acid-induced writhing test in 
mice. Petroleum ether, chloroform and ethyl acetate extracts showed significant and 
dose-dependent activity in both the tests. In order to find out the involvement of opiod 
receptors, effect of naloxone(1mg/kg, sc) on the action of extracts was checked in hot 
plate test. Petroleum ether, chloroform and ethyl acetate extracts showed significant 
and dose dependent antinociceptive activity. The antinociceptive action of the extracts 
was blocked by naloxone, suggesting involvement of opiod receptors in the action. 
Attenuating effect of Sesbania sesban (L) Merr. extract on neuropathic pain in 
streptozotocin-induced diabetic rats: an evidence of neuroprotective effects  
Ramdas B. Pandhare, B. Sangameswaran, Popat B. Mohite, Shantaram G. Khanage 
MES College of Pharmacy, Sonai, Ahmednagar, Maharashtra-414105.   
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 Principal and Prof, Adesh Institute of Pharmacy and Biomedical Sciences, Bathinda, 
Punjab.  
 Research Scholar, Department of Pharmacy, Suresh Gyan Vihar University, Jaipur, 
Rajasthan,  India.  
Phytopharmacology 2012, 2(1) 190-201 
The aim of present study was to investigate the attenuating effects of Sesbania 
sesban leaves aqueous extract (SSLAE), in streptozotocin (STZ)-induced diabetic 
rats. SSLAE (250 and 500 mg/kg per day) was given to diabetic rats for 12 weeks. 
Cold and hot water tail immersion tests, photoactometer and Rota-rod tests were 
performed to assess degree of colder, thermal spontaneous motor activity and motor 
co-ordination changes respectively at different time intervals i.e., week 0, 4, 8 and 12. 
Tissue superoxide anion and total calcium levels were determined after 12 weeks to 
assess biochemical alterations. Histopathological evaluations of sciatic nerve were 
also performed. SSLAE increased tail flick latency significantly in diabetic rats. 
SSLAE also reduced superoxide anion and total calcium levels. These results 
suggested that SSLAE has attenuated development of diabetic neuropathy in 
streptozotocin-induced diabetic rats when compared with pregabalin (10 mg/kg, p.o.) 
and could be beneficial in preventing the progression of diabetic neuropathy.  
Potent spermicidal effect of oleanolic acid 3-beta-D-glucuronide, an active 
principle isolated from the plant Sesbania sesban Merrill. 
Das N, Chandran P, Chakraborty S. 
 Epub 2010 Jun 25. 
Reproductive Biology Research Department, Cell-Biology and Physiology Division, 
Indian Institute of Chemical Biology (A Unit of CSIR), Kolkata-700 032, India. 
The spermicidal activity of oleanolic acid 3-β-D-glucuronide (OAG), an active 
principle isolated from root extracts of Sesbania sesban, was evaluated.Under the 
Sander-Cramer test criteria, the sperm-immobilizing activity of OAG was studied 
using highly motile rat sperm. Sperm mortality and membrane integrity were assessed 
by supravital staining, hypo-osmotic swelling (HOS), transmission electron 
microscopy (TEM) and sperm membrane lipid peroxidation (LPO). In vitro 
microbicidal potential and hemolytic index of OAG were examined in Lactobacillus 
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culture and rat red blood corpuscles (RBCs), respectively. Post-intravaginal OAG 
application, the in vivo contraceptive efficacy was evaluated in rats. Ames test 
destined the carcinogenic potential of OAG. The minimum effective concentration 
(MEC) of OAG was 50 mcg/mL. More than 97% of the OAG-treated sperm lost their 
HOS responsiveness in a dose-dependent manner.  
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4. MATERIALS AND METHODS 
The  trial drug  Karunchembai Ilai Chooranam was taken  from a  siddha  
literature  Gunapadam  mooligai  written  by  Murugesa  mudaliyar. 
Collection  and  authentication of the  materials.   
The plant material used in this study was collected  from Erode Dist, 
Tamilnadu, India and authenticated from the Gunapadam experts in  Department of   
Gunapadam,  Govt. siddha medical college, Chennai-106 and Certified from Botanist, 
Central Research Institute For Siddha, Arumbakkam, Chennai-106 
Purification of the Raw Drug: 
The leaves of the plant  were well rinsed in water to remove the impurities. 
Then the roots were cut into pieces and dried in shade. 
Preparation of the chooranam: 
The well dried leaves of Sesbania sesban (Karunchembai)  were made into 
fine powder. The finest physical form of this drug was obtained when the powdered 
material is sieved through a white cotton cloth (Vashthirakayam). 
Purification of chooranam: 
 The Chooranam was kneaded mildly with cow’s milk. The pot was half filled 
with milk and water. The mouth of the pot was tied with white cotton cloth over 
which the above chooranam was placed. The lid was replaced by another mud pot. 
The gap between the two mud pots were held tightly using a wet cloth in order to 
prevent evaporation. Then this arrangement was boiled until level of water gets 
reduced. Then the powder was taken, dried, powdered finely and preserved for usage. 
Preservation:  
           The purified Chooranam was stored in a clean, air tight glass container. Since 
the self life period of the Chooranam is only three months, the prepared Chooranam 
must be used within 3 months period. 
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                     Fig.No.1.Showing Karunchembai (Sesbania Sesban) 
 
 
 
                             
                       Fig.no.2.Showing Karunchembai Ilai Chooranam 
 
 
Administration of the drug: 
• Form of the medicine  : Chooranam 
• Route of Administration : Oral 
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• Dose    : 1gm 
• Adjuvant             : Honey 
• Times of Administration : Two times a day; after food 
• Duration    : 1-3 months 
4.2. STANDARDIZATION OF THE DRUG  
4.2.1. PHARMACOGNOSTIC STUDY: 
Collection and authentication of the materials 
Plant specimen for the proposed study were collected from Erode Dist and 
identified and authenticated by the Gunapadam experts in Department of P.G. 
Gunapadam, Govt. Siddha medical college, Chennai – 106 and certified by Botanist, 
Central Research Institute for Siddha, Chennai – 106. Care was taken to select healthy 
plants and normal leaves.  
Staining: 
                  The required samples of leaves were  removed from the plant and fixed in 
FAA (Formalin-5ml+ Acetic acid-5ml + 70% Ethyl alcohol-90ml).After 24 hrs of 
fixing, the specimens were dehydrated with graded series of tertiary –Butyl alcohol as 
per the schedule given by Sass, 1940. Infiltration of the specimens was carried by 
gradual addition of paraffin wax (melting point 58-60 C) until TBA solution attained 
super saturation. The specimens were cast into paraffin blocks. 
Sectioning 
                  The paraffin embedded specimens were sectioned with the help of Rotary 
Microtome. The thickness of the sections was 10-12 μm. Dewaxing of the sections 
was by customary procedure (Johansen, 1940). The sections were stained with 
Toluidine blue as per the method published by O’Brien et al. (1964). Since 
Toluidine blue is a polychromatic stain. The staining results were remarkably good; 
and some cytochemical reactions were also obtained. The dye rendered pink colour to 
the cellulose walls, blue to the lignified cells, dark green to suberin, violet to the 
mucilage, blue to the protein bodies etc. wherever necessary sections were also 
stained with safranin and Fast-green and IKI(for Starch) 
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For studying the stomatal morphology, venation pattern and trichome 
distribution, paradermal sections (sections taken parallel to the surface of leaf) as 
well as clearing of leaf with 5% sodium hydroxide or epidermal peeling by partial 
maceration employing Jeffrey’s maceration fluid (Sass, 1940) were prepared. 
Glycerine mounted temporary preparations were made for macerated/cleared 
materials. Powdered materials of different parts were cleared with Naoh and mounted 
in glycerine medium after staining. Different cell component were studied and 
measured. 
Photomicrograph 
 Microscopic descriptions of tissues are supplemented with micrographs 
wherever necessary. Photographs of different magnifications were taken with Nikon 
lab photo 2 microscopic Unit. For normal observations bright field was used. For the 
study of crystals, starch grains and lignified cells, polarized light was employed. 
Since these structures have birefringent property, under polarized light they appear 
bright against dark background. Magnifications of the figures are indicated by the 
scale-bars. Descriptive terms of the anatomical features are as given in the standard 
Anatomy books (Esau, 1964).  
4.2.2. QUALITATIVE PHYTOCHEMICAL ANALYSIS: 
Materials and methods:                        
  The leaves of Sesbania sesban were collected, washed and shade dried 
exposing the leaves for desiccation. The leaves were later ground to obtain the fine 
powder using an electric blender. The yield of extract was estimated. Phytochemical 
screening procedures carried out determines the biologically active compounds that 
contribute to the odour, colour and other characteristics of vegetable leaves. 
Test for Phenol 
Substance in water is added with 5 % alcoholic ferric chloride. Dark blue or green 
colour shows presence of phenol. 
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Test for Tannin 
Substance is shaken with water and added with lead acetate solution. White 
precipitate shows the presence of tannin. 
Test for Flavonoids (Shinoda test) 
Substance is dissolved in alcohol, added with magnesium bits and 
concentrated hydrochloric acid. On heating over a water bath, the appearance of 
majenta colour shows the presence of flavonoids.  
Triterpenoids (Noller’s Test)  
To few mg of extract, add tin and thionyl chloride and heat in water bath. 
Purple colour indicates the presence of triterpenoids. 
Test for Glycosides  
Substance is treated with anthrone and concentrated sulphuric acid. On heating 
over a water bath, the appearance of green colour shows the presence of glycoside. 
Test for Saponins 
To few mg of extract distilled water is added and shaken well. The formation 
of foam indicates the presence of saponin. 
 
Test for Cardiac glycoside (Keller-Killani Test) 
Add 2 ml of glacial acetic acid containing a drop of ferric chloride solution  and 
and 0.5 ml of concentrated sulphuric acid to the chloroform extract of the plant. The 
blue color in the  acetic acid layer shows presence of cardiac glycosides.  
4.2.3. PHYSICO-CHEMICAL ANALYSIS: 
(a) Physico - chemical parameters  
Determination of Total Ash 
 3 g of the powder was incinerated in a silica dish at a temperature not 
exceeding 450º until free from carbon, cool and weigh. The percentage of ash was 
calculated with reference to the air-dried drug. 
Determination of Acid Insoluble Ash 
The obtained ash was boiled for 5 minutes with 25 ml of dilute hydrochloric 
acid and insoluble matter was collected in ashless filter paper. Then, it was washed 
with hot water and ignited to constant weight. The percentage of acid-insoluble ash 
was calculated with reference to the air dried drug. 
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Determination of Alcohol Soluble Extractive 
5 g of powder was mixed with 100 ml of Ethanol of the specified strength in a 
closed flask and kept alone for twenty-four hours.  Filtered rapidly with taking 
precautions against loss of solvent.  25 ml of the filtrate was evaporated to dryness in 
a tarred flat bottomed shallow dish, and dried at 105º, to constant weight and weighed. 
The percentage of alcohol-soluble extractive was calculated with reference to the air-
dried drug. 
Determination of Water Soluble Extractive 
5 g of powder was mixed with 100 ml of chloroform water of the specified 
strength in a closed flask and kept alone for twenty-four hours.  Filtered rapidly with 
taking precautions against loss of solvent.  25 ml of the filtrate was evaporated to 
dryness in a tarred flat bottomed shallow dish, and dried at 105º, to constant weight 
and weighed. The percentage of water-soluble extractive was calculated with 
reference to the air-dried drug. 
Determination of Moisture Content (Loss on Drying) 
10 g of drug was taken in the tarred evaporating dish and dried at 105º for 5 
hours, and weighed. (Continue the drying and weighing at one hour interval until 
difference between two successive weighing corresponds to not more than 0.25 per 
cent. Constant weight is reached when two consecutive weighing after drying for 30 
minutes and cooling for 30 minutes in a desiccator, show not more than 0.01 g 
difference). 
Potential of hydrogen (pH): 
The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 being neutral. 
Readings less than 7.0 indicate acidic solutions, while higher readings indicate 
alkaline or base solutions.  
Thin Layer Chromatography: 
Solvent system: 
Toluene : Ethyl acetate (6:1.5). 
TLC plate: 
  Aluminium plate precoated with silica gel 60F254 of 0.2 mm thickness 
(Merck). 
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Developing chamber: 
 Camag’s twin trough chamber. 
Visualizing reagent: 
 Vanillin-sulphuric acid reagent. 
Extract Preparation: 
             4 g of the chooranam was soaked overnight in chloroform. Boiled on a water 
bath for 10 mins, filtered and concentrated to 10 ml.  
Procedure: 
The extract was applied on the TLC using capillary and developed in the 
solvent system.  The developed TLC plate was air dried and photograph was taken in 
white light. Then dipped in vanillin-sulphuric acid reagent, heated in an oven at 
105°C until the development of coloured spots and photograph taken.  
4.2.4. PROXIMATE CHEMICAL ANALYSIS OF A DRUG 
Methodology For Chemical Analysis 
Preparation of Extract : 
Add 5 gm of the Karunchembai Ilai Chooranam to 50ml of distilled water. Boil the 
solution for 20 minutes, cool and then filter. Use the Extract for the following tests. 
Table 1: 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative 
reagent, add 10 drops of extract, 
then boil for two minutes 
Absence of Green / 
Yellow / Red 
precipitate 
Absence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of 
acetic acid and then add few drops 
of N/50 Iodine Solution. 
Absence of Blue 
Colour 
Absence of 
Starch 
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3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% 
Sodium Hydroxide mix and add 2 
drops of Copper Sulphate 
Solution. 
Presence of Violet 
or Purple Colour 
Presence of 
Proteins 
4. Test for amino Acid : 
Place  2 drops of extract on a filter 
paper and allow to dry well. Then 
spray 1% ninhydrin over the same 
and allow to dry. 
Presence of  Violet 
Colour 
Presence of 
Amino Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of 
Esboch’s reagent. 
Absence of  Yellow 
precipitate 
Absence of  
Albumin 
6. Test for Phosphate : 
To 2ml of extract, add 2ml of 
ammonium Molybdate solution 
and 2ml of concentrated Nitric 
Acid. 
Absence of Yellow 
precipitate 
Absence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
Absence of White 
precipitate 
Absence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric 
acid till the effervescence ceases. 
Then add 2 ml of Silver Nitrate 
Solution. 
Presence  of 
Cloudy White 
precipitate 
Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of 
ammonium thio cynate solution 
and add 2ml of concentrated 
Nitric Acid. 
Presence of Red 
Colour 
Presence of Iron 
10. Test for Calcium : Presence of White Presence  of 
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INSTRUMENTAL ANALYSIS: 
SCANNING ELECTRON MICROSCOPE (SEM): 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are advantages using the SEM instead of a 
light microscope. 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12 x to greater than 1, 00,000 X 
The SEM has a large depth of field, which allows a large amount of the 
sample to be in focus at one time. The SEM also produces images of high resolution, 
which means that closely spaced features can be examined at a high magnification. 
Preparation of the samples is relatively easy since most SEM one require the sample 
To 2 ml of extract, add 2 ml of 
4% ammonium Oxalate Solution. 
precipitate Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of 
the sample with Hcl and Introduce 
it into the blue flame.  
Absence of Yellow 
Flame 
Absence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml 
of Sodium Nitrate Solution. Then 
add 2ml of Cobal Nitrate in 20% 
acetic acid. 
Presence of Yellow 
precipitate 
Presence of 
Potassium 
13. Test for Zinc : 
To 2ml of extract, add few drops 
of Sodium Hydroxide. 
Absence of White 
precipitate 
Absence of Zinc 
14. Test for Magnesium : 
To 2ml of extract, add few drops 
of Sodium Hydroxide Solution 
Absence of White 
precipitate 
Absence of 
Magnesium 
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to be conductive. The combination of higher magnification, larger depth of focus, 
greater resolution, and easy of sample observation marks the SEM one of the most 
heavily used instruments in research areas today. 
FOURIER TRANSFORM INFRARED SPECTROSCOPY  (FTIR): 
Instrument details: 
Model   :  Spectrum one: FT-IR Spectrometer  
Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid. 
 Fourier Transform Infrared Spectroscopy (FTIR) is an analytical technique 
used to identify mainly organic materials. FTIR analysis results in absorption spectra 
which provide information about the chemical bonds and molecular structure of a 
material. The FTIR spectrum is equivalent to the "fingerprint" of the material and can 
be compared with cataloged FTIR spectra to identify the material. 
Infrared spectrum is useful in identifying the functional groups like -OH, -CN, 
-CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases for 
chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, water 
and rubber samples can be analyzed.  
The drug sample was analyzed by the FTIR to identify the chemical bonds and 
molecular structure of a material. 
4.2.5 TOXICOLOGICAL STUDY 
Materials and methods 
Animals 
 Male albino Wistar rats (190-210 g) and 25-32g of mice were obtained from 
the animal house of the School of Pharmaceutical Sciences, Vels University, Chennai. 
They were kept at standard environmental conditions (12/12-h light/dark cycle) and 
were allowed free access to food and water. Before each test, the animals were fasted 
for 24 h with free access to water. The rats were randomly divided into test and 
control groups, each group consisted of age and weight matched rats (n =6). The 
experimental protocol was approved by the animal ethical committee of Vels 
University. (Approval number: 
XIII/VELS/PCOL/14/2000/CPCSEA/IAEC/08.08.2012) 
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Stock solution and Acute toxicity study 
 Acute oral toxicity study was performed as per OECD-425 guidelines. Mice 
(n=6) of either sex selected by random sampling technique were used for acute 
toxicity study. The animals were kept fasting for overnight providing only water, after 
which the Karunchembai Ilai Chooranam in 2% CMC was administered orally at the 
different dose levels in up and down dosing schedule according to body weight by 
gastric intubation and observed for 14 days.  
4.2.6 PHARMACOLOGICAL STUDIES 
Antihistaminic activity of Karunchembai Ilai Chooranam 
Materials and methods 
Drugs and stock solution  
 Drugs used were Histamine diphosphate (Sigma Chemical, USA). Histamine 
dihydrochloride was dissolved in distilled water and desired concentrations were 
prepared. The test drug Karunchembai Ilai Chooranam concentration was 
100microgram per ml prepared by suspending with 2% CMC and then the volume 
was adjusted to 10 ml with normal saline for making the concentration of 100μg/ml in 
distilled water. 
Animals 
 Male albino guinea pig weighing 350– 400g was kept in fasting condition 18 
hours prior to commencement of experiment and given water ad libitum. It was 
housed under standard laboratory conditions of temperature (25 ± 2°C) and 12/12 hr 
light/dark cycle and then sacrificed by a blow to the head and exsanguinated as per 
CPCSEA recommended guidelines. 
In-vitro antihistaminic study 
 Guinea pig was sacrificed and a segment from ileum (2 cm) was dissected 
from the terminal ileum and mounted in an organ bath containing Tyrode solution (10 
ml) between two stainless steel hooks under 0.5 to 1 g initial tension. The lower hook 
was fixed at the bottom of the organ bath and upper one was connected to an isotonic 
transducer. The Tyrode solution composition (pH 7.4) was (concentration in gm/lit.) 
NaCl 8.0, KCl 0.2, CaCl2 0.2, MgCl2 0.1, NaHCO3 1.0, NaH2PO4 0.05, and 
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Glucose1.0gm/liter. It was continuously aerated and maintained at 37 ± 0.5ºC. The 
equilibrium period was 60 min and the bath solution was refreshed every 15 min. 
After equilibrium period, a dose response curve for histamine in variant molar 
concentrations, by maintaining 45 min time cycle.  
Statistical Analysis 
 Ileum contractions induced by agonist were assumed as 100% and reductions 
induced by test drug calculated. Percentage of ileum contraction was expressed as 
mean ± SEM. Results were analyzed using one-way analysis of variance (ANOVA). 
Probability value less than 0.05 were considered as significant. 
 
Acute anti - inflammatory activity of karunchembai Ilai Chooranam in rats 
Materials and methods 
Animals 
 Male albino Wistar rats (190-210 g) and 25-32g of mice were obtained from 
the animal house of the School of Pharmaceutical Sciences, Vels University, Chennai. 
They were kept at standard environmental conditions (12/12-h light/dark cycle) and 
were allowed free access to food and water. Before each test, the animals were fasted 
for 24 h with free access to water. The rats were randomly divided into test and 
control groups, each group consisted of age and weight matched rats (n =6). The 
experimental protocol was approved by the animal ethical committee of Vels 
University. (Approval number: 
XIII/VELS/PCOL/14/2000/CPCSEA/IAEC/08.08.2012) 
Acute anti-inflammatory evaluation 
Formalin induced method 
 Male Albino Wistar rats, 190–210 g, were kept in Polypropylene cages with 
free access to food and water. Testing took place in the middle of the light period of a 
12:12-h light:dark cycle. The Karunchembai Ilai Chooranam was suspended in 
vehicle (2% carboxy methyl cellulose (CMC) in saline) and administered orally at a 
dose of 100, 250, 500 mg/kg and 45mg/kg for Diclofenac sodium. The rats were 
divided in to five groups (n=6) and the first group treated with saline (5ml/kg), second 
group treated with Diclofenac sodium (45mg/kg) and third, fourth and fifth group 
treated with Karunchembai Ilai Chooranam 100, 250 and 500mg/kg respectively 
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through orally. Oedema was produced by subplantar injection of formalin in the right 
hindpaw of each rat one hour after the administration of corresponding drugs. The 
paw volume was measured at 1,2,3 and 4 hr after the injection of formalin using the 
plethysmometer. Mean increase in the paw volume of oedema was measured. 
Statistical analysis 
 The data are expressed as mean±SEM. Student t-test followed by Dunnet ‘t’ 
test was used to determine significant differences between groups. p-values less than 
0.05 were considered as indicative of significance. 
Antimicrobial activity of Karunchembai Ilai Chooranam 
 Materials and methods 
Antimicrobial assay-Isolation and maintenance of cultures 
 Esherichia coli and Bacillus subtilis were extracted from food stuffs by serial 
dilution agar plate method. In this method, serial dilutions of samples obtained from 
food stuffs were prepared and aliquots from each dilution were added to the plates 
containing nutrient agar to allow the growth of microbes. All the bacterial isolates 
were identified by cultural, morphological biochemical characteristics (Gram and 
endospore staining). The plates were kept in an incubator at 37ºC. The slants were 
prepared from the pure cultures obtained and kept in the refrigerator at 40C for further 
use. 
Standardization of inoculum 
 The microbial inoculum was standardized at 0.5 McFarland. In microbiology, 
McFarland standards are used as a reference to adjust the turbidity of bacterial 
suspensions so that the number of bacteria will be within a given range. Original 
McFarland standards were made by mixing specified amounts of barium chloride and 
sulfuric acid together. Mixing the two compounds forms a barium sulfate precipitate, 
which causes turbidity in the solution. A 0.5 McFarland standard is prepared by 
mixing 0.05 ml of 1.175% barium chloride dihydrate (BaCl2•2H2O), with 9.95 ml of 
1% sulfuric acid (H2SO4). The standard could be compared visually to a suspension of 
bacteria in sterile saline or nutrient broth. 
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Antibacterial Activity 
 The antibacterial activity was determined using the hole-in-plate bio assay 
procedure. The pure cultures of the microorganisms were inoculated onto Muller-
Hilton nutrient broth incubated at temperature of 37°C for 24 hours. Using a sterile 
cork-borer of 5mm diameter, three holes were made into the Petri dishes seeded with 
bacterial culture. Concentrations of 25, 50 and 100µg/ml solution were reconstituted 
in distilled water and transferred into the wells. The plates were incubated at 
temperature of 37°C for 18 hours. S. aureus, E. coli, Salmonella typhi, P.aurigunosa, 
St. pyogenes and Candida albicans were used as the test microorganisms. All 
microbial cultures were maintained on nutrient agar slants at temperature of 4ºC and 
sub cultured onto nutrient agar broth for 24 hours prior to testing.  
 The plates were kept for 30 min at room temperature to allow diffusion of the 
test drug, and then were incubated at temperature of 37º C for 18 hours. After the 
incubation period, the zones of inhibition will be measured using a caliper. Studies 
were performed in triplicates and the mean value was calculated. The mean zones of 
inhibitions were compared by one way analysis of variance.  
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4.3. CLINICAL STUDY 
The study was conducted on Eczema patients to assess the anti-histaminic 
activity of Karunchembai Ilai Chooranam. 
Aim and Objective: 
 To study the pharmacological and adverse effects of the pharmaceutical 
products on humans, in determining the safety and efficacy. 
 To evaluate the Anti-histamine activity of Karunchembai Ilai Chooranam. 
Study centre: 
             The clinical study for Eczema was carried out in outpatients department and 
inpatients ward of Government Siddha medical college hospital and Arignar Anna 
government hospital, Arumbakkam,Chennai-600 106.  
Design of the study: 
Open clinical trial, phase II B  
Selection: 
50 patients from both men and women in the age group of 20-65 years were 
chosen. The selection was based on the including and excluding criteria. They were 
clinically diagnosed on the basis of Siddha  Principles with modern laboratory 
findings. 
Registration process: 
To register a patient, the following documents has been proceeded. 
¾ Copy of required laboratory tests 
¾ Signed patient consent form 
 then  I verified  eligibility and assigned  a study number to the patient, drug dose and 
registered the patient on the study. 
Criteria Selection: 
Inclusion Criteria 
 Itching, Erythema 
 Papules 
 Oedema 
 Vesicles 
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 Crusting 
 Odour 
 Oozing  
Exclusion criteria : 
 Diabetes mellitus 
 Bronchial Asthma 
 Varicose vein  
 Urticaria  
Withdrawal Criteria 
 Patients undergo irregular medications 
 Irregular Visit of the patients 
 Itching not subsided within a week  
 Patient with unrestricted diet  
Among the 50 patients 40 patients were treated as out patients and 10 patients 
were treated as inpatients in Arignar Anna Government hospital of Indian medicine 
and Homeopathy, Chennai – 106. 
Investigation : 
 The patients were undergone routine blood, urine, motion investigations. All 
the patients were diagnosed as suffering from Eczema after the above clinical 
observations and investigations. 
 The duration of treatment ranges between 7-8 weeks according to the severity 
of symptoms.  Clinical investigations were done before and after treatment. 
    The patients were treated with Karunchembai Ilai Chooranam 1gm bd with 
honey. They were observed systematically and symptomatically. 
Routine examination and assessment 
 The full details of history and physical examination of the patients were 
recorded as per the proforma. The clinical assessment was done at regular intervals 
during treatment and at the end of 21 days follow up were done. The laboratory 
investigationand the physiological parameters will be recorded initially and the end of 
the treatment and at follows up as per the Proforma. 
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Dose: 
The trial drug Karunchembai Ilai Chooranam was given in the dose of 1gram 
with honey depending  upon the severity of the case. 
Administration of the drug: 
Form of the drug                                 :      Chooranam 
Route of Administration                     :      Oral  
Dose                                                    :    1 gm 
Adjuvant                                             :  Honey 
Times of Administration                 :     2 times a day 
Life span of medicine                      :     3 months 
 
                                            DIET AND MEDICAL ADVISE 
 Diet to be avoided  
 Diet aggravating the symptoms should be avoided. 
 Egg, sea foods, dry fish and chicken.  
 Brinjal, tomato, bitter gourd.  
 Spicy, acidic, sour fried, oily and greasy food. 
 Drinking tea, coffee, alcohol and smoking.  
 Usage of detergent powder and soap.  
 Usage of synthetic cloth plastics and rubber.    
 Diet to be advised: 
 To drink 3-4 liters of water a day is good. 
 To take greens, leafy vegetables, sweet fruits, nuts, seeds, grains. 
 To take corn, lentils and soya products. 
 To take less salt and less spicy diet.     
Trial conduct: 
 This study will be conducted in compliance with the protocol approved by the 
Institutional Review Board, and according to Good Clinical Practice standards. No 
deviation from the protocol will be implemented without the prior review and 
approval of the IRB except where it may be necessary to eliminate an immediate 
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hazard to a research subject. In such case, the deviation will be reported to the IRB as 
soon as possible. 
Criteria for assessment of response to therapy. 
1. Good Response: 
90% of the symptoms were relieved. 
2. Moderate Response: 
 60% to 80%  of the symptoms were relieved.  
3. Fair Response: 
 20% to 45%  of the symptoms were relieved.  
4. Poor Response: 
Poor relief of symptoms.  
Follow up 
Assessment was taken for every three days before treatment and after 
treatment. During this period clinical assessment and laboratory investigation was 
carried out. 
Statitical analysis 
The data will be tabulated and analyzed by students ‘T’ test. The resuls are 
showed in Table. 
Ethical Review:  
The protocol and any amendments regarding have been submitted to the Govt. 
Siddha Medical College, Chennai-106. Institutional Ethical Committee (IEC) for 
formal approval to conduct the study. All subjects for this study will be provided a 
consent form describing this study and providing sufficient information for subjects to 
make an informed decision about their participation in this study. This consent form 
was also submitted with the protocol for review and it was approved by the IEC. The 
formal consent of a subject, using the IEC-approved consent form, has been obtained 
before that subject was admitted to any study procedure. This consent form was 
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signed by the subject or legally acceptable surrogate, and the investigator-designated 
research professional obtaining the consent. 
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                              CLINICAL STUDY ON KARUNCHEMPAI ILAI 
CHOORNAM FOR ECZEMA 
O.P. No. Name 
Age/ 
Sex 
DATE OF 
FIRST 
VISIT 
Symptoms 
DATE OF 
LAST VISIT 
 
Resu
7518 KALIMUTHU 57/M 18.6.2012 
Itching, erythema,pustules,  oozing present in the extremities
 
5.8.2012    GOO
7540 RENGARAJAN 66/M 18.6.2012 Itching, erythema, oedema present in the extremities  8.8.2012 FAIR
138 GNANASELVAM 65/F 25.6.2012 
Itching,,erythema, pustules, oozing, ulcer present in the 
extremities 
30.8.2012 FAIR
5424 VISWANATHAN 37/M 16.7.2012 Itching, erythema, scaling present in the extremities 7.9.2012 GOO
5462 SAKILA 30/F 16.7.2012 
Itching, erythema,vesicles,  oozing present in the extremities
 
30.9.2012 FAIR
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5504 RAO 64/M 18.7.2012   Itching,,erythema, pustules oozing present in the extremities 10.9.2012 GOO
6207 LENIN 62/M 19.7.2012 Itching,,erythema,oozing present in the extremities 7.9.2012 FAIR
7165 SARADHA 45/F 23.7.2012 Itching, erythema, oedema present in the extremities  3.9.2012 GOO
7259 KARPAGAMBAL 49/F 23.7.2012   Itching,,erythema,oozing, ulcer present in the extremities 30.9.2012 FAIR
7837 AMSA 50/F 25.7.2012 Itching, erythema, oedema present in the extremities 12.10.2012 FAIR
                                                                                                               PG Gunapadam 
 
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
                                                                                                               PG Gunapadam 
 
51 
 
 
 
.  O.P. No.  Name 
Age/ 
Sex 
DATE OF 
FIRST VISIT 
Symptoms 
DATE  OF 
LAST VISIT 
 7932 PUSHPA 47/F 25.7.2012 Itching, erythema, oedema,pustules  present in the  lower extremities 
2.10.2012 
 7965 KATHIRESAN 38/M 28.7.2012 Itching, erythema, scaling, ulcer present in the extremities 4.10.2012 
 8432 MURUGESAN 45/M 2.8.2012 Itching, erythema, vesicles, oozing present in the upper extremities 8.10.2012 
 9254 SAIRA BAANU 52/F 4.8.2012 Itching, erythema present, scaling present in the extremities 12.10.2012 
. 803 ASHA 53/F 6.8.2012 Itching, erythema, oedema, pustules  present in the extremities  3.10.2012 
6.  836 SELVARAJ 52/M 6.8.2012 Itching, erythema, , vesicles present in the extremities  26.10.2012 
7. 1469 SEKAR 48/M 9.8.2012 Itching, erythema, oedema present in the extremities 27.10.2012 
. 2852 NIRMALA 32/F 14.8.2012 
Itching, erythema, scaling,  oozing, ulcer present in the extremities
 
26.10.2012 
9. 4589 RAMESH 35/M 22.8.2012 Itching, erythema, oedema, vesicles present in the extremities  3.11/2012 
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                    4.3.4.CLINAL STUDY ON KARUNCHEMBAI ILAI CHOORANAM  
FOR ECZEMA 
0. 6238 PARIMALA 39/F 1.9.2012 Itching,,erythema, pustules, oozing, ulcer  present in the extremities 5.11.2012 
Sl.No. O.P. No. Name Age/ Sex 
DATE OF 
FIRST 
VISIT 
Symptoms 
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                                4.3.4.CLINICAL  STUDY  ON  KARUNCHEMBAI  ILAI  CHOORANAM    FOR 
ECZEMA 
 
 
 
 
 
 
21. 7215 GANAPATI 69/M 3.9.2012 Itching, erythema, oozing present in the upper extremitie
22. 2755 LATHA 33/F 26.9.2012 Itching, erythema,  vesicles, oedema presentin the extrem
23. 3952 SOUNDHER 60/M 2.10.2012 Itching,,erythema,oozing present in the extremities 
24. 4660 ELUMALAI 49/M 4.10.2012 Itching,,erythema, pustules oozing present in the extremi
        25. 8016 MUTHUSELVAKUM
AR 
32/M 18.10.2012 Itching, erythema present, scaling present in the extremit
         26. 9436 RAJA 35/M 26.10.2012 Itching, erythema, oedema, ulcer presentin the extremitie
  27. 9455 SATHYA 40/F 26.10.2012 Itching, erythema, pustules  presentin the extremities 
28. 9611 SAKTHIVEL 59/F 27.10.2012 Itching, erythema,  vesicles,oedema presentin the extrem
29. 1675 KAMALA 35/F 30.10.2012 Itching,,erythema,oozing, ulcer present in the extremities
30. 1678 RAJESWARI 42/F 6.11.2012 Itching, erythema, scaling present in the extremitie 
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4.3.4.CLINICAL STUDY ON KARUNCHEMBAI ILAI CHOORANAM FOR 
ECZEMA 
 
4.3.7. GENERAL HAEMATOLOGICAL INVESTIGATION 
Sl. 
No. 
O.P. 
No. Name 
Age/ 
Sex HAEMATOLOGICAL REPORT 
Sl. 
No. 
I.P. No. Name Age/ Sex 
                                                                 4.3.8   HAEMATOLOGICAL REPORT 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) BL.SU
TC 
CU/mm 
DC TC 
CU/mm 
DC BT       AT     Hb(Gm) 
BT 
P L E P L E 1 hr 1hr BT AT 
41. 1077/7053 RAJALAKHSMI 52/F 9400 56 32 13 8900 62 36 6 15 14 9.0 9.3 98 
42. 1128/8173 SELVI   37/F 7600 48 46 6 7800 52 43 5 14 13 9.2 10.2 96 
43. 1220/1115 MOHAMMADBAEG   50/M 9700 55 36 5 9450 65 30 5 13 24 10.6 10.6 117 
44. 1231/1419 KAASI 59/M 9200 53 40 7 9200 59 42 5 14 12 10.6 10.8 121 
45. 1317/4312 DHANALAKHSMI 53/F 7600 63 32 5 8000 52 44 4 16 15 12.0 12.4 108 
46. 1399/6626 RAMESH 35/M 9400 58 36 7 9200 60 36 4 15 14 12.0 12.7 98 
47. 1419/7245 SAROJA   43/F 8700 59 35 6 8800 58 39 6 14 13 13.0 13.8 89 
48. 74/1979 PADMAVATHI 65/F 9800 63 31 6 9400 60 33 5 14 14 10.0 10.4 132 
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B.KANI
49. 320/9361 MARY 50/F 9800 64 32 4 8500 52 44 4 12 11 9.0 9.3 127 
50. 349/925 PAMIATH 55/F 9600 57 33 5 9800 58 34 5 12 12 12.0 12.5 124 
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Student 1 2 %
Driver 1 2 %
 
Inference: 
 Among 50 patients, 
  24 %  of the patients were Farmer 
 44 % of the patients were building labourer  
 16 % of the patients were Painter 
 8 % of the patients were House wife 
 2 % of the patients were Tailor. 
 2 % of the patients were Electrician 
 2 % of the patients were Student. 
 2 % of the patients were Driver 
                                  Table 8.Showing Personal Habits 
Personal habit No. of cases Percentage % 
Vegetarian 5 10 % 
Non Vegetarian 45 90 % 
Smoking 12 24 % 
Alcohol 16 32 %  
Inference: 
¾ Among 50 patients, 
¾ 10% of the patients were vegetarian 
¾ 90% of the patients were non vegetarian 
¾ 24% of the patients had smoking habit 
¾ 32 % of the patients were Alcoholic 
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5. RESULTS AND DISCUSSION 
Various studies have been carried out in this trial drug Karunchembai Ilai 
Chooranam. The study includes literary collections, Pharmacognostic study, physico 
and Phyto chemical analysis, toxicological study, pharmacological study and clinical 
study. Karunchembai Ilai Chooranam was taken for the treatment of Eczema. The 
drug has been selected for the treatment of Eczema in reference with Gunapadam 
mooligai vaguppu written by K.S.Murugesa Mudaliyar. 
 Literary collections indicates the efficacy of the drug in the treatment of 
Eczema. Botanical aspect deals with the identification, description, cultivation and 
ethno medicinal importance of the plant.  
Pharmacognostic study: 
Microscopic characters: 
Leaf: 
        The leaf has fairly prominent midrib and thick lamina.(fig.1.1). The midrib is 
plano convex in sectional view with flat adaxial side and semicircular abaxial 
side.(fig.1.2). The midrib is 420 μm thick 380 μm wide. The epidermal cells along the 
abaxial part of the midrib are slightly papillate and thick walled; The cells on the flat 
adaxial side are narrowly rectangular and cylindrical. This is thick vertical segment  
of collenchyma cells on the adaxial median part of the midrib. The abaxial part 
consists of thin walled parenchyma cells. The vascular strand is single, wide and 
thick. These are 7 or 8 rows of short, wide angular xylem elements. Phloem occurs in 
thick are beneath xylem strand. 
Lamina(fig.2.2): 
        The lamina is 150-170 μm thick. It is smooth and even on both adaxial and 
abaxial sides. The lamina is amphistomatic(having stomata on both surfaces). The 
epidermal cells are thick and cylindrical with thin walls. The adaxial epidermis is 20 
μm thick and abaxial epidermis is 12-15 μm thick. The palisade zone consists of a 
single layer of narrowly cylindrical loosely arranged cells. The spongy parenchyma 
cells are spherical or lobed and loosely arranged with air-spaces.(2.2). 
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Leaf-margin:  
        The marginal part of the lamina is 110 μm thick. The margin is semicircular and 
straight. The epidermal cells of the marginal lamina are slightly larger. The mesophyll 
tissue consists of distinct palisade layer and spherical spongy parenchyma. 
            
       Fig.3. T.S. of leaf through midrib                Fig. 4. T.S. of midrib enlarged 
 
                         
           
          Fig.5.T.S. of Leaf Margin                               Fig.6. T.S. of  Lamina 
AbE - Abaxial epidermis,  
AdE - Adaxial Epidermis,  
LM - Leaf margin,  
PM - Palisade Mesophyll,  
SM - Spongy Mesophyll 
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 QUALITATIVE  PHYTOCHEMICAL ANALYSIS 
                Table 9 . 
1. Steroids   + ve 
2. Triterpenes + ve 
3. Glycosides + ve 
4. Saponin + ve 
5. Phenol + ve 
6. Flavonoids + ve 
7. Tannins + ve 
 
PHYSICO - CHEMICAL ANALYSIS 
           Table 10 : 
S.No Parameter Mean Value 
1. Loss on Drying at 105°C 9.498 % 
2. Total Ash  10.173 % 
3. Acid insoluble Ash   0.275 % 
4. Water Soluble Extractive 35.7 % 
5. Alcohol Soluble Extractive 29.9 % 
6. Particle size Completely 
passes through 
sieve no.44 
7. Ph 6.5 
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                                 After spray with Visualizing reagent 
                                                                   
 
 
 
 
 
 
 
 
                                                 Fig.No.7.Showing  Rf Value 
                            Table 11: 
Sl.No After Dipping in Vanillin-Sulphuric acid 
 
Rf value Colour of the spot 
1 0.18 Blue 
2 0.25 Blue 
3 0.32 Grey 
4 0.48 Violet 
5 0.57 Blue 
6 0.62 Violet 
7 0.71 Grey 
8 0.78 Bluish grey 
9 0.94 Violet 
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CHEMICAL ANALYSIS 
Table 12:  
Test for chemicals 
 
Observation Inference 
Reducing sugar 
 
Absence of green/yellow/red 
precipitate 
_ 
Starch 
 
Presence of Violet/purple colour _ 
Protein 
 
Presence of violet colour + 
Amino acid 
 
Absence of yellow precipitate + 
Albumin 
 
Absence of yellow precipitate _ 
Phosphate 
 
Absence of white precipitate _ 
Sulphate 
 
Presence of cloudy white 
precipitate 
_ 
Chloride 
 
Presence of red colour + 
Iron 
 
Presence of white precipitate + 
Calcium 
 
Presence of white precipitate + 
Sodium 
 
Absence of yellow flame _ 
Potassium 
 
Presence of yellow precipitate _ 
Zinc 
 
Absence of white precipitate _ 
Magnesium 
 
Absence of white precipitate _ 
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                                      Fig.8.Showing SEM picture of KIC  
Results:  
  SEM picture shows Nano particle (Micro level) size of the sample.  
  Karunchembai Ilai chooranam have good nano particle size that indicates 
absorption is very good. 
                             
FTIR absorption 
 
                
                              Fig No. Showing FTIR absorption 
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Table 13. Showing FTIR Absorption results 
0Frequency, cm-
1 
Bonds  Functional 
groups 
3344.1 N-H Stretch Anhydrides  
2918.1 O-H Stretch Carboxylic 
acids 
2850 C-H Aldehyde Stretch Aldehydes 
1653 C=C stretch(Isolated) Alkenes 
1419 C-H in plane bend 
O-H bend 
Alkenes 
Carboxylic 
acids 
1256 C-C(O)-Cstretch 
(acetates) 
Esters 
1073 C-O stretch(alkyl) Amines 
668.6 C-Cl stretch Alkyl halides 
 
 
TOXICOLOGICAL STUDY 
Table 10 : Dose finding experiment and behavioural Signs of Toxicity   
No Dose mg/kg 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1. 500 + - - + - + - - - - - - - - - - - - - - 
2 1000 + - - + - + - - - - - - - - - - - - - - 
3 2000 + - - + - + - - - - - - - - - - - - - - 
4 5000 + - - + - + - - - - - - - - - - - - - - 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch Response 7. Decreased Motor 
Activity 8. Tremors 9. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. 
Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. Mortality. 
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  Acute toxicological study reveal that the drug Karunchembai Ilai Chooranam 
does not having any toxic effect  upto 5000 mg/ kg and safety of the drug is recorded 
through the histopathological results of animal model. 
PHARMACOLOGICAL STUDY: 
Antihistaminic activity of Karunchembai Ilai Chooranam 
In isolated guinea pig ileum preparation, a right side shift of dose response 
curve of histamine was observed in the presence of the Karunchembai Ilai 
Chooranam indicating antihistaminic action. It was observed that antihistaminic 
activity in Karunchembai Ilai Chooranam was effective. The resultant antihistaminic 
effect may be caused by the suppression of antibody production and stabilization of 
the mast cell membrane, inhibition of antigen-induced histamine release or non-
availability of antibodies on the mast cell surface. Most allergic and non-allergic 
asthmatics, including those with mild asthma, having bronchial eosinophilia and there 
is significant association between eosinophil activation and asthma severity as well as 
bronchial hyper-responsiveness.  
 The current market is flooded with enormous medicated products for the 
treatment of asthma as it is one of the most common diseases prevailing in the world 
population. These drugs effectively control the incidence of sign and symptoms of 
asthma but none promise to provide a complete relief. Among them antileukotrienes 
are the newest classes of antihistaminic drugs available.  
 Moreover, they are also associated with a number of side effects like kidney, 
liver failure, increased hunger, compromised immune system and high blood pressure. 
The current approaches to the treatment of asthma are mainly focused on anti-
inflammatory drugs such as steroids, bronchodialators and blocking of inflammatory 
mediator. The available treatment for respiratory tract diseases has major limitations 
owing to low efficacy and associated adverse effects. Siddha, an Indian system of 
medicine, has described several drugs for the treatment of bronchial asthma and 
allergic disorders. 
Histamine produces dose dependent contraction of Guinea pig ileum 
preparation. In the present study, Thus, it can be concluded from the results obtained 
the Karunchembai Ilai Chooranam  significantly inhibited (p<0.01) the histamine-
induced contraction of isolated Guinea pig tracheal chain preparation and found to be 
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                                      Fig. 9 Showing Anti-Histamine Activity 
Anti - inflammatory activity of Karunchembai Ilai Chooranam in rats 
An important feature of the formalin test in rodents is that the animal show 
two phases of nociceptive behavior which possibly involves two distinctly different 
stimuli. The first phase starts immediately after injection of the formalin and lasts for 
3-5 min. Evidences show that effect on the opioid receptors is one of the main ways 
involved in exertion of antinociceptive effects in this phase. The most widely used 
primary test to screen new anti-inflammatory agents measures the ability of a 
compound to reduce local edema induced in the rat paw by injection of an irritant 
agent. This edema depends on the participation of kinins and polymorphonuclear 
leukocytes with their proinflammatory factors including prostaglandins.  
 The specific chemical mediators vary with the type of inflammatory process 
and include amines such as histamine, serotonin, lipids such as prostaglandins and 
small peptides such as Kinins.  Formalin-induced pain is caused primarily by 
peripheral tissue inflammation. Acute inflammation may last for relatively shorter 
duration, ranging from few minutes to few days. Exudation of fluid and plasma 
proteins, emigration of leukocytes, and predominantly neutrophils, are characteristic 
changes. The Karunchembai ilai chooranam as well as diclofenac showed 
antiphleogestic activity. It can be assumed that the test drug Karunchembai ilai 
chooranam exert its anti-inflammatory effect through mechanism similar NSAIDs.
 Formalin-induced paw oedema is one of the most suitable test procedures to 
screen chronic anti-inflammatory agents, as it closely resembled human arthritis. The 
nociceptive effect of formalin is also biphasic; an early neurogenic component 
followed by a later tissue-mediated response. The result suggests the usefulness of 
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Karunchembai ilai chooranam in the treatment of inflammation associated diseases 
like arthritis. The pattern of anti-inflammatory activity exhibited by this 
Karunchembai ilai chooranam was similar to that of diclofenac which suggests that 
the activity may be mediated by cyclooxygenase I and II inhibition. This anti-
inflammatory activity was found to be statistically significant (P<0.01) at all the 
concentration used after 120minutes of drug treatment. 
 
  Table 14: Effect of Karunchembai Ilai chooranam on Formalin induced acute 
paw oedema in rats 
Treatment Dose 
(mg/kg) 
Paw volume (mL) 
1 hr 2 hr 3 hr 4 hr 
 
Control 5ml/kg 0.46 ± 0.15 0.72 ± 0.17 0.78 ± 0.14 0.80 ± 0.17 
Diclofenac 
Na 
45mg/kg 0.17 ± 0.04 0.20 ± 
0.05** 
0.20 ± 
0.06** 
0.18 ± 
0.04** 
KIC I 100mg/kg 0.44 ± 0.05 0.40 ± 0.05 0.35 ± 
0.10** 
0.29 ± 
0.10** 
KIC II 250mg/kg 0.37 ± 0.06 0.34 ± 
0.05* 
0.32 ± 
0.05** 
0.25 ± 
0.06** 
KIC III 500mg/kg 0.38 ± 0.05 0.36 ± 
0.06* 
0.32 ± 
0.05** 
0.30 ± 
0.07** 
Values were compared with control; *P<0.05; **P<0.01 was considered as significant 
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:                           
                                    Fig.10.Showing Anti-Microbial Activity 
 
         Table 15: Improvement showing signs & symptoms before and after 
treatment 
Signs & 
Symptoms 
No. of 
cases 
Before 
No. of 
cases After
Improvement Percentage 
Improved  
Itchy 
erythema 
50 -  
50 100% 
Oozing 20 5 15 75.0% 
Papules 5 2 3 60.0% 
Vesicles 10 3 7 70.0% 
Pustules 11 3 8 72.7% 
Scaling 23 4 19 26.1% 
Ulcer 10 3 7 70.0% 
Oedema 20 4 16 80.0% 
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improvement in the subjective parameters produced by Karunchembaii Ilai 
Chooranam is statistically significant 
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6.CONCLUSION 
 The medicinal plant Karunchembai Ilai Chooranam was taken for the 
study mainly to evaluate anti-histamine activity in the treatment of 
Eczema. 
 The drug is easily available and preparation is very simple as per 
evidences about the plant, thus proving the efficacy of the drug in the 
treatment of Eczema. 
 Qualitative analysis proved the presence of Triterpenoid, Flavonoid,  
Tannin, Saponin and Phenols. 
 Presence of Iron increases the Hb production and helps in transport of 
O2 to the tissues also participates in cellular oxidation mechanisms. 
 The trial medicine is less expensive. 
 No any adverse effects has been reported. 
              Hence Karunchembai Ilai Chooranam proves itself as a satisfactorily 
effective drug for Eczema. 
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7.SUMMARY 
 The herb Karunchembai Ilai was collected from Erode Dist., and 
purified then powered and stored and was subjected to various studies. 
 Karunchembai leaves were selected for this study to evaluate the  Anti 
– histamine activity, and to prove its efficacy and safety in Eczema. 
 The Gunapadam aspect expressed that the drug possess good effect on 
Eczema and other skin diseases. 
 Pharmacological study showed significant anti-histaminic activity, 
anti-microbial activity, anti-inflammatory activity. 
 The microbial studies of the test drug proves highly sensitivity to all 
micro organism. 
 Scanning Electron microscope (SEM) the trial drug have good nano 
particle size that indicated absorption is very good and pharmaco 
therapeutic value is good.  
 Qualitative analysis for the trial drug evaluated the presence of 
Triterpenoid, Flavonoid, Saponins,Glycosides, Tannin and Phenol.  
 The clinical study showed improvement in symptoms like itching, 
oozing, erythema, scaling, pustules etc. 
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1.INTRODUCTION 
The name Siddha medicine relates to the earlier esoteric medicinal postulates 
concerning longevity, even immortality, and the later iatrochemical formulations as 
conceived and practiced by 18 Siddhars, located in what is today, the Tamil Nadu. It 
is for this reason, the entire Siddha medical literature is in Tamil. The Siddha alchemy 
came to the fore in India between 500 and 600 CE, and the Siddha medicine between 
900 and 1000 CE. Two millennia old Siddha system received the patronage of tamil 
Kings and Chieftans as well as the general public all through. 
 Minerals, metals, salts, toxic substances and even herbs are classified in the 
Siddha system as male and female, which is reminiscent of the practice in the Latin 
language which ascribes genders to nouns. These substances are also recognised as 
friendly or inimical, probably based on their mutual compatibility or otherwise. The 
Siddha system identifies 120 uparasas, nine metals and nine gems, each requiring an 
elaborate processing, most often by high physical heat before they are considered fit 
for use in a medical composition. The formation of the embryo, physiological 
processes, six rasas, tridhathu, tridosha, curative practices and the like, find rational 
relative theories in Siddha. 
          In the Siddha system, Kaayakalpam has a very conspicuous place. Inherent in 
Kaayakalpam is the belief of the Siddha physicians that the human body consists of 
72,000 veins and nerves, six vital centres, 10 vital airs, and 10 vital pulses. These 
appear to relate to tantrik and yogic concepts. One of the notable characteristics of 
Kaayakalpam is the intake of muppu, the three salts, besides the administration of 
meticulously processed minerals and other rejuvenating compositions, use of potent 
herbal extracts, breathing regulation, conservation of sperm and others. Muppu is 
believed to enhance the efficacy of any Siddha medicine. 
         Nowadays people do suffer from many ailments like urolithiasis, oedema, 
hypertension, ascites due to change in lifestyle, restricted water intake, increased 
intake of spicy, salty fast foods, increased intake of carbohydrate and fat rich foods, 
lake of proper balanced diet etc.., so to the demand of the day and to control the 
ailments, diuretics are the preferable choice.      
         Diuretics are the substances which causes the removal of fluid from the body 
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through urination, more commonly known as “water pills”. The word “diuretic” 
comes from a combination of the greek “dia”-thoroughly, “ourein” to urinate=to 
urinate thoroughly. 
Diuretic therapy are indicated for many diseases such as oedema associated 
with sodium retention (Cardiac oedema, Hepatic oedema, Renal oedema, pulmonary 
oedema, cerebral oedema, oedema of pregnancy and idiopatic oedema), Urolithiasis, 
Hypertension, Ascites etc.., 
             Current treatments as in modern side includes diuretics like Xanthines, 
Thiazides, Acetazolamide, spironolactone, mannitol, glycerol, Isosorbide, 
Triamterene, Amiloride, Frusemide and Ethacrynic acid. 
             The adverse effects of these diuretics include hypokalemia, blood dyscrasias, 
muscle weakness, allergic reactions, metabolic acidosis, vomiting, diarrhoea, 
hyperkalemia, liver and bone marrow changes, cardiac arrest on intravenous 
administration. 
                Nowadays it is our duty to bringout the Siddha medicines to this modern 
world thereby providing effective and humoral based healing to our body which gives 
eternal wellbeing to this mankind. 
                  Thiraavagam means acidic liquid preparations obtained by a process of 
destructive distillation of salts and alkalies with or without any addition of fluids in a 
peculiar distillation setup called valaiyanthiram. Thiraavagam has peculiar properties, 
where little dosage of the drug and its easy absorption will increases the curative 
aspect of the condition to a greater extent. 
                 As per Siddha literature, Ashta gunma thiraavagam made from 
combination of 6 salts will be more effective, less toxic and also till no researches 
have been done on above medicine, here this study deals with Ashta gunma 
thiraavagam on diuretic activity. 
 
 
 
                                                                                                               PG Gunapadam 
 
81 
 
2.AIM AND OBJECTIVES 
Aim 
The Aim of the study is to prove the Diuretic efficacy of  Ashta Gunma 
Thiraavagam. Oedema, Hypertension, Renal calculus etc are some conditions in 
which diuretics are much necessary.  
Synthetic Diuretics such as Loop Diuretics[Frusemide] and Thiazide like 
Diuretics accomplish the demand. These synthetic diuretics cannot be used for long 
term as they produce decrease in concentration of electrolytes which in turn results in 
serious conditions. These diuretics do not contain any active constituents, nutrients or 
any other medicinal or tonic properties to mankind. 
Ashta Gunma Thiraavagam is a drug which enhances elimination of excess body 
fluids as in oedema, ascites etc which are indicated in the literature.  
Hence the Aim of the Study is to test the safety and efficacy of Ashta Gunma 
Thiraavagam for diuretic activity. 
 
Objectives 
  The drug was studied in the following aspects. 
1. Literature reviews. 
2. Chemical Analysis of Ashta Gunma Thiraavagam 
3. Toxicological activity. 
4. Pharmacological activity. 
5. Clinical study. 
6. Statistical analysis of the results. 
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3.REVIEW OF LITERATURE 
3.1.GUNAPADAM ASPECT OF THE DRUGS: 
Vediuppu: 
Synonyms: 
             Pottiluppu, Inangan, padai rasan, poomikoormai, navachara mithru. 
Action: 
           Refrigerant, diaphoretic, diuretic. 
General characters: 
           மல்லாரு மட்டகுன்ம மாதருத ரக்கட்டி 
          கல்லா மைதப்புநƫக் கட்டருக-ெலல்லாேம 
          கம்பிகம்பி ெயன்றுங் கருவுண்டா மங்கிநின்ற 
          கம்பிகம்பி ெயன்றுைரக்குங் கால். 
                                     தாது-சவீ வகுப்பு 
  This cures ulcers, bleeding piles, urinary calculi and burning sensation.  It 
reduces the frequency of pulse, useful in dropsy, small pox, catarrh, acute rheumatism 
and bleeding from lungs. 
Vengaaram: 
Synonyms: 
          Porikaram, karam, urukkinam, urukkumithran, tanganam, thoomathaiadakki. 
Action: 
        Refrigerant, diuretic, lithotriptic, antiseptic, emmenagogue, astringent, alterative. 
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General characters: 
                      ெசாறிபுைடெயண் குன்மநைம ேசாr யாசம் 
           பறிகிரகணி கல்லூனம் பன்ேனாய்-ெநறிையத் 
           தடங்கணங்க பங்கிருமி சƫப்பவிடஞ் சந்ந 
           யிடங்கணங்க லக்கிற்ேபா ெமண். 
                                   தாது-சவீ வகுப்பு 
This cures ulcers, bleeding piles, urinary calculi, skin diseases, puerperal 
convulsions, amenorrhoea and cystitis. 
Navacharam: 
Synonyms: 
        Ishtigai, salligai, sooligai, padu  
Action: 
       Expectorant, diaphoretic, diuretic, cholagogue 
General characters: 
              குன்மம் குடற்சூைல ெகால்லும் மேகாதரத்ைத 
       வன்ைமயுறு கல்லைடப்ைப மாற்றுங்காண்-சன்மக் 
       கவிச்சுமுத் ேதாடங் கனவாத நக்கும் 
       நவச்சார மாேத நவில். 
                               தாது-சவீ வகுப்பு 
     This cures stomachache, ascites, urinary calculi. It stimulates mucosa, relieves 
hepatic congestion, urinary secretion and in dropsy. 
 
Padikaram: 
Synonyms: 
         Padiki, cheenam. 
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Action: 
Astringent, styptic, antiseptic, anti-spasmodic. 
General characters: 
         சனீெமனுங் காரமது சறீிவரு பல்லரைண 
        ஆைனக்கால் கண்ேணாய் அனிலெமாடு-மாநிலத்தில் 
        துன்மாங் கிசம்வாயு ேதாலாத உள்ளழைல 
        குன்மமிைவ ேபாக்குெமனக் கூறு. 
                               தாது-சவீ வகுப்பு 
 This cures filariasis, eye diseases,pallaranai, nethiravayu(eye diseases) and 
ulcers.   
Pooneeru: 
Synonyms: 
         Moorkkan, Tharaninathan, theerkkan, Uvar, Poosarathi, Satthi, savudu. 
Action: 
        Antacid, diuretic 
General characters: 
       கரப்பான் சதீத்ைத கண்டிக்கும் ேபதி 
      யுரப்பாகும் வாயுதைன ேயாட்டும் சுரப்பாகும் 
      உந்திவலி குன்மம் ஒழிக்கும் பூநறனேவ 
      ெசந்தாமைர முகத்தாய் ெசப்பு. 
                       தாது-சவீ வகுப்பு 
This  cures eczema, cold, ulcers and stomach pain. 
 
 
                                                                                                               PG Gunapadam 
 
85 
 
Savukkaram: 
Action: 
        Demulcent, disinfectant.General characters: 
             காƫேமகத் துƫப்பைடயும் கட்டிக் கரப்பனுடன் 
        காƫேமக வூறற் றழும்பலரும்-ேசƫேமகத் 
        ெதாட்டி வரும்நகத்தி னூற லகற்றிவிடும் 
        கட்டிச் சவுக்காரங் காண். 
                           - பதாƫத்தகுண விளக்கம் 
This is used externally for karumpadai, katti, scabies, eczema and itching of 
the genital region. 
Preparations: 
Pancha lavana parpam: 
Drugs: 
          Common salt-sottruppu- 35 gms 
          Rock salt-      Indhuppu- 35 gms 
          Salt petre-     Vediuppu-   35 gms 
          Borax     -    Venkaram-  35 gms 
          Alum     -      Padikaram- 35 gms 
          Karpoora silasathu- 175 gms 
          Acalypha juice- sufficient quantity 
Process: 
Grind the mixture of the above said salts.Along with it add acalypha juice and 
grind it for 12 hours and calcine with cow dung cakes. 
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Dose: 
         8 to 16 kunri with chukku kudineer, lemon juice and seeraka kudineer. 
Indications: 
        Indigestion, ulcer, stomach ache. 
                                                 Sanka Thiraavagam  
Drugs: 
          Salt petre- vediyuppu   - 12 parts 
          Rock salt- Induppu   - 8 parts 
          Common salt- sotruppsu  - 4 parts 
          Sal ammoniac- Navacharam  - 10 parts 
          Green vitriol- Annabhedi  - 1 part 
          Blue vitriol- Thurusu   - 1 part 
          Common alum- Padikaram  - 1 part 
          Salt from alkaline earth- Pooneeru - 3 parts 
          Borax- venkaram   - 4 parts 
Process:  
       Powder the drugs separately and mix. Charge in a glazed earthern still  and distill 
. The condensate is acidic and should be collected in porcelain ,enameled or glass 
containers. 
Indications 
       Ascitis, enlargement of liver and spleen, colic and spasmodic pains in the 
abdomen and chest . 
Dose 
         1 to 5 drops with sombu theeneneer or water twice ,daily. 
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 Vediuppu cheyaneer 
Indications- Anuria, renal calculi, retention of urine, burning micturition. 
 
 Vediuppu kattu 
 
          Indications- stomach ache, retention of urine, ulcers. 
 Padikara chunnam 
 
Indications- myocele, retention of urine, renal calculi. 
 Pooneeru cheyaneer 
 
Indications- stomach ache, ulcers, uterus problems. 
 Savukkara chunnam 
Indications- ulcers, indigestion. 
 
 Navacharathi kuzhambu 
 
Indications- Ascites, jaundice, anaemia. 
 
 Venkaara mezhugu 
 
Indications- anuria, retention of urine. 
 Aaruppu cheyaneer 
 
  Indications- indigestion, gastric problems. 
 Maha thiraavagam 
 
Indications- ulcer,indigestion, retention of urine, ascites, anemia. 
 Pancha pootha chenduram 
  
Indications- Fistula, cough, tuberculosis. 
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 Thiripurathi chenduram 
 
Indications- bronchial asthma, soolaikattu, vadha disease. 
 Neela kanda paalai 
 
Indications- 18 types of soolai, scabies. 
 Lavana kuzhambu 
 
Indications- Ascites, anemia, jaundice. 
3.2.MODERN ASPECT OF THE DRUG: 
Potassium nitrate: 
Vernacular names: 
            Tamil  : pottiluppu 
            Sanskrit : surakshara 
            Telugu  : surekaramu 
            Kannada : patluppu 
            Malayalam : vediyuppu 
            Hindi  :           sarakalmi 
                Potassium nitrate (also known as nitre and saltpeter; KNO3, mp 
334degreeC) is manufactured by the following methods: 
i) Lixiviation of earth containing nitre 
ii) Fractional crystallization of an aqueous solution of sodium nitrate (Chile 
saltpeter) and potassium chloride 
iii) Action of dilute nitric acid on potassium chloride, and  
iv) Reaction of potassium chloride with ammonium nitrate. 
The first method is widely used in India. The second method is commonly used all 
over the world. 
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 Potassium nitrate occurs as a natural efflorescence on soils over extensive 
areas in Bihar, Punjab and Uttar Pradesh. 
Properties and uses: 
 Potassium nitrate forms colourless transparent prisms, or a white powder. It is 
odourless, has a saline taste and produces a cooling sensation in the mouth. It is easily 
soluble in hot water and much less in cold, and almost insoluble in alcohol. It is an 
important fertilizer and is particularly suited for tea plants. Other minor applications 
are in the manufacture of certain types of glass and ceramic glazes, and in meat 
curing, freezing mixtures, impregnating candle wicks, heat treating of steel. It is also 
used as a saline diuretic. 
Common alum 
Vernacular names: 
     Tamil                :         padikaaram 
     Sanskrit            :         sphatika 
     Telugu,kannada:         padikaaram 
     Hindi                :         phatkari 
                  Alums are represented by the general formula R2SO4, R2’’’(SO4)3. 
24H2O, where R and R ‘’’ are respectively monovalent and trivalent positive radicals, 
Potash alum is the common alum. Ammonia alum, chrome alum, ferric alum and soda 
alum find occasional uses. 
Solutions of alums coagulate proteins and precipitate them; they harden 
gelatin.  
             In industry, alum is used for the same purposes as aluminium sulphate, and is 
largely replaced by the latter which is cheaper. Alum is also used in manufacture of 
matches to impregnate the untipped ends to render them fire-proof, burnt alum is used 
by taxidermists as a preservative. 
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Medicinal uses: 
                It is used as an astringent and as a gargle, and externally as a styptic. 
Exsiccated alum is used as a dressing for ulcers and sores and as an astringent for 
swollen gums. 
Borax: 
Vernacular name: 
       Tamil :        Venkaaram 
       Sanskrit :        Tankana 
       Telugu :        Veligaram 
       Kannada :        Biligaara 
       Malayalam :        Pongaaram 
       Hindi :        Tincal  
            Borax occurs in the form of large transparent monoclinic prisms, often dulled 
on the surface (sp.gravity-1.69 to 1.72). It is sparingly soluble in cold water, but is 
more soluble in hot water. 
          Borax is the most important polyborate. These were apparently regions of 
volcanic activity in the past, and boron was transported to the surface by host springs 
or steam in the form of boric acid. There the acid combined with surface rocks such as 
carbonates or satins and was converted into alkali or alkaline earth metal borate. If 
this activity occurred in an arid region the water soon evaporated after borate 
formation leaving immense beds of borate salts. 
 Its chemical name is sodium borate, or sodium tetraborate. Exposure to moist 
air causes crystals to cluster, for which reason most people think of borate in terms of 
powders, water softeners, soap. Use of various forms of boron in medicine and 
eyewash probably goes back to Hippocrates himself. 
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Structure:                    
       H 
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                       O          B             O 
HO         B                     O                      B            OH 
                         O           B           O 
 
                                      O 
                                      H 
                                  Na2B4O7.10H2O 
 
The latest calculations have it that in the construction of the serine amino acid 
and nature’s directed protein, the DNA-RNA code calls for 15,198,623 transactions 
using boron during protein construction. In the first instance, rate of fission is 
controlled by the depth of boron rods in the reactor; in the second, by the presence or 
absence of boron in the human metabolic function 
  Boron is required in trace amounts for healthy bones and muscle growth. The 
genome code in its paper record said to be as high as the Washington Monument, has 
held that ACGT language in escrow for all who wish to follow every phase of the 
human body’s functions.  
Uses: 
¾ Organic boron assists in the production of natural steroid compounds.  
¾ Boron is mandated for the metabolism of calcium, phosphorus and 
magnesium. 
¾ First-rate research points to enhanced brain function when boron is in 
adequate supply. 
¾ In Minerals for the Genetic Code, boron comes off as one of four magnificent 
minerals— the other three being iodine, selenium and magnesium — that 
belong in the survival kit of most people in most parts of the country. 
¾ Boron plays a part in the body’s sugar metabolism equation. .  
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¾ The official assessment is that people are not generally deficient in boron 
because most people consume foods that contain it. Such a statement may be 
evasive. It loops elderly people in with the mass population. In fact, it borders 
on elder abuse when boron supplementation is withheld. Usually older people 
have problems with absorption. There’s the oft-noted fact that old people in 
rest homes are deprived of vitamin D, the sunshine vitamin.  
¾ Vitamin D deficiency is enlarged when boron deficiency is a reality, 
recognized or not. 
¾ USDA research reveals that 3 milligrams of boron supplemented each day 
drastically reduces calcium loss, by 40 percent in approximately a week.  
¾ The amino acid that connects with boron on the Olree Standard Genetic 
Periodic Chart is serine.  
 
Fullers earth: 
          
 Fuller’s earth is characterized by the absence of plasticity, high water content 
and foliated structure; dehydrated samples show a tendency to adhere strongly to the 
tongue. Montmorillonite [(Mg,Ca)O.Al2O.A12O3.5SiO2.nH2O] is a dominant, 
though not essential, constituent of most fuller’s earths; beidellite [Al2O3.3SiOH20] 
is the dominant clay mineral in some of them. The ratio of silica to aluminium varies 
from 4 to 6 in earths of good quality, which also contain a relatively high proportion 
of hydrous silica.  
Indian fullers’ earth consists of well-bedded, non-arenaceous, unctuous clay or 
shale, varying in colour from cream to yellow, yellowish brown, buff, greenish grey 
or light grey. It is essentially a hydrated aluminium silicate with lime, magnesia and 
iron oxide as impurities; it contains a large proportion (up to 30%) of water. It is soft 
when freshly excavated, but hardens appreciably on exposure to the atmosphere. 
Uses: 
          Fuller’s earth is extensively employed in refining oils, greases and lard. 
Practically all liquid fractions of petroleum, including crude naphtha, crude kerosene 
and shale oil, are clarified by treatment with fuller’s earth. It is used as a carrier for 
pigments, size for textiles, poultice for skin eruptions, substitute for talcum powder, 
filler for paper and soap, and conditioner for foundry sands. Selected soft grades are 
                                                                                                               PG Gunapadam 
 
93 
 
incorporated in compositions used in pencil manufacture. It is used in the laboratory 
for the detection of colouring matter added to butter, whisky, etc. 
 Fuller’s earth has been employed in India as a substitute for soap in washing 
clothes and hair 
Ammonium chloride: 
Vernacular names: 
            Tamil  :  Navacharam 
            English : Sal Ammoniac 
Arab  : Armina 
Ben  : Navasagara, Nishadal 
Hindi  :  Navasadara 
Guj & Mah :  Navasagar 
Burm  :  Lovas, Zarasa 
 Ammonium chloride, NH4Cl3, commonly known as sal ammoniac, in a white 
crystalline solid with a fibrous structure. It is odourless and has a saline taste. It is 
slightly hygroscopic and is readily soluble in water. When heated, it volatilizes. 
Uses: 
 Ammonium chloride is used in galvanizing, in dyeing and calico-printing and 
in the manufacture of Leclanche cells and dry batteries. It is employed as a soldering 
flux, and in electroplating. In medicine, the salt is used as an expectorant, diaphoretic 
and diuretic, and in inhalations. 
 The salt is generally not used as fertilizer, as it is likely to increase the total 
chlorine content of the soil when other fertilizers like potassium chloride are also 
employed. In other cases it is as effective as the sulphate, but it is slightly more 
expensive. A fertilizer grade of synthetic ammonium chloride contains N, 24 per cent. 
 Ammonium chloride is more effective for grain crops than for root crops. 
When applied to barley, the grains contain a lower percentage of nitrogen than when 
ammonium sulphate is used, which raises its malting and money value. 
            Ammonium chloride is usually produced by passing ammonia gas into 
hydrochloric acid, or by neutralizing ammoniacal liquor with hydrochloric acid. The 
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salt is purified by crystallization from water, or by sublimation. A very pure product is 
obtained by mixing gaseous ammonia and hydrogen chloride diluted with hydrogen 
maintaining the temperature at 230-310 degrees. 
                                        3.2 SIDDHA ASPECT OF THE DISEASE 
Kalladaippu: 
Synonym: Achmari 
Definition: 
      This disease is characterized by intermittent cessation of urine, pain at the tip of 
the penis, burning micturition, backache and small pebbles found in the urine. 
Aetiology:  
 Drinking of stagnant water 
 Carbohydrate diet 
 Excess intake of vadha food 
Classification: 
          It is classified into 4 types. They are 
 Vadha kalladaippu 
 Pitha kalladaippu 
 Kapha kalladaippu 
 Mukktra kalladaippu 
General symptoms: 
 Frequency of urination 
 Intermittent cessation of urine 
 Pricking pain of penis 
 Inflammation of penis 
 Irritation of bladder and lower abdomen 
 Haematuria 
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Oothal noi: 
Synonyms: 
            Thommai noi, sokai noi, sobai noi. 
Definition: 
This disease is characterized by anaemia and pallor, also the upper and lower 
extremities, face and abdomen distends against normal. This is called as ‘oothal’ 
disease. Since the patient feels so grieviance, this is called as ‘sogai’. Since anasarca 
is present, this disease is called ‘veekam’. 
Aetiology: 
 Follows anemia 
 Toxicosis 
 Food variants 
 Dysfunctioning of paravukaal 
 Sittha pramai sanni 
 Snake bite 
 Hilly residence 
 Damp and marshy areas 
 Pick’s disease 
Pre monitory symptoms: 
 Emaciation 
 Oedema 
 Exhaustion 
 Dyspnoea 
 Headache 
 Fainting 
 Oedema of lower extremities, face and abdomen 
 
 
                                                                                                               PG Gunapadam 
 
96 
 
Classification: 
          This is classified into 4 types. They are 
 Vadha oothal noi 
 Pitha oothal noi  
 Kapha oothal noi 
 Mukktra oothal noi 
General symptoms: 
 Anorexia 
 Exhaustion 
 Hydrocele 
 Thickness of the ear pinna 
 Hearing impairment 
 Squint 
 Pallor 
 Dyspnoea 
Diuresis: 
          A diuretic is any substance which increases urine and solute excretion. 
Diuretics are normally required to remove oedema fluid which is composed of water 
and solutes of which sodium is the most important. 
         Most clinically useful diuretics are organic anions and are transported from the 
blood, through the tubular cells and into the tubular fluid. 
Sites and mode of action:  
         As a result of active reabsorption of sodium chloride and sodium bicarbonate 
from the renal tubular lumen and passive reabsorption of accompanying water, 65% 
of the glomerular filtrate is reabsorbed iso-osmotically from the proximal tubule. The 
epithelium of the proximal tubule is described as leaky because of its free 
permeability to water and a number of solutes. 
         Osmotic fluids such as mannitol are solutes which are not reabsorbed  in the 
proximal tubule  and therefore carry into the urine equivalent volumes of fluid. The 
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physiological changes are best understood by considering first the ascending limb.In 
the thick segment chloride ion is transported actively from the tubular fluid taking 
with it sodium ion but not water, to which this part of the tubule is impermeable. 
        In consequence the tubular fluid becomes dilute, the interstitium becomes 
hypertonic and fluid in the descending limb which is permeable to water becomes 
more concentrated as it approaching the tip of the loop, because the hypertonic 
interstitial fluid sucks water out of the tubule. 
       Diuresis may also achieved by extra-renal mechanisms by raising the cardiac 
output and increasing renal blood flow.eg. with dobutamine and dopamine. 
Moderate efficacy diuretics: 
(Thiazide and related diuretics) 
       Thiazides raise potassium excretion to an important extent. It lowers blood 
pressure, chiefly due to reduction in intravascular volume but probably also to 
reduction of peripheral vascular resistance, for in chronic use they diminish the 
responsiveness of vascular smooth muscle to noradrenaline. 
       Thiazides are generally well absorbed from the gut and most begin to act within 
an hour. There are numerous derivatives and differences lie principally in duration of 
action. The relatively water soluble eg.cyclopenthiazide, chlorothiazide, 
hydrochlorothiazide are most rapidly eliminated, their peak effect occurring within 4 
to 6 hours and passing off  by 10 to 12 hours. 
       Adverse effects results in rashes. Long term treatment with thiazide type drugs 
causes total serum cholesterol to increase by about 7%. 
       Chlorthiazide acts for 48 to72 hours after a single oral dose. 
       Xipamide is structurally related to chlorthialidone and to frusemide. It induces a 
dieresis for about 12 hours that is brisker than with thiazides which may trouble the 
elderely. 
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Low efficacy diuretics: 
      Trimaterene(dytac) is a potassium sparing diuretic which has an action and use 
similar to that of  aminolide . The diuretic effect extends over 10 hours. 
Gastrointestinal upsets occur. Reversible , non-oliguric  renal failure may occur when  
triamterene is used with indomethacin(and presumably other NSAIDS). 
Osmotic diuretics: 
      Osmotic diuretics are small molecular weight substances that are filtered by the 
glomerulus but are not reabsorbed by the renal tubule and that  increases the 
osmolarity of the tubular fluid. Mannitol-a polyhydric alcohol is most commonly 
used.It is given in addition to its effect. It encourages the movement of water from 
inside cells to the extracellular fluid. 
3.3 MODERN ASPECT OF THE DISEASE 
Urolithiasis 
Definition 
       Urinary calculi consists of aggregates of crystals and small amounts of proteins 
and glycoprotein. 
Types according to the chemical constituent: 
 Oxalate calculus 
 Phosphate calculus 
 Uric acid and urate calculus 
 Cystine calculus 
 Xanthine calculus 
 Indigo calculus 
Types according to the site: 
 Renal calculus 
 Ureteric calculus  
 Vesical calculus 
 Prostatic calculus 
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 Urethral calculus 
Clinical features: 
 Pain in the loin which radiates round the flank to the groin and often into 
the testis or labium. 
 Pallor, sweating and often vomiting. 
 Frequency, dysuria and hematuria may occur. 
Investigations: 
 Radiography 
 Intravenous urography 
 Cystoscopy 
 Retrograde pylography 
Hypertension : 
Definition: 
Systemic hypertension is the persistent rise of basal blood pressure above the 
arbitrary level of 150/90 mmhg recorded on three or more successive occasions. 
Hypertension may be systemic or pulmonary. 
Classification of hypertension: 
• Essential or Idiopathic hypertension 
• Secondary or Symptomatic hypertension 
 Renal cause-chronic nephritis, polycystic kidney, hydronephrosis, 
chronic pyelonephritis. 
 Endocrine cause-thyrotoxicosis, myxedema, acromegaly, cushings 
syndrome, primary aldosteronism, phaeochromocytoma. 
 Metabolic cause-diabetes mellitus, chronic gout, toxaemias of 
pregnancy. 
 Drugs-contraceptives pills, steroids, liquorice. 
Clinical features: 
 Headache, often occipital and occurs particularly in the morning. 
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 Easy fatiguability. 
 Insomnia 
 Dizziness 
 Lack of concentration 
 Loss of memory 
 Occasional palpitation 
Investigations: 
 ECG 
 X-ray of the chest 
 Echocardiography 
 Ultra sonogram 
Oedema: 
Definition: 
 Oedema is a collection of excess fluid in the body interstitium, from the 
intravascular compartment. 
 Classification of oedema: 
Generalized oedema: 
 Cardiac oedema 
 Renal oedema  
 Hepatic oedema 
 Nutritional oedema 
 Idiopathic 
Localized oedema: 
 Venous oedema 
 Lymphatic oedema 
 Inflammatory oedema 
 Allergic oedema 
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 Pitting and Non-Pitting oedema: 
 Cutaneous edema is referred to as "pitting" when, after pressure is applied to a 
small area, the indentation persists for some time after the release of the 
pressure. Peripheral pitting edema, as shown in the illustration, is the more 
common type, results from water retention. It can be caused by systemic 
diseases, pregnancy in some women, either directly or as a result of heart 
failure or local conditions such as varicose veins thrombophlebitis, insect 
bites, and dermatitis. 
 Non-pitting edema is observed when the indentation does not persist. It is 
associated with such conditions as lymphedema, Lipoedema and myxedema. 
Clinical features according to various causes: 
 Ankle swelling is characteristic , but oedema develops over the sacrum 
in bed-bound patients. 
 Ascites is common and often an earlier feature in children or young 
adults, and in liver disease. 
 Pleural effusions are common and can be a feature of any cause of 
generalized oedema 
 Facial oedema on waking is common in adults with low oncotic pressure 
oedema 
 Features of intravascular volume depletion(tachycardia, postural 
hypotension) may occur when oedema is due to decreased oncotic 
pressure or increased capillary permeability. 
Investigations: 
 Liver function tests,Renal function tests 
 Complete hemogram 
 Serum electrolytes,Ultra sonogram of abdomen 
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 4. MATERIALS AND METHODS 
Materials: 
  Ashta Gunma Thiraavagam has been selected from the classical siddha 
literature, “Anuboga Vaithya Navaneetham”.Ingredients of the test drug are Salt petre, 
Alum, Borax, Sal ammoniac, Alkaline earth salt and savukaram. 
Purification of  the raw drugs: 
Salt petre (Potassium nitrate) 
        The drug is soaked in lemon juice, then its dried in sunlight until the moisture 
content is lost. 
Common Alum 
         The lumps are dissolved in pure water, filtered and allowed to boil in a pan. 
When it attains thicky molten consistency, it is allowed to cool. 
Borax 
         It is allowed to heat on a pan to complete dehydration. 
Sal ammoniac 
        It is grinded with cow’s urine and allowed to dry. 
Alkaline earth salt 
       The salt is dissolved in 4 times of fresh water, stirred well, allowed to remain for 
sometime decant the clear supernatant liquid in flat porcelain vessels, then it is 
allowed to boil till all the moisture evaporates. The earthy portions were discarded. 
The dried quintessence thus got above is subjected to the same process ten more 
times. 
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            Fig.1.Showing Purified Vediuppu        Fig.Showing Purified Padikaram 
 
 
 
 
 
 
                                
      Fig.3.Showing Purified Vengaaram               Fig.4.Showing Purified Navacharam       
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     Fig.5.Showing  Purified Pooneeru                         Fig.6.Showing Purified  
             Savukaaram 
 
 
                                                               
                                              Fig.7.Showing  Ashta Gunma Thiraavagam 
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4.1.Preparation of Ashta Gunma Thiraavagam 
Ingredients: 
          Purified Salt petre (Potassium nitrate)   -280 gms 
          Purified common Alum     -105 gms 
          Purified Borax(Sodium biborate)   -21 gms 
          Purified Alkaline earth salt    -10.5 gms 
          Purified Sal ammoniac(Ammonium chloride) -10.5 gm 
          Purified  Savukaram(Sapo mollis)  -8.4 gms 
Process: 
 The salts were grinded well and transferred to the Valaiyanthiram made of 
earthern distillation set up and intensely heated . During the process of heating the 
salts decompose  completely releasing the acidic fumes and then they get condensed 
at the condenser submerged in cold water and collects at the receiver vessel kept 
adjacently. Then, it is stored in air tight glass containers. 
Administration of the drug: 
    Form of the drug :  Liquid (Thiraavagam) 
    Root  : Enteral (Oral) 
    Dose  : 8 drops 
    Adjuvant  : Nerunjil ver kudineer  
     Duration  :  3 to 4 weeks 
Nerunjil(Adjuvant): 
Botanical name :Tribulus terrestris  
Vernacular names: 
Tamil             :  Thirigandam, Nerunjiputhum, Asuvasattiram, Kaamarasi. 
English :  Small caltrops, Land caltrops 
Hindi             :  Gakhru 
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Telugu             :  Palleru 
Malayalam :  Nerunji 
Description: 
 It is a prostrate herb of thorn variety. The thorn of this plant resembles the 
horn of cow. It has yellow flowers. 
Part used :  Whole plant 
Suvai             :  Astringent, sweet 
Thanmai :  Seetham 
Pirivu              :  Inippu 
Action                          : Diuretic 
     :Refrigerant 
     :Demulcent 
      :Tonic 
      :Astringent 
General Characters: 
  நல்ல ெநருஞ்சிலது நாளுங்கி rச்சாரத்ைத 
      வல்ல சுரமனைல மாற்றுங்காண்-ெமல்லியேல! 
      மாநிலத்தில் கல்லைடப்பும் வாங்காத நƫக்கட்டும் 
      கூனுறுெமய் வாதமும்ேபாக் கும். 
       -அகத்தியƫ குணவாகடம். 
Uses: 
 Oliguria 
 Renal calculi 
 Anuria 
 Leucorrhoea 
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 Burning micturition 
 Fever 
 
4.2.STANDARDISATION OF THE TEST DRUG 
4.2.1.Chemical analysis: 
Preparation of extract of test drug: 
Add 5 ml of the Ashta Gunma Thiraavagam to 50ml of distilled water. Boil the 
solution for 20 minutes, cool and then filter. Use the Extract for the followingtests. 
  Table 1:Chemical analysis 
S.No Experiment Observation Inference 
1. Test for reducing Sugar : 
To 5ml of Benedicts qualitative 
reagent, add 10 drops of extract, 
then boil for two minutes 
Absence of Green / 
Yellow / Red 
precipitate  
Absence of 
Reducing Sugar 
2. Test for Starch : 
To 5 ml of extract add 2ml of 
acetic acid and then add few drops 
of N/50 Iodine Solution. 
Absence Blue 
Colour 
Absence of 
Starch 
3. Test for Proteins : 
To 2 ml of extract, add 2ml of 5% 
Sodium Hydroxide mix and add 2 
drops of Copper Sulphate 
Solution. 
Absence Violet or 
Purple Colour 
Absence of 
Proteins 
4. Test for amino Acid : 
Place 2 drops of extract on a filter 
paper and allow to dry well. Then 
spray 1% ninhydrin over the same 
and allow to dry. 
Absence Violet 
Colour 
Absence of 
Amino Acid 
5. Test for Albumin : 
To 2 ml of extract, add 2ml of 
Esboch’s reagent. 
Absence Yellow 
precipitate 
Absence of 
Albumin 
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6. Test for Phosphate : 
To 2ml of extract, add 2ml of 
ammonium Molybdate solution 
and 2ml of concentrated Nitric 
Acid. 
Presence of Yellow 
precipitate 
Presence of 
Phosphate 
7. Test for Sulphate : 
To 2 ml of extract add 2ml of 4% 
ammonium oxalate solution. 
Presence of White 
precipitate 
Presence of 
Sulphate 
8. Test for Chloride :  
Add 2ml of extract to dilute nitric 
acid till the effervescence ceases. 
Then add 2 ml of Silver Nitrate 
Solution. 
Presence of Cloudy 
White precipitate 
Presence of 
Chloride 
9. Test for Iron : 
To 2ml of extract, add 2ml of 
ammonium thio cynate solution 
and add 2ml of concentrated Nitric 
Acid. 
Presence of Red        
Color 
Presence of Iron 
10. Test for Calcium : 
To 2 ml of extract, add 2 ml of 4% 
ammonium Oxalate Solution. 
Presence of White 
precipitate 
Absence of 
Calcium 
11. Test for Sodium : 
Make a paste with 2 pinches of the 
sample with Hcl and Introduce it 
into the blue flame.  
Absence of Yellow 
Flame 
Absence of 
Sodium 
12. Test for Potassium : 
Add a pinch of the sample to 2 ml 
of Sodium Nitrate Solution. Then 
add 2ml of Cobal Nitrate in 20% 
acetic acid. 
Presence of Yellow 
precipitate 
Presence of 
Potassium 
13. Test for Zinc : 
To 2ml of extract, add few drops 
of Sodium Hydroxide. 
Absence of White 
precipitate 
Absence of Zinc 
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14. Test for Magnesium : 
To 2ml of extract, add few drops 
of Sodium Hydroxide Solution 
Absence of White 
precipitate 
Absence of 
Magnesium 
15. Test for Alkaloids : 
a. To 2ml of extract, add 2ml 
of Potassium Iodide 
Solution 
 
b. To 2ml of extract add 2ml 
of Picric Acid. 
 
c. To 2 ml of extract add 2ml 
of Phosphotunqstic Acid. 
 
 
Absence of Red 
Colour 
 
Absence of Yellow 
Colour 
 
Absence of White 
ppt 
 
Absence of 
Alkaloids 
 
Absence of 
Alkaloids 
 
Absence of 
Alkaloids 
16. Test for Tannic Acid : 
To 2ml of extract add 2 ml of 
Ferric Chloride Solution 
Absence of Black 
ppt 
Absence of 
Tannic Acid 
 
4.2.2..PHYSICOCHEMICAL ANALYSIS OF THE TEST DRUG: 
SCANNING ELECTRON MICROSCOPE: 
The Scanning Electron Microscope (SEM) is a microscope that was electrons 
rather than light to form an image. There are many advantages to using the SEM 
instead of a light microscope. 
Resolution : 1.2 nm gold particle separation on a carbon substrate 
Magnification : From a min of 12 x to greater than 1, 00,000 X 
The SEM has a large depth of field, which allows a large amount of the 
sample to be in focus at one time. The SEM also produces images of high resolution, 
which means that closely spaced features can be examined at a high magnification. 
Preparation of the samples is relatively easy since most SEM one require the sample 
to be conductive. 
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The combination of higher magnification, larger depth of focus, greater 
resolution, and easy of sample observation marks the SEM one of the most heavily 
used instruments in research areas today. 
FOURIER TRANSFORM INFRARED SPECTROSCOPY (FTIR): 
Instrument details: 
Model   :  Spectrum one: FT-IR Spectrometer  
Scan Range   :  MIR 450-4000 cm-1  
Resolution   :  1.0 cm-1  
Sample required :  50 mg, solid or liquid. 
 Fourier Transform Infrared Spectroscopy (FTIR) is an analytical technique 
used to identify mainly organic materials. FTIR analysis results in absorption spectra 
which provide information about the chemical bonds and molecular structure of a 
material. The FTIR spectrum is equivalent to the "fingerprint" of the material and can 
be compared with cataloged FTIR spectra to identify the material. 
Infrared spectrum is useful in identifying the functional groups like -OH, -CN, 
-CO, -CH, -NH2, etc. Also quantitative estimation is possible in certain cases for 
chemicals, pharmaceuticals, petroleum products, etc. Resins from industries, water 
and rubber samples can be analyzed.  
The drug sample was analyzed by the FTIR to identify the chemical bonds and 
molecular structure of a material. 
 
4.2.3.TOXICOLOGICAL STUDY 
Acute and sub acute toxicity study on Ashta Gunma Thiravagam in rodents 
Animals:  
 Mice of either sex weighing 25-30g and rats weighing 210-240g were 
obtained from the animal house of Vels University. The animals were used with the 
approval of the Institute animal ethics committee and obtained from Vels University, 
Chennai. They were fed with a balanced standard pellet diet and maintained under 
standard laboratory conditions, providing 24-280C temperature, standard light cycle 
(12 h light, 12 h dark) and water ad libitum. Animals were kept in cages with raised 
floors of wide mesh to prevent coprophagy. Animal welfare guidelines were observed 
during the maintenance period and experimentation. The rats were randomly assigned 
                                                                                                               PG Gunapadam 
 
111 
 
to control and different treatment groups, six animals per group. The animals were 
acclimatized for one week under laboratory conditions.  
Acute toxicity study: 
 Acute oral toxicity test for the Ashta Gunma Thiravagam was carried out as 
per OECD Guidelines 425. As with other sequential test designs, care was taken to 
ensure that animals are available in the appropriate size and age range for the entire 
study. The test substance is administered in a single dose by gavage using a stomach 
tube or a suitable intubation cannula. The fasted body weight of each animal is 
determined and the dose is calculated according to the body weight. After the 
substance has been administered, food was withheld for a further 2 hours in mice. The 
animals were observed continuously for the first 4 h and then each hour for the next 
24 h and at 6 hourly intervals for the following 48 h after administering of the test 
drug, to observe any death or changes in general behaviour and other physiological 
activities. Single animals are dosed in sequence usually at 48 h intervals. However, 
the time interval between dosing is determined by the onset, duration, and severity of 
toxic signs. Treatment of an animal at the next dose was delayed until one is confident 
of survival of the previously dosed animal.  
Observation of toxicity signs:  
General behaviour, respiratory pattern, cardiovascular signs, motor activities, 
reflexes, change in skin and fur, mortality and the body weight changes were 
monitored daily. The time of onset, intensity, and duration of these signs, if any, was 
recorded.  
Sub-acute toxicity:  
 In a 28-days sub acute toxicity study, twenty four either sex rats were divided 
into four groups of 6 rats each. Group I that served as normal control was 
administered with distilled water (p.o.) while groups II, III and IV were administered 
daily with the Ashta Gunma Thiravagam (p.o.) for 28 days at a dose of 0.1, 0.2 and 
0.4ml/kg respectively. The animals were then observed daily for gross behavioural 
changes and any other signs of sub-acute toxicity. The weight of each rat was 
recorded on day 0 and weekly throughout the course of the study, food and water 
consumption per rat was calculated. At the end of the 28 days they were fasted 
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overnight, each animal was anaesthetized with diethylether, following which they 
were then dissected and blood samples were obtained by cardiac puncture into 
heparinised tubes. The blood sample collected from each rat was centrifuged with 
3000 X g at 4oC for 10 min to separate the serum and used for the biochemical assays.  
Hematological and blood biochemical analyses 
At the end of the study, all animals were kept fasted for 16-18 h and then 
anesthetized with anaesthetic ether on the 28th day. Blood samples for hematological 
and blood chemical analyses were taken from retro orbital vein. Heparinized blood 
samples were taken for determining complete blood count (white blood cell count, 
differential white blood cell count, platelet count, red blood cell count, hematocrit, 
and hemoglobin) by semiautomated hematology analyzer. The serum from non-
heparinized blood was carefully collected for blood chemistry and enzyme analysis 
glucose, creatinine, total protein, albumin, total and direct bilirubins, serum 
glutamate-oxaloacetate transaminase(SGOT), serum glutamate pyruvate transaminase 
(SGPT), and alkaline phosphatase (ALP)) were automatically determined using 
autoanalyzer. 
Necropsy:  
 All rats were sacrificed after the blood collection. The positions, shapes, sizes 
and colors of internal organs were evaluated. The Spleen, Testes, Pancreas, Lung, 
Liver, Brain, Heart, Stomach, Intestine, Bone, Ovary, and Kidney tissues were 
excised from all rats to visually detect gross lesions, and weighed to determine 
relative organs’ weights and preserved in 10% neutral formalin for histopathological 
assessment. The tissues were embedded in paraffin, and then sectioned, stained with 
haematoxylin and eosin and were examined microscopically. 
Statistical analysis 
 Values were represented as mean ± SEM. Data were analysed using one-way 
analysis of variance (ANOVA) and group means were compared using the Tukey-
Kramer Multiple Comparisons Test using GraphPad Instat-V3 software. P values < 
0.05 were considered significant. 
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4.2.4.PHARMACOLOGICAL STUDY 
Diuretic activity of Ashta Gunma Thiravagam in rats 
Materials and methods: 
Drugs and Chemicals 
 Frusemide was procured from Himedia Laboratories, Mumbai, Other 
chemicals and reagents used in this study were analytical grade was purchased from 
SRL labs. 
Animals  
For acute toxicity studies, albino mice of either sex weighing between 28 and 30 g 
were selected. For the diuretic study, male Wistar weighing between 180-220 g were 
used. (Approval number:XIII/VELS/PCOL/21/2000/CPCSEA/IAEC/08.08.2012). 
The animals were acclimatized to standard laboratory conditions (temperature: 
25±2°C) and maintained on 12-h light: 12-h dark cycle.  They were provided with 
regular rat chow and drinking water ad libitum.  
Evaluation of Diuretic activity 
 The screening was performed on healthy rats (180-220gms). Frusemide (20 
mg/kg), and Ashta Gunma Thiraavagam (0.5 and 1ml/kg) were used as reference 
standards and were dissolved in saline solution for administration while normal saline 
(25 ml/kg) was used as vehicle. The rats were divided in 3groups each containing 6 
rats (n = 6). Rats were kept for fasting for 18 hrs before the study. The control group 
received normal saline and test groups received Ashta Gunma Thiraavagam (0.5 and 
1ml/kg). The doses of Ashta Gunma Thiraavagam were decided on the basis of acute 
toxicity study. The doses were given by oral route and rats were kept in specially 
designed metabolic cages for the collection of urine for 6 hrs. The urine volume 
during 6 hrs is measured and urine electrolyte estimation was carried out for Na+, K+ 
using flame photometer and Cl- was estimated by titration. 
Statistical analysis 
 All results are expressed as mean ± standard error. The data was analyzed 
statistically using ANOVA followed by Dunnett’s Multiple Comparison Test. 
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                                Fig.7.Analysis of Diuretic activity 
 
          4.3.CLINICAL STUDY OF ASHTA GUNMA THIRAAVAGAM 
Aim & Objectives: 
 To evaluate the Diuretic activity of  Ashta Gunma Thiraavagam. 
 To explore the efficacy of  Ashta Gunma Thiraavagam in patients with 
Oedema, Hypertension, Urolithiasis. 
Design of the study: 
Randomized controlled trial. 
Study centre: 
Arignar Anna Government Hospital of Indian Medicine and Homeopathy, 
Arumbakkam, Chennai –106. 
Study participants: 
Both men and women and members of all races and ethnic groups are eligible 
for this trial. Treatment will be administered on an inpatient/outpatient basis. The 
patients will be selected from the In-patient and Out-patient department of Arignar 
Anna Government Hospital of Indian Medicine and Homeopathy, Chennai – 106. 
Number of subjects: 
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Number of participants will be 40- 50. 
At the beginning of the study, 50 patients will be treated with a low dose of 
the drug. If this dose does not cause bad side effects, it will slowly be made higher as 
new patients take part in the study. A total of 100 patients are the most that would be 
able to enter the study. 
Registration process: 
To register a patient, the following documents should be completed by the 
investigator. 
 Copy of required laboratory tests 
 Signed patient consent form. 
 Other appropriate forms (e.g., Eligibility Screening Worksheet, Registration 
Form). 
The investigator will then verify eligibility and will assign a patient study number, 
drug dose and register the patient on the study. 
Criteria for inclusion: 
Patients with Oedema, Hypertension, Urolithiasis are eligible for entry to the 
trial if the following criteria are satisfied. The criteria of inclusion are: 
 Oedema 
 Hypertension ranging 140/90 mmhg. 
 Pain present in the either/both loins. 
 Patients with known urolithiasis with USG reports. 
 Uraemic Patients if possible. 
Criteria for exclusion: 
 Severely ill patients. 
 AIDS 
 Malignancy 
 Pregnant and lactating women 
 TB 
 Patients with CVS complaints 
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 Age below 10 years 
 Syphilis 
Withdrawal criteria 
Patients will be removed from study when any of the criteria listed below applies. 
The reason for the withdrawal and the date, the patient removed must be documented 
in the Case Report Form. 
In the absence of treatment delays due to adverse events, treatment may continue 
for 2 cycles or until one of the following criteria applies: 
 Disease progression, 
 Deterioration of vital signs with cardiac, respiratory, hepatic, renal and CNS 
changes. 
 Intercurrent illness that prevents further administration of treatment, 
 Unacceptable adverse events, 
 Patient’s unwillingness to continue treatment, or  
 General or specific changes in the patient’s condition render the patient 
unacceptable for further treatment in the judgment of the investigator. 
Routine examination and assessment 
The full details of history and physical examination of the patients is to be 
recorded as per the proforma (form I and I A). The clinical assessment will be done 
initially at the end of 4 days, 7 days, 14 days and 21 days during treatment and at the 
end of the 21 days follow up (form II) to be done. The laboratory investigation and 
the physiological parameters will be recorded initially at the end of the treatment and 
at the end of follow up as per the proforma (form III). 24hrs urine volume estimation 
will be done in all patients before and after the intake of the drug. 
Trial drug 
Ashta Gunma Thiraavagam 
Dosage 
Dose will be fixed after finding the LD50. 
Duration of trial 
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Study Period : 4weeks. 
Treatment plan 
Administration of the drug: 
 Form of the medicine  :  Liquid(Thiraavagam) 
 Route of Administration : Enteral(oral) 
 Dose    : 8 drops 
           Adjuvant   :Nerunjil ver kudineer 
 Times of Administration : Two times a day; after food 
 Duration   : 3-4 weeks 
Diet restriction and medical advice 
 The patients will be instructed to follow easily digestible foods. 
 They will be advised to take tender coconut, and vegetables like radish, juice 
of plantain stem. 
 Avoid bitter gourd, agathi greens, brinjal, non-vegs. 
 The patient will advise to cold damp climate. 
 The patient will be advised to take rest. But prolonged immobilization should 
be avoided. 
 The clinical improvement will be observed and recorded daily in the proforma 
of case sheet. 
Trial conduct 
This study was conducted in compliance with the protocol approved by the 
Institutional Review Board, and according to Good Clinical Practice standards. No 
deviation from the protocol was  implemented without the prior review and approval 
of the IRB except where it may be necessary to eliminate an immediate hazard to a 
research subject. In such case, the deviation will be reported to the IRB . 
Classification of results: 
1. Good Response 
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Relief of Symptoms above 75% and improvement towards normalcy in 
laboratory parameters. 
2. Fair Response 
50% to 75% relief in symptoms. Significant improvement in laboratory           
parameters. 
3. Poor Response 
25% to 49% relief in symptoms and minimal improvement in 
laboratory           
parameters. 
4. No Response 
No relief in symptoms and no significant improvement in laboratory 
parameters. 
Follow up: 
Assessment was taken for every three days before treatment and after 
treatment. During this period clinical assessment (form II) and laboratory 
investigation (form III) was carried out. 
Statistical analysis: 
The data was tabulated and analyzed by students ‘T’ test. 
Ethical review: 
This protocol and any amendments were submitted to the Govt. siddha 
medical college Institutional Ethical Committee (IEC) for formal approval to conduct 
the study. The decision of the IEC concerning the conduct of the study was made in 
writing to the investigator. 
All subjects for this study were provided a consent form describing this study 
and providing sufficient information for subjects to make an informed decision about 
their participation in this study. This consent form was submitted with the protocol for 
review and approval by the IEC. The formal consent of a subject, using the IEC-
approved consent form, was obtained before that subject is submitted to any study 
procedure. This consent form must be signed by the subject or legally acceptable 
surrogate, and the investigator-designated research professional obtaining the consent. 
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           CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM IN IN AND OUT 
PATIENTS DEPT. FOR DIURETIC ACTIVITY 
 
      
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
Sl.No. OP. No. Name Age/ Sex 
Date of first 
visit Symptoms 
21. 5648 JEYALAKSHMI 43/F 
14.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing  
22. 7579 SIVALINGAM 72/M 
16.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
23. 9238 SOKKALINGAM 54/M 
25.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
24. 9275 ARUN 30/M 
25.10.2012       Pain present in the rt.loin, nausea, dizziness, tiredness
                                            present                  
   25.      403 RUBY 65/F 
31.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
26. 436 SULOKSHANA 45/F 
31.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
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CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM  IN IN AND OUT 
PATIENTS DEPT. FOR DIURETIC ACTIVITY 
27. 437 RAMASWAMY 50/M 
31.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
28. 1101 SASIKALA 50 /F 
4.11.12 Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
29. 1102 RAMACHANDRAN 55/M 
4.11.2012 
       Dizziness, headache, loss of sleep, tiredness, difficult
                                         breathing 
30. 1214 JAYAGOPAL 48/M 
9.11.2012 
Diziness, headache,loss of sleep,tiredness,difficulty i
breathing 
Sl.No. O.P. No. Name Age/ Sex Date of first visit Symptoms 
31. 1273 RANI    50/F 
5.11.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathi
32. 340 KUMAR 45/M 
5.11.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathi
33. 1806 PRATHAP     54/M 
7.11.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present
34. 2405  ALAMELU 48/F 
9.11.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present
35. 3768  RAJESWARI 45/F 
17.11.2012  Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
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4.3.6. CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM  IN IN AND OUT 
PATIENTS DEPT. FOR DIURETIC ACTIVITY 
36. 4145 RAJENDRAN    53/M 
19.11.2012 Swelling  pitting of the oedema  present in lower    
extremity,tiredness 
37. 5451  SUGANTHI 45/F 
24.11.2012
Dizziness, headache, loss of sleep, tiredness, difficulty in brea
38. 6210   DEVI    35/F 
27.11.2012
Swelling, pitting of the oedema present in lower extremities 
39. 7170  PRAKASH 40/M 
1.12.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathi
40. 7177 PRIYA 45/F 
1.12.2012  
Swelling, pitting of the oedema present in lower extremities 
Sl.No. I.P. No. Name Age/ Sex Date of first visit Symptoms 
41. 1339/4958 ELLAMMAL 55/F 
24.8.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathi
42. 1446/8001 GNANAMBAL 52/F 
6.9.2012 
Diziness, headache,loss of sleep,tiredness,difficulty in breathi
43. 54/1611 SARAVANAN 43/M 
22.9.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present
44. 70/1920  GEETHALAK   55/F 
24.9.2012
Dizziness, headache, loss of sleep, tiredness, difficulty in brea
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SHMI 
45. 83/2084  PERUMAL 52/M 
24.9.2012  Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
46. 256/7740 MAHADEVAN    52/M 
17.10.2012 Swelling  pitting of the oedema  present in lower    
extremity,tiredness 
47. 357/1231 
 
SABEERUSSA
IN 
 56/M 
5.11.2012
Dizziness, headache, loss of sleep, tiredness, difficulty in brea
48. 446/4154 DEVAKI 48/F 
19.11.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present
49. 487/4920  CHANDRA  50/F 
22.11.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathi
50. 536/6242 MOORTHY 58/M 
28.11.2012  
Dizziness, headache, loss of sleep, tiredness, difficulty in brea
Sl. 
No. 
O.P. 
No. Name 
Age/ 
Sex 
HAEMATOLOGICAL REPORT 
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4.3.9. 24 HRS URINE VOLUME BEFORE AND AFTER  ASHTA GUNMA 
THIRAAVAGAM 
 
S.N
O 
OP.NO. NAME AGE/ 
SEX 
24 HRS URINE 
VOLUME 
BEFORE 
TREATM
ENT 
AFTER 
TREATME
NT 
1. 5562 KANNAN 
 
48/M 950ML 1200ML 
2. 5678 MOORTHY 
 
52/M 1100ML 1660ML 
3. 6273 KANNAMMAL 
 
43/F 1200ML 2200ML 
4. 6658 KANAGA 
 
42/F 1400ML 2600ML 
5. 7266 VALLI 
 
45/F 1500ML 2300ML 
6. 7455 MANIKANDAN 
 
55/M 1300ML 1850ML 
7. 7792 SARAVANAN 
 
48/M 1200ML 1950ML 
8. 7856 ARUMUGAM 
 
54/M 1400ML 2200ML 
9. 7963 ABDUL 
KADHER 
 
45/M 1300ML 2030ML 
10. 8299 MALLIGA 
 
50/F 1200ML 1830ML 
11. 9487 SUSILA 
 
39/F 950ML 1650ML 
12. 9567 CHINNASAMY 
 
51/M 1000ML 1600ML 
13. 9762 GUHANATHAN 
 
55/M 1140ML 1700ML 
14. 9964 CHINNAPPA 
 
56/M 1360ML 1760ML 
 
15. 
 
106 
 
PONNAMMAL 
   
39/F 
 
 
1650ML 
 
2530ML 
16. 208 KANDHASAMY 
 
45/M 1550ML 2100ML 
17. 378 GOMATHY 
 
47/F 1450ML 2430ML 
18. 562 VENKATESAN 
 
55/M 1350ML 1800ML 
19. 893 KARTHIKEYAN 
 
53/M 950ML 1600ML 
20. 1165 RAMASAMY 
 
58/M 970ML 1500ML 
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21. 5648 JEYALAKHSMI 
 
43/F 1170ML 1590ML 
22. 7579 SIVALINGAM 
 
62/M 1020ML 2450ML 
23. 9238 SOKKALINGA
M 
 
54/M 1300ML 2380ML 
24. 9275 ARUN 
 
30/M 900ML 1700ML 
25. 403 RUBY 
 
65/F 980ML 1750ML 
26. 436 SULOKSHANA 
 
45/F 900ML 1530ML 
27. 437 RAMASAMY 
 
50/M 1050ML 1900ML 
28. 1101 SASIKALA 
 
50/F 1650ML 2300ML 
29. 1102 RAMACHANDR
AN 
 
55/M 1250ML 1800ML 
30 1214 JAYAGOPAL 
 
48/M 2220ML 2860ML 
31. 
 
 
1273 RANI 
 
50/F 1300ML 1950ML 
32 1340 
 
KUMAR 
 
45/M 1400ML 2350ML 
33. 1806 
 
PRATHAP 54/M 1380ML 1950ML 
34. 2405 ALAMELU 
 
48/F 1350ML 1880ML 
35. 3768 RAJESWARI 
 
45/F 1530ML 2300ML 
36. 4145 RAJENDRAN 
 
53/M 1400ML 2000ML 
37. 5451 SUGANTHI 
 
45/F 1450ML 1900ML 
38. 6210 DEVI 
 
35/F 1150ML 1800ML 
39. 7170 PRAKASH 
  
40/M 1120ML 1800ML 
40. 7177 PRIYA 
 
45/F 950ML 1500ML 
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                                        5.RESULTS AND DISCUSSION 
                                    Table 4: Physico chemical analysis 
S.No Parameter Mean Value 
1. pH 2.2 
2. Specific gravity 1.167 
 
                        Table 5: Chemical analysis of Ashta Gunma Thiraavagam 
 
S.No. Acid radicals Result 
1. Sulphate + 
2. Chloride + 
3. Phosphate + 
      
                        
                          
                         Fig. 9. SEM picture of Ashta Gunma Thiraavagam 
Results:  
  SEM picture shows Nano particle (Micro level) size of the sample.  
Ashta Gunma Thiraavagam have good nano particle size that indicats 
absorption is very good and pharmaco therapeutic value is good. 
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                       :
 
           Fig.No.8 Showing  FTIR results 
           
                             Table 6:FTIR Absorption results 
0Frequency, cm-1 Bonds  Functional 
groups 
3347.6 N-H Stretch Anhydrides  
2344.8 N-H Stretch Anhydrides 
1637 N-H bend Amines 
1387.7 C-F Stretch Alkyl halides 
679 C-Cl stretch Alkyl halides 
 
Toxicological study of Ashta Gunma Thiraavagam: 
Acute toxicity: 
In acute toxicity study, the animals treated with 2ml/kg were showed tolerance 
with toxic signs. Hence the one tenth of the dose was selected as median therapeutic 
dose for the further study. In sub acute toxicity study, animals were shown significant 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
0.0
5
10
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cm-1
%T 
3447.6
2363.2
2344.8
2079.5
1637.0
1387.7
679.0
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toxic clinical signs during the dosing period of 28 days. Animals from Ashta Gunma 
Thiravagam treated dose groups not survived throughout the dosing period of 28 days 
and it was found two animals dead after 14days of treatment in high dose. Results of 
body weight determination of animals of control and different dose groups exhibited 
reduction in body weight (P>0.01) after one week of the dosing period.  
 During dosing period, the quantity of food consumed by animals from 
different dose groups was found to be comparable (P>0.05) and normal with that of 
control animals. Ophthalmoscopic examination of animals in control and Ashta 
Gunma Thiravagam treated group revealed abnormality as liver damage. Urine 
analysis data of control group and Ashta Gunma Thiravagam treated group of animal 
determined revealed abnormalities like increase in urine volume. Gross pathological 
examination of animals in control as well as the Ashta Gunma Thiravagam treated 
group revealed abnormalities like liver damage at higher dose treated animals and also 
and microanatomical changes in bone and spleen tissue.  
 The results of haematological investigations, revealed mild changes (P>0.05) 
when compared with those of respective controls especially in platelet levels. Results 
of Biochemical investigations conducted on days 28 revealed the significant changes 
in the values of different parameters like ALP, AST and ALT when compared with 
those of respective controls (P<0.01), Uric acid level was elevated in animals of 0.1 
and 0.4 ml/kg group (P<0.05). Other all biochemical and Haematological parameters 
were found to be within normal limit as compared to control group values.  
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Table 7:Dose finding experiment and its behavioral Signs of Toxicity 
No 
Dose 
ml/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
1. 1 + + + + - + - + - + - - - - + + - - - - 
2 2 + + + + - + - + + + - - - - + + - + + + 
3 5 + + + + - + - + + + - - - - + + - + + + 
1.Alertness 2. Aggressiveness 3. Pile erection 4. Grooming  5. Gripping  6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9. Convulsions 10. Muscle 
Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 14. Analgesia 
15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. Respiration 20. 
Mortality 
 
Sub acute toxicity: 
Table 8: Weight of rats as affected by doses of Ashta Gunma Thiravagam after 
28days of administration. 
Dose 
(ml/kg) 
Initial 
Weight 
1st Week 2nd Week 3rd Week 4th Week 
Control 187.80±1.42 187.41±1.22 187.12±1.48 189.10±1.54 188.90±1.21 
0.1 194.18±0.90 191.14±0.71* 192.02±0.92 194.02±0.67 192.74±0.70 
0.2 203.12±2.10 204.02±3.44 204.50±3.46 Dead  Dead  
0.4 205.45±1.10 209.57±1.47** Dead  Dead  Dead 
Values are mean ± SEM. *=significantly different from the control (p<0.05). 
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Table 9: Effect of Ashta Gunma Thiraavagam on Liver function indices in rats. 
Dose 
(ml/kg
) 
TP(g/dl
) 
TA(g/dl
) 
TB(g/dl
) 
ALP(IU/L) AST(IU/L) ALT(IU/L) 
Control 6.42±2.2
8 
4.42±0.4
2 
4.90±2.2
1 
108.60±1.41 24.30±2.12 10.10±1.02 
0.1 6.30±1.0
4 
4.12±1.1
0 
5.18±2.1
1 
310.40±2.50*
* 
30.32±2.18* 15.32±0.49*
* 
0.2 6.18±2.0
2 
4.01±0.5
3 
5.21±3.4
2 
400.41±2.25*
* 
36.23±0.40*
* 
22.51±1.24*
* 
0.4 5.70±1.1
6 
3.50±0.6
0 
5.80±2.2
4 
431.22±2.20*
* 
48.28±0.52*
* 
28.24±0.44*
* 
Values are mean ± SEM. * p< 0.05; **p< 0.01=significantly different from the control. 
             
 
Table 10:  Effect of Ashta Gunma Thiravagam on Kidney function parameters in rats. 
Dose 
(ml/kg) 
Creatinine 
(µmole/l) 
Urea 
(mmol/l) 
Uric acid 
(µmole/l) 
Sodium 
(ppm) 
Potassium 
(ppm) 
Control 84.37±0.72 9.82±1.71 201.56±0.82 32.07±0.48 8.88±1.90 
0.1 85.14±0.81 10.00±0.38 206.29±0.76** 31.22±0.52 9.36±0.48 
0.2 92.02±1.10 11.50±0.40 202.39±0.48 31.12±1.10 9.45±0.82 
0.4 96.24±0.72 12.14±0.42 217.21±0.75** 28.24±0.18** 10.2±2.00 
Values are mean ± SEM. * p< 0.05; **p< 0.01=significantly different from the control. 
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Table 11:.Effects of Ashta Gunma Thiravagam on body weight and relative organ 
weights of treated rats. 
Parameter Control 0.1ml/kg 0.2ml/kg 0.4ml/kg 
Initial b.w.(kg) 150±7.1 149±7.2 154±8.6 151±7.2 
Final b.w.(kg) 300±10.1 299±12.4 284±10.4 292±10.2 
Heart(g) 0.68±0.07 0.58±0.08 0.61±0.09 0.58±0.06 
Liver(g) 4.14±0.50 4.12±0.48 4.90±0.50 4.80±0.48 
Lung(g) 0.67±0.04 0.68±0.06 0.70±0.05 0.69±0.05 
Spleen(g) 0.65±0.05 0.62±0.03 0.74±0.02 0.65±0.05 
Kidney(g) 1.00±0.3 1.00±0.04 1.86±0.2** 1.72±0.04* 
Testis(g) 1.02±0.03 0.96±0.05 0.94±0.04 0.94±0.03 
Ovary(g) 0.04±0.00 0.04±0.01 0.04±0.00 0.04±0.02 
Data are expressed as Mean ± SEM., n=6. *P<0.05; **P<0.01 and NS-Not significant as 
compared to Group 1. 
Table 12: Effects of Ashta Gunma Thiravagam on Hematological parameter of 
treated rats. 
Parameter Control 0.1ml/kg 0.2ml/kg 0.4ml/kg 
RBC (X106/mm3) 4.95±0.40 4.92±0.34 4.26±0.30 4.21±0.32 
Hemoglobin (g/dl) 14.02±0.25 14.12±0.28 14.21±0.25 14.42±0.22 
PCV (%) 44.11±2.10 45.23±2.31 44.50±2.45 46.34±2.14 
MCV (fl) 89.78±4.4 88.45±4.12 86.34±3.82 85.24±4.21 
MCH (pg) 28.00±1.4 29.52±1.54 30.00±1.58 30.11±1.26 
MCHC (g/dl) 35.55±0.82 34.16±0.90 35.39±1.40 35.82±2.00 
Platelets (X105/µl) 1.72±0.04 1.50±0.06* 1.52±0.05* 1.46±0.04** 
WBC (X103/mm3) 3.561±171 3.730±143 3.874±140 2.924±128 
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PMNL 46.34±2.15 44.02±2.36 45.13±2.41 45.22±2.00 
Lymphocytes 42.02±0.8 44.72±1.1 46.32±1.2* 46.22±1.08* 
RBC-Red Blood Cell, WBC-White Blood Cell, PCV-Packed cell volume, MCV-Mean 
Corpuscular Volume, MCH- Mean Corpuscular Hemoglobin,MCHC-Mean Corpuscular 
Hemoglobin Concentration. Mean ± SEM., n=6.Comparisons were made between Group I 
and Group II, III, and IV. *P<0.05; **P<0.01 and NS-Not significant as compared to Group I. 
 
Table 13: Effects of Ashta Gunma Thiravagam on Biochemical parameter of 
treated rats. 
Parameter Control 0.1ml/kg 0.2ml/kg 0.4ml/kg 
Glucose (mg/dl) 102±9.4 100±10.2 105±12.5 103±11.2 
Cholesterol (mg/dl) 74±2.0 76.4±4.1 68.2±3.2 72.4±3.8 
Protein (g/dl) 4.0±0.3 4.13±0.3 4.22±0.4 4.25±0.5 
Bilirubin (mg/dl) 0.72±0.14 0.70±0.12 0.74±0.12 0.68±0.10 
Urea (mg/dl) 33.76±4.5 35.14±4.0 34.12±4.1 32.2±4.2 
Creatinine (mg/dl) 0.81±0.25 0.80±0.24 0.82±0.30 0.75±0.35 
ALP (IU/L) 68±4.2 69.10±5.6 59.20±4.4 60.0±4.34 
AST (IU/L) 91.04±4.2 90.21±5.0 88.30±4.08 83.8±6.00 
ALT (IU/L) 68.00±6.2 79.20±6.01 81.0±6.05 80.5±5.24 
ALP-Alkaline Phosphatase, AST-Aspartate Aminotransferase, ALT-Alanine 
Aminotransferase. Mean ± SEM., n=6.Comparisons were made between Group I and Group 
II, III, and IV. *P<0.05; **P<0.01 and NS-Not significant as compared to Group I. 
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Table­14: Urine Analysis 
Parameters 
Control 0.1ml/kg 0.2ml/kg 0.4ml/kg 
Colour Yellow Yellow Yellow Yellow 
Transparency Clear Slightly turbid cloudy turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.0 >8.0 >9.0 
Protein Nil 3+ 3+ 3+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve -ve 
Ketones -ve +ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen 
Normal Abnormal Abnormal Abnormal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-
1cells/HPF 
Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
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SUBACUTE TOXICITY OF ASHTA GUNMA THIRAAVAGAM: 
Fig.No.10.Bone 
                  0.1 ml of AGT           0.2 ml of AGT                         0.4 ml 0f AGT 
                                          
Fig.No.11.Brain 
0.1 ml of AGT    0.2 ml of AGT    0.4 ml 0f AGT                         
                          
                                                             
Fig.No.12.Heart 
0.1 ml of AGT            0.2 ml of AGT    0.4 ml 0f AGT                                                   
                            
                                                 AGT-Ashta Gunma Thiraavagam 
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      Fig.No.13.Intestine 
                   0.1 ml of AGT            0.2 ml of AGT                       0.4 ml 0f AGT                                     
                                          
            
Fig.No.14.Kidney 
                       0.1 ml of AGT              0.2 ml of AGT                       0.4 ml 0f AGT                                 
                                             
 
           Fig.No.15.Liver 
                     0.1 ml of AGT                    0.2 ml of AGT                      0.4 ml 0f AGT                              
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          Fig.No.16.Lungs 
                         0.1 ml of AGT                     0.2 ml of AGT                        0.4 ml 0f AGT                         
                                            
            Fig.No.17.Ovary 
                            0.1 ml of AGT                0.2 ml of AGT                        0.4 ml 0f AGT                            
                                         
     Fig.No.18.Pancreas 
                              0.1 ml of AGT                     0.2 ml of AGT               0.4 ml of AGT                              
                                       
                                                     
AGT-Ashta Gunma Thiraavagam 
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Fig.No.19.Spleen 
                           0.1 ml of AGT                    0.2 ml of AGT               0.4 ml of AGT                                  
                                        
                Fig.No 20.Stomach 
                           0.1 ml 0f AGT                       0.2 ml of AGT                0.4 ml of AGT                              
                                        
 
            Fig.No 21.Testis 
                        0.1 ml 0f AGT                       0.2 ml of AGT                   0.4 ml of AGT                            
                                                      
                                                      AGT-Ashta Gunma Thiraavagam 
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Diuretic activity  of Ashta Gunma Thiraavagam in rats: 
 In acute toxicity study, the animals treated with 2, 5, 10ml/kg were showed 
toxic signs. Hence the 0.5 and 1ml per kg body weight was selected as median 
therapeutic dose for the further study. Frusemide treated rats showed a significant 
increase in volume of urine and urinary excretion of sodium (p<0.01) but not 
potassium and chloride as compared to control The 1ml/kg Ashta Gunma 
Thiraavagam was not produced statistically significant diuretic actions but at high 
dose of 1ml/kg showed significant increase in volume of urine and also urinary 
excretion of sodium, potassium and chloride when compared to control was observed.  
 Diuretics relieve pulmonary congestion and peripheral edema. These agents 
are useful in reducing the syndrome of volume overload, including orthopnea and 
paroxysmal nocturnal dyspnoea. They decrease plasma volume and subsequently 
venous return to the heart (preload). This decreases cardiac workload, oxygen demand 
and plasma volume, thus decreasing blood pressure. Thus, diuretics play an important 
role in hypertensive patients.  
 In present study, Ashta Gunma Thiravagam may produce diuretic effect by 
increasing the excretion of Na+, K+ and Cl-. The control of plasma sodium is 
important in the regulation of blood volume and pressure; the control of plasma 
potassium is required to maintain proper function of cardiac and skeletal muscles. The 
regulation of Na+/ K+ balance is also intimately related to renal control of acid-base 
balance.  
 The K+ loss that occurs with many diuretics may lead to hypokalemia. For 
this reason, generally potassium-sparing diuretics are recommended. In present study, 
Ashta Gunma Thiravagam showed elevated levels of K+ in urine, which may increase 
risk of hypokalemia, Results of present investigation showed that 1ml/kg is most 
effective in increasing urinary electrolyte concentration of all the ions i.e. Na+, K+ 
and Cl – while 0.5ml/kg did not show significant increase in urinary electrolyte 
concentration. 
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        CLINICAL STUDY 
                                         Fig.No.22.Net increase in urine volume 
                  
 
 Table 17:Showing Improvement in clinical features: 
 
 Before  After  % Before 
treatment 
% After 
Treatment 
Improveme
nt 
% 
Improved 
Dizziness 28 8 56 16 20 
40 
Head ache 33  3  66  6  30 
60 
Loss of sleep  33 10 66 20 23 
46 
Tiredness 48 2 96 4 46 
92 
Difficulty in 
Breathing 
30 5 60 10 25 
50 
Pain in the loin 
region 
3 1 6 2 2 
4 
Nausea 11 1 22 2 10 
20 
Pitting Oedema 5 1 10 2 4 
80 
 
 
12.0%
50.0%
28.0%
8.0% 2.0%5
Net Increase in 24 Hrs Urine 
Volume 
<500
501‐750
751‐1000
1001‐1250
1251‐1500
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50 patients of both sexes were selected. 
  Among the 50 patients, 40 patients were treated as out- patients in the Post 
graduate department of Gunapadam, Govt.Siddha medical college hospital and Govt. 
Arignar Anna hospital, Arumbakkam, Chennai- 106.  10 patients were treated as in - 
patients. 
 The patients were observed regularly. 
 The trial drug Ashta Gunma Thiraavagam  was given to the patients at the 
dose of 8 drops twice a day. On administration of Ashta Gunma Thiraavagam 30 ml 
twice for 4 weeks showed significant Diuretic activity.  
  Out of 50 patients 12% of the pts had an increase in excretion of nearly 500 ml 
of urine per day, 50% of the pts had 501 to 750 ml more urine per day, 28% of the pts 
excreted an increase 751-1000ml of urine per day, 8% of the pts had an increase of 
1001-1250ml of urine per day, 2% of the pts had an increase of 1251-1500ml of urine 
per day. 
Among the patients, 60% of the patients were relieved from headache, 8% 
were relieved from Oedema, 20% were relieved from Nausea, 40% of patients were 
relieved from dizziness, 46% of patients were relieved from loss of sleep, 92% were 
relieved from Tiredness 50% relieved from Difficulty in Breathing and 4% were 
relieved from Pain in the loin region. 
 The results revealed that the drug possess 62.5% good relief, 37.5%fair relief.  
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Statistical analysis 
Descriptive statistical for improvement of urine output in patients 
Paired “t” test result: 
Table 19: “p” value & statistical significance: 
Treatment Signs & 
symptoms 
Mean S.D S.E.M 
Before treatment 50 1265.80 246.834 34.908 
After treatment 50 1983.00 363.280 51.376 
 
From the table we calculated the descriptive statistic like Mean, S.D & S.E.M of 
Mean for the improvement score before and after treatment. 
Table 20: “t” Table: 
t-Table S.D “t” Value “p” Value 
Pre vs Post 229.374 -22.110 0.000 
The two-tailed P value is less than 0.000.By conventional criteria, this difference is 
considered to be extremely significant. 
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6.CONCLUSION 
 The evaluation of the efficacy of Ashta Gunma Thiraavagam for 
diuretic  activity in the managements of oedema,urolithiasis and 
hypertension gave significant results. 
 The presence of chloride, calcium and sulphate enhances the diuretic 
activity. 
 Pharmacological animal study shows that Ashta Gunma Thiraavagam  
acts as potent diuretic comparable to that of standard drug. 
 The drug gives very good therapeutic effect because of its easy 
absorption. 
 Clinically, the drug relieved the symptoms of SHT,Urolithiasis,oedema 
and showed net increase in 24 hrs urine output. 
 No adverse reactions were produced during the period of the clinical 
study. 
 So I conclude that Ashta Gunma Thiraavagam act as a good diuretic. 
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7.SUMMARY 
 Ashta Gunma Thiraavagam was selected for this study to establish the 
safety and efficacy of its diuretic activity 
 The Physico – chemical analysis shows the precence of Potassium, 
Iron, Calcium, Sulphate and Chloride.. These elements are useful in 
eliminating urine from the body and helps in many metabolic functions 
of our body. 
 Acute and Sub acute toxicological studies shows strong evidence of the 
drug. The results showed.  
 The pharmacological analysis showed that the drug has got significant 
efficacy. 
 In clinical study, the drug has showed improvement in 65% of cases. 
 The patients were responding well from the beginning of the treatment 
and no adverse effects were reported. 
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S.NO 
IP.NO NAME AGE/ 
SEX 
24 HRS URINE VOLUME 
BEFORE 
TREATMENT 
 
41. 1339/4958 ELLAMMAL 
 
55/F AFTER 
TREATMENT 
1450ML 
42. 1446/8001 GNANAMBAL 
 
65/F 1200ML 1960ML 
43. 54/1611 SARAVANAN 
 
43/M 1500ML 2300ML 
44. 70/1920 GEETHALAKSHMI 
 
55/F 1450ML 2600ML 
45. 83/2084 PERUMAL 
 
62/M 1500ML 2700ML 
46. 256/7740 MAHADEVAN 
 
52/M 1200ML 1750ML 
47. 357/1231 SABEERHUSSAIN 
 
56/M 1200ML 1950ML 
48. 446/4154 DEVAKI 
 
58/F 1400ML 2300ML 
49. 487/4920 CHANDRA 
 
50/F 1300ML 2130ML 
50. 536/6242 MOORTHY 
 
58/M 1200ML 1830ML 
 
 
Form: I 
CONSENT FORM 
 
 I certify that I have disclosed all the details about the study in the terms readily 
understood by the patient. 
 
DATE:        SIGNATURE 
         NAME 
 
CONSENT BY THE PATIENT 
 I have been informed to my satisfaction by the attending physician the purpose of the 
clinical trial and the nature of the drug treatment and follow up including the lab investigations to 
be performed to monitor and safeguard my body functions. 
 
 I am aware of my right to opt out of the trial at any time during the course of the trial 
without having to give reasons for doing so. 
 
 I ,exercising  my free power of choice , hereby give my consent to be included as a 
subject in the clinical trial of ………………………….for the treatment 
of…………………………………………….. 
 
DATE:       SIGNATURE 
        NAME 
 
yh<Hkz<!hcul<!
Nb<UGxqk<knk<kjekguz<gjtBl<!Ofibitqwtqkqz<!Hvqf<Kogit<Tl<!ujgbqz<!
Ofibitqg<Guqtg<gqBt<Ote<!we<XdXkqbtqg<gqOxe<!
!
!
Okkq;! ! ! ! ! Nb<uitvqe<!jgobih<hl<;!
! ! ! ! ! ! ! ! !
ohbv<;!
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Ofibitqbqe<!yh<Hkz<<!
! -f<kNb<UGxqk<k!LP!kguz<gt<?lVf<kqe<!ke<jl?weKdmz<!fze<!
Gxqk<kNb<Ugt<?Nb<Ug<gielVk<KuhvqOsikjegt<!lx<Xl<!sqgqs<jsuqhvr<gt<!
Ngqbnjek<Kl<!lVk<Kuviz<!LPjlbiguqtg<gqg<!%xh<hm<Mt<tK/!
! -f<kNb<uqzqVf<Kwf<kfqjzbqZl<?wu<uqkgiv{Llqe<xquqzgqg<ogit<tweg<G!LP!
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! -f<kNb<uqz<?……………………………………………………………………………………….yVhbeitqbigwe<
jedm<hMk<kqg<!ogit<tWu<uqkliefqv<hf<kLlqe<xqLPleKme<!sl<lkqg<gqOxe<!we<hjkk<!
okvquqk<Kg<!ogit<gqOxe</!
!
!
Okkq;! ! ! ! ! ! ! jgobih<hl<;!
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S.N
O 
OP.NO. NAME AGE/ 
SEX 
           EASI SCORE 
      BT       AT 
1. 7518 KALIMUTHU 57/M       6    2.4 
2. 7540 RENGARAJAN 66/M    2.7    1.4 
3. 138 GNANASELVAM 65/F   11.2    5.4 
4. 5424 VISWANATHAN 37/M    4    1.2 
5. 5462 SAKILA 30/F    7.2    2.8 
6. 5504 RAO 64/M     12    5.2 
7. 6207 LENIN 62/M    2.8     1.2 
8. 7165 SARADHA 45/F     2.7     1.4 
9. 7259 KARPAGAMBAL 49/F      2     1.2 
10. 7837 AMSA 50/F    1.2   0.6 
11. 7695 PUSHPA 47/F    1.8    0.7 
12. 7932 KATHIRESAN 38/M    3.5    1.2 
13. 8432 MURUGESAN 45/M    3    1.3 
14. 9254 SAIRA BAANU 52/F   5.4    1.9 
15. 803 ASHA   53/F 1.6  0.4 
16. 836 SELVARAJ 52/M    4.8    1.3 
17. 1469 SEKAR 48/M    4    1.6 
18. 2852 NIRMALA 32/F    1.6    0.3 
19. 4589 RAMESH 35/M    5    1.2 
20. 6238 PARIMALA 39/F    4.6     2 
21. 7215 GANAPATHI 69/M   7.1    2.3 
22. 2755 LATHA 33/F    3.8    0.8 
23. 3952 SOUNDHAR 60/M   2.5    1.4 
24. 4660 ELUMALAI 49/M    1.6    0.4 
25. 8016 MUTHUSELVA
KUMAR 
32/M    1.2    0.4 
26. 9436 RAJA 35/M    2.2    0.6 
27. 9455 SATHYA 40/F    1.6     0.3 
28. 9611 SAKTHIVEL 59/M     2     0.4 
29. 1675 KAMALA 35/F  2.4   0.8 
30 1678 RAJESWARI 42/F    3    1.2 
31. 1851  MARI 36/F  1.8   0.4 
32 1849 PUSHPA 50/F     2   0.8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33. 2243 SANKAR 28/M    2.6   1 
34. 2406 LAKHSMI 35/F    3.5   1.2 
35. 8107 SELVARAJ 50/M   4.2   2.1 
36. 8865 KANNAN 46/F     3   1.4 
37. 9265 MUNIRAJ 49/M    2.8  0.8 
38. 9368 KASTHURI 51/F    2.5   1.3 
39. 9621 MATHIVANAN 49/M   4.6  1.8 
40. 9981 VAELLAMMAL 42/F   2.3  0.6 
 
S.NO 
IP.NO NAME AGE/ 
SEX 
EASI SCORE 
BT AT 
41. 1077/7053 RAJALAKHSMI 52/F  3.2 1 
42. 1128/8173 SELVI 37/F  2.6 1.4 
43. 1220/1115 MOHAMMAD 
BAEG 
50/M   4 2.6 
44. 1231/1419 KAASI 59/M    3.8 1.4 
45. 1317/4312 DHANALAKHS
MI 
53/F    2.5 0.8 
46. 320/9361 MARY 50/F    5.2 1.6 
47. 1419/7245 SAROJA 43/F  5.8 2.3 
48. 74/1979 PADMAVATHI 65/F    3  1.2 
49. 320/9361 MARY 50/F  4.3  1.8 
50. 349/925 PAMIATH 55/F 2.1  0.6 
      Aringnar Anna Govt.Hospital of Indian Medicine and  Homeopathy,Chennai-106. 
                                    Govt.Siddha Medical College , Chennai-106. 
Name of the 
study. 
Diuretic activity of Ashta Gunma Thiraavagam 
Dose :8 to 10 drops with Nerunjil Ver Kudineer  
Date: 
OP NO: Name: Age: Sex: Religion: 
 
Country: 
 
 
Marital status: 
 
Personal Habits: Past history:  
□DM 
□SHT □BA□TB□Allery 
□Epilepsy 
□Drug intake: 
 
□Surgery□Trauma 
Others; 
Address: 
Vitals: PR RR 
 
BP 
 
T˚ 
 
S.No        SYMPTOMS Before 
treatment 
              After treatment[in weeks] 
   I   II   III  IV    V  VI   VII 
1. Changes in Urination  
 
        
2. Fatigue 
 
        
3. Nausea and Vomiting 
 
        
4. Dizziness  
 
        
5. Flank Pain         
6. Pain in loin 
 
        
7. Constipation         
 
 
 
Inspection Before 
treatment 
                             After treatment[in weeks] 
I II III IV V VI VII 
1. Swelling of legs         
2. Pallor         
3. Icterus         
4. Clubbing         
5. Abdominal 
distension 
        
6. Skin rashes         
 
Palpation Before 
treatment 
                           After treatment[in weeks] 
I II III IV V VI VII 
1. Tenderness          
2. Palpable mass          
3. Pitting of the 
edema 
        
4. Abdominal 
rigidity 
        
 
Percussion Before 
treatment 
                         After treatment[in weeks] 
I II III IV V VI VII 
1. Dullness of the 
abdomen 
        
2. Dullness of the 
chest 
        
 
Auscultation Before 
treatment 
                          After treatment[in weeks] 
I II III IV V VI VII 
1. Heart sounds         
          
2. Respiratory 
sounds 
        
          
3. Bowel sounds         
          
 
Signature of the 
M.O. 
        
 
                                              Laboratory investigations:BLOOD: 
 Before treatment After treatment 
TC   
DC   
ESR   
HB   
Serum bilirubin    
SGOT    
SGPT   
Blood Urea   
Serum Creatinine   
Albumin /globulin ratio   
Blood sugar    
   
 
                                            Laboratory investigations:URINE 
 Before treatment After treatment 
Albumin   
Sugar   
Deposits   
 
 Before treatment After treatment 
X-Ray   
USG   
OTHERS   
 
Ofib<!fimz<.SIDDHA SYSTEM  OF DIAGNOSIS: 
 
w{<!ujg!Oki<U;9!! sqgqs<jsg<G!Le<! sqgqs<jsg<G!hqe<!
2fic! ! !
3/hiqsl<! ! !
4/fi! ! !
5/fqxl<! ! !
6/olipq! ! !
7/uqpq! ! !
8/lzl<! ! !
9/&k<kqvl<! ! !
!fQi<Gxq;!
!!fqxl<!
!!l{l<!
!!Fjv!
ofb<Gxq;!
!
! !
!
 
 
 
SIGNATURE OF THE H.O.D                                          SIGNATURE OF THE  M.O. 
 
 
                  GOVT. SIDDHA  MEDICAL  COLLEGE  &  HOSPITAL 
                                                CHENNAI-106 
                                M.D(S) - Branch  II (GUNAPADAM) 
Name of  the medicine : Karunchembai Ilai Chooranam  
Name of the disease     : Karappan (Eczema)  
Dose & Adjuvant         : 1 gm bd after food with honey  
O.P. NO : Date : Height : 
Name : Age/Sex : Weight : 
Address : 
 
BP : 
Occupation : Marital status : PR : 
 
    SIGNS&SYMPTOMS                                   WEEKS 
  0   1   2   3    4    5    6   7   8 
Itching          
Erythema          
Oedema          
Vesicles          
Pustules          
Oozing          
Scaling          
Lichenification          
Ulcer          
Pain and burning sensation          
Varicose vein          
Family H/O of EAHU          
Others 
 
         
Signature of AL/MO          
  
ASSESSMENT 
 
 Eczema Area and Severity  
   Index( EASI)Score 
         Before treatment          After treatment 
  
 
CALCULATION OF EASI SCORE 
EASI=0.1{Eh+Ih/Oh/Ph+Exh+Lh}(A)h+0.2{Eu+Iu/Ou/Pu+Exu+Lu}Au+0.3{Et+It/Ot/Pt+Ext+
Lt}At+0.4{El+Il/Ol/Pl+Exl+Ll}Al 
 
Eh-Erythema of head 
Ih-Induration of head 
Oh-Oedema of head 
Ph-Papulation of head 
Exh-Excoriation of head 
Lh-Lichenification of head 
(A)h-Area of head 
Upper extremities-u 
Trunk-t 
Lower extremities-l 
E, I, O, P, Ex, and L are assessed according to a 3-point scale where 0=no symptoms, 1=slight, 
2=moderate, 3=marked. A is assigned a numerical value based on the extent of lesions in a given 
anatomic site: 1=<10%, 2=10-29%, 3=30-49%, 4=50-69%, 5=70-89% and 6=90-100%. 
  
EASI SCORE= 
 
 
 
LABORATORY INVESTIGATIONS 
 
  Before treatment After treatment 
 
 
       Blood 
        TC   
        DC   
        ESR   
         Hb   
  Blood sugar   
         IgE   
 
       Urine 
  Albumin   
  Sugar   
  Deposit   
Specific patch test    
 
 
SIDDHA SYSTEM OF EXAMINATION 
ENVAGAI THERVUGAL 
           Before treatment              After treatment 
        Naadi   
        Sparisam   
        Naa   
        Niram   
        Mozhi   
        Vizhi   
        Malam   
        Moothiram   
 
 
 
 
 
Signature of AMO                                                                                    Signature of HOD 
                         CLINICAL STUDY ON KARUNCHEMBAI ILAI CHOORNAM FOR ECZEMA 
 
 
 
 
 
 
Sl.
No. O.P. No. Name 
Age/ 
Sex 
Date of 
first visit Symptoms 
DATE OF 
LAST 
VISIT 
 
Results 
1.. 7518 KALIMUTHU 57/M 18.6.2012 Itching, erythema,pustules,  oozing present in the extremities 
5.8.2012    GOOD 
        
2. 7540 RENGARAJAN 66/M 18.6.2012 Itching, erythema, oedema present in the extremities  
8.8.2012 FAIR 
        
3. 138 
GNANASELVA
M 65/F 25.6.2012 Itching,,erythema, pustules, oozing, ulcer present in the extremities 
30.8.2012 FAIR 
        
4. 5424 
VISWANATHA
N 37/M 16.7.2012 Itching, erythema, scaling present in the extremities 
7.9.2012 GOOD 
       
5. 5462 SAKILA 30/F 16.7.2012 
Itching, erythema,vesicles,  oozing present in the extremities 
 
30.9.2012 FAIR 
       
6. 5504 RAO 64/M 18.7.2012   Itching,,erythema, pustules oozing present in the extremities 
10.9.2012 GOOD 
       
7. 6207 LENIN 62/M 19.7.2012 Itching,,erythema,oozing present in the extremities 
7.9.2012 FAIR 
       
8. 7165 SARADHA 45/F 23.7.2012 Itching, erythema, oedema present in the extremities  
3.9.2012 GOOD 
        
9. 7259 
KARPAGAMBA
L 49/F 23.7.2012   Itching,,erythema,oozing, ulcer present in the extremities 
30.9.2012 FAIR 
       
10. 7837 AMSA 50/F 25.7.2012 Itching, erythema, oedema present in the extremities 
12.10.2012 FAIR 
 
                            CLINICAL STUDY ON KARUNCHEMBAI ILAI CHOORANAM FOR ECZEMA 
 
 
 
 
Sl.No. O.P. No. Name Age/ Sex 
DATE OF 
FIRST 
VISIT 
Symptoms 
DATE OF 
LAST VISIT 
 
Results 
    11. 7932 PUSHPA 47/F 25.7.2012 Itching, erythema, oedema,pustules  present in the  lower extremities 
2.10.2012 FAIR 
    12. 7965 KATHIRESAN 38/M 28.7.2012 Itching, erythema, scaling, ulcer present in the extremities 
4.10.2012 GOOD 
    13. 8432 MURUGESAN 45/M 2.8.2012 Itching, erythema, vesicles, oozing present in the upper extremities 
8.10.2012 GOOD 
    14. 9254 SAIRA BAANU 52/F 4.8.2012 Itching, erythema present, scaling present in the extremities 
12.10.2012 FAIR 
     15. 803 ASHA 53/F 6.8.2012 Itching, erythema, oedema, pustules  present in the extremities  
3.10.2012 FAIR 
     16.  836 SELVARAJ 52/M 6.8.2012 Itching, erythema, , vesicles present in the extremities  
26.10.2012 GOOD 
     17. 1469 SEKAR 48/M 9.8.2012 Itching, erythema, oedema present in the extremities 
27.10.2012 FAIR 
     18. 2852 NIRMALA 32/F 14.8.2012 Itching, erythema, scaling,  oozing, ulcer present in the extremities 
26.10.2012 GOOD 
     19. 4589 RAMESH 35/M 22.8.2012 Itching, erythema, oedema, vesicles present in the extremities  
3.11/2012 FAIR 
     20. 6238 PARIMALA 39/F 1.9.2012 Itching,,erythema, pustules, oozing, ulcer  present in the extremities 
5.11.2012 GOOD 
                             CLINICAL STUDY ON KARUNCHEMBAI ILAI CHOORANAM  FOR ECZEMA 
 
 
  
 
 
 
Sl.No
. 
O.P. 
No. Name 
Age/ 
Sex 
DATE OF 
FIRST 
VISIT 
Symptoms 
DATE OF LAST 
VISIT 
 
Result 
21. 7215 GANAPATI 69/M 3.9.2012 Itching, erythema, oozing present in the upper extremities 
7.9.2012  
FAIR 
22. 2755 LATHA 33/F 26.9.2012 Itching, erythema,  vesicles, oedema presentin the extremities 
15.11.2012 GOOD 
23. 3952 SOUNDHER 60/M 2.10.2012 Itching,,erythema,oozing present in the extremities 
4.12.2012 FAIR 
24. 4660 ELUMALAI 49/M 4.10.2012 Itching,,erythema, pustules oozing present in the extremities 
18.11.2012 FAIR 
        
25. 8016 
MUTHUSELVAKUMA
R 32/M 18.10.2012 Itching, erythema present, scaling present in the extremities 
1.12.2012 GOOD 
         
26. 9436 RAJA 35/M 26.10.2012 Itching, erythema, oedema, ulcer presentin the extremities 
8.12.2012 FAIR 
  27. 9455 SATHYA 40/F 26.10.2012 Itching, erythema, pustules  presentin the extremities 
6.12.2012 GOOD 
28. 9611 SAKTHIVEL 59/F 27.10.2012 Itching, erythema,  vesicles,oedema presentin the extremities 
10.12.2012 FAIR 
29. 1675 KAMALA 35/F 30.10.2012 Itching,,erythema,oozing, ulcer present in the extremities 
14.12.2012 GOOD 
30. 1678 RAJESWARI 42/F 6.11.2012 Itching, erythema, scaling present in the extremitie 
25.12.2012 FAIR 
                                CLINICAL STUDY ON KARUNCHEMBAI ILAI CHOORANAM  FOR ECZEMA 
 
 
 
 
 
 
 
Sl.No. O.P. No. Name Age/ Sex 
DATE OF 
FIRST 
VISIT 
Symptoms 
Date of last 
visit 
 
Results 
31. 1851 MARI 36/F 7.11.2012 Itching, erythema, scaling present in the extremities 
18.12.2012  
GOOD 
32. 1879 PUSHPA 50/F 7.11.2012 Itching, erythema,  vesicles, oedema presentin the extremities 
20.12.2012 FAIR 
33. 2243 SANKAR 28/M 9.11.2012 Itching, erythema, oedema presentin the extremities 
18.12.2012 FAIR 
34. 2406 LAKSHMI 35/F 10.11.2012 Itching,,erythema,oozing present in the extremities 
23.12.2012 GOOD 
             
35. 8107 SELVARAJ 50/M 12.11.2012 Itching, erythema pustules,  scaling, ulcer present in the extremities 
14.12.2012 FAIR 
           
36. 8865 KANNAN 46/M 15.11.2012 Itching, erythema, oedema present in the  lower extremities 
22.12.2012 GOOD 
37. 9265 MUNIRAJ 49/M 18.11.2012 Itching,,erythema,oozing present in the extremities 
16.12.2012 FAIR 
38. 9368 KASTHURI 54/F 23.11.2012 Itching, erythema, vesicles scaling present in the extremitie 
28.12.2012 FAIR 
39. 9621 MATHIVANAN 49/M 27.11.2012 Itching, erythema, pustules, oedema presentin the extremities 
24.12.2012 GOOD 
40. 9981 VAELLAMMAL 42/F 27.11.2012 Itching,,erythema,oozing, ulcer  present in the extremities 
26.12.2012 FAIR 
                 CLINICAL STUDY ON KARUNCHEMBAI ILAI CHOORANAM FOR ECZEMA 
 
 
 
 
 
 
 
Sl.No. I.P. No. Name Age/ Sex 
DATE OF 
FIRST VISIT Symptoms 
DATE OF 
LAST 
VISIT 
 
Results 
41. 1077/7053 RAJALAKSHMI 43/F 23.7.2012 Itching, erythema, oedema presentin the extremities 
10.9.2012  
FAIR 
42. 1128/8173 SELVI 37/F 26.7.2012 Itching, erythema, oozing present in the extremities 
17.9.2012 GOOD 
43. 1231/1419 KAASI 59/M 8.8.2012 Itching, erythema, oedema presentin the extremities 
17.9.2012 GOOD 
44. 1220/1115 MOHAMMAD BAEG 50/M 9.8.2012 Itching, erythema,  vesicles scaling present in the extremitie 
22.9.2012 FAIR 
         
45. 1317/4312 
DHANALAKHS
MI 53/F 21.8.2012 Itching,,erythema, pustules, oozing, ulcer  present in the extremities 
29.9.2012 FAIR 
         
46. 1399/6626 RAMESH 35/M 31.8.2012 Itching,,erythema,oozing present in the extremities 
6.9.2012 GOOD 
47. 1419/7245 SAROJA 43/F 3.9.2012 Itching, erythema, oedema presentin the extremities 
24.9.2012 FAIR 
48. 74/1979 PADMAVATHI 65/F 24..2012 Itching, erythema, oedema presentin the extremities 
12.10.2012 GOOD 
49. 320/9361 MARY 50/F 26.10.2012 Itching,,erythema, vesicles oozing present in the extremities 
6.11.2012 FAIR 
50. 349/925 PAMIATH 55/F 3.11.2012 Itching, erythema, scaling present in the extremities 
21.11.2012 GOOD 
CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM IN IN AND OUT PATIENTS DEPT. FOR DIURETICACTIVITY 
 
 
               
Sl.No. I.P. No. Name Age/ Sex Date of first visit Symptoms 
   
Date of last visit 
 
Results 
1. 5562 KANNAN 48/M 12.7.2012 Diziness, headache,loss of sleep,tiredness,difficulty in breathing  
24.8.2012 GOOD 
2. 5678 MOORTHY 52/M 18.7.2012 Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
14.8.2012 FAIR 
3. 6273 KANNAMMAL 43/F 19.7.2012 Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
22.8.2012 FAIR 
4. 6658 KANAGA 42/M 
23.7.2012      Pain present in the rt.loin, nausea, dizziness, tiredness 
                                        present 
28.8.2012 GOOD 
5. 7266 VALLI    45/F 4.8.2012 Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
5.9.2012 FAIR 
6. 7453 MANIKANDAN 55/M 
7.8.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
12.9.2012 GOOD 
7. 7792 SARAVANAN 48/M 
14.8.2012      Pain present in the rt.loin, nausea, dizziness, tiredness 
                                          present 
19.9.2012 FAIR 
8. 7856 ARUMUGAM 54/M 22.8.2012 Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
27.9.2012 FAIR 
9. 7963 ABDUL KADHAR 45/M 
25.8.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
23.9.2012 GOOD 
10. 8299 MALLIGA 50/F 28.8.2012 Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
24.9.2012 FAIR 
             CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM IN IN AND OUT PATIENTS DEPT. FOR DIURETIC ACTIVITY 
              
 
            
Sl.No. O.P. No. Name Age/ Sex Date of first visit Symptoms 
  Date of last 
visit 
 
 
Results 
11. 9487 SUSILA 39/F 
2.9.2012   Swelling and pitting present in lower extremity,  
                       Tiredness present                                        
4.10.2012 FAIR 
12. 9567 CHINNASAMY 51/M 
6.9.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
10.10.2012 GOOD 
13. 9762 GUGANATHAN 55/M 
12.9.2012 Pain present in the rt loin ,nausea,dizziness ,tiredness 
present 
18.10.2012 GOOD 
14. 9964 CHINNAPPA 56/M 
18.9.2012 Swelling& pitting present in lower extremity,tiredness, 
present 
25.10.2012 FAIR 
        15. 106 PONNAMMAL 39/F 
23.9.2012 Pain present in the rt loin ,nausea,dizziness ,tiredness 
present 
28.10.2012 FAIR 
        16. 208 KANDHASAMY 45/M 
26.9.2012 Pain present in the rt &ltloin ,nausea,dizziness ,tiredness 
present 
2.11.2012 GOOD 
        17. 378 GOMATHY      47/F 
28.9.2012 Pain present in the rt loin ,nausea,dizziness ,tiredness 
present 
5.11.2012 GOOD 
        18. 562 VENKATESAN 55/M 
3.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
15.11.2012 FAIR 
        19. 893 KARTHIKEYAN 53/M 
8.10.2012 
Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
23.11.2012 GOOD 
        20. 1165 RAMASAMY 58/M 
13.10.2012 
Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
25.11.2012 FAIR 
            
            CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM IN IN AND OUT PATIENTS DEPT. FOR DIURETIC ACTIVITY 
 
 
 
Sl.No. OP. No. Name Age/ Sex 
Date of first 
visit Symptoms 
  Date of 
last visit 
 
Results
21. 5648 JEYALAKSHMI 43/F 
14.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing  
22.11.2012 GOOD 
22. 7579 SIVALINGAM 72/M 
16.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
20.11.2012 FAIR 
23. 9238 SOKKALINGAM 54/M 
25.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
28.11.2012 FAIR 
24. 9275 ARUN 30/M 
25.10.2012       Pain present in the rt.loin, nausea, dizziness, tiredness 
                                            present                  
15.11.2012 GOOD 
    25.      403 RUBY 65/F 
31.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
21.11.2012 FAIR 
26. 436 SULOKSHANA 45/F 
31.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
22.11.2012 FAIR 
27. 437 RAMASWAMY 50/M 
31.10.2012 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
28.11.2012 FAIR 
28. 1101 SASIKALA 50 /F 
4.11.12 Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
3.12.2012 GOOD 
29. 1102 RAMACHANDRAN 55/M 
4.11.2012 
       Dizziness, headache, loss of sleep, tiredness, difficulty in 
                                         breathing 
27.11.2012 FAIR 
30. 1214 JAYAGOPAL 48/M 
9.11.2012 
Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
2.12.2012 GOOD 
 CLINICAL STUDY ON  ASHTA GUNMA THIRAAVAGAM  IN IN AND OUT PATIENTS DEPT. FOR DIURETIC ACTIVITY 
 
 
 
Sl.No. O.P. No. Name Age/ Sex Date of first visit Symptoms 
Date of last 
visit 
 
Results 
31. 1273 RANI    50/F 
5.11.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathing  
8.12.2012 FAIR 
32. 1340 KUMAR 45/M 
5.11.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
3.12.2012 GOOD 
33. 1806 PRATHAP     54/M 
7.11.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present 
10.12.2012 GOOD 
34. 2405  ALAMELU 48/F 
9.11.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present 
6.12.2012 FAIR 
35. 3768  RAJESWARI 45/F 
17.11.2012  Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
22.12.2012 FAIR 
36. 4145 RAJENDRAN    53/M 
19.11.2012 Swelling  pitting of the oedema  present in lower    
extremity,tiredness 
25.12.2012 GOOD 
37. 5451  SUGANTHI 45/F 
24.11.2012
Dizziness, headache, loss of sleep, tiredness, difficulty in breathing 
22.12.2012 FAIR 
38. 6210   DEVI    35/F 
27.11.2012
Swelling, pitting of the oedema present in lower extremities 
24.12.2012 GOOD 
39. 7170  PRAKASH 40/M 
1.12.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
28.12.2012 FAIR 
40. 7177 PRIYA 45/F 
1.12.2012  
Swelling, pitting of the oedema present in lower extremities  
30.12.2012 FAIR 
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41. 1339/4958 ELLAMMAL 55/F 
24.8.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathing  
8.9.2012 GOOD 
42. 1446/8001 GNANAMBAL 52/F 
6.9.2012 
Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
3.10.12 FAIR 
43. 54/1611 SARAVANAN 43/M 
22.9.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present 
25.10.2012 GOOD 
44. 70/1920 
 
GEETHALAK
SHMI 
  55/F 
24.9.2012
Dizziness, headache, loss of sleep, tiredness, difficulty in breathing 
16.10.2012 GOOD 
45. 83/2084  PERUMAL 52/M 
24.9.2012  Diziness, headache,loss of sleep,tiredness,difficulty in 
breathing 
12.10.2012 FAIR 
46. 256/7740 MAHADEVAN    52/M 
17.10.2012 Swelling  pitting of the oedema  present in lower    
extremity,tiredness 
3.11.2012 GOOD 
47. 357/1231 
 
SABEERUSSA
IN 
 56/M 
5.11.2012
Dizziness, headache, loss of sleep, tiredness, difficulty in breathing 
27.11.2012 FAIR 
48. 446/4154 DEVAKI 48/F 
19.11.2012
Pain present in the rt loin ,nausea,dizziness ,tiredness present 
10.12.2012 GOOD 
49. 487/4920  CHANDRA  50/F 
22.11.2012
Diziness, headache,loss of sleep,tiredness,difficulty in breathing 
7.12.2012 FAIR 
50. 536/6242 MOORTHY 58/M 
28.11.2012  
Dizziness, headache, loss of sleep, tiredness, difficulty in breathing  
27.12.2012 GOOD 
Sl. 
No. 
O.P. 
No. Name 
Age/ 
Sex 
HAEMATOLOGICAL REPORT URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm)          Hb(Gm) BL.UREA BT AT 
TC 
CU/mm 
DC TC 
CU/mm 
DC BT AT 
BT AT ALB 
SU
G DEP 
AL
B SUG DEP P L E P L E 1 hr 
1hr   
1. 5562 KANNAN 48/M 8600 63 34 5 8900 54 42 5 19 21 10 10.1 29 27 NIL NIL NIL NIL NIL NIL 
2. 5678 MOORTHY 52/M 9800 62 33 5 9700 61 38 4 13 12 12.0 12.5 32 28 NIL NIL NIL NIL NIL NIL 
3. 6273 KANNAMMAL 43/F 8700 52 39 6 8800 52 44 5 14 15 10.3 10.6 34   31 NIL NIL NIL NIL NIL NIL 
4. 6658 KANAGA   42/F 9000 60 38 5 9800  60   43     4 18 17 11 11.2    28 32 NIL NIL NIL NIL NIL NIL 
  5. 7266 VALLI   45/F 7800 57 41   6 8000 54 40 5 14 15 10.6 10 34 33 NIL NIL NIL NIL NIL NIL 
6. 7455 MANIKANDAN  55/M 8600 49 39 5 7900 53 32 4 14 13 9 9.8    28 34 NIL NIL NIL NIL NIL NIL 
7. 7792 SARAVANAN  48/M 9400 55 35 6 9800 54 41 4 15 14 10.2 10.4 27 32 NIL NIL NIL NIL NIL NIL 
8. 7856 ARUMUGAM   54/M 9000 53 34 5 9500 55 41 5 18 16 14 13.2 37 35 NIL NIL NIL NIL NIL NIL 
9. 7963 ABDUL KADHER   45/M 9700 57 38 6 9400 62 33 5 14 14 10.0 10.4 33 35 NIL NIL NIL NIL NIL NIL 
10. 8299 MALLIGA  50/F 7600 48 46 5 7800 50 45 5 14 12 12.0 12.0 25 24 NIL NIL NIL NIL NIL NIL 
11. 9487 SUSILA  39/F 9000 49 45 6 9300 50 45 5 19 18 13.0 13.6 26 27 NIL NIL NIL NIL NIL NIL 
12. 9567 CHINNASAMY 51/M 7400 53 41 6 7600 52 40 8 17 16 10.7 11.0 30 31 NIL NIL NIL NIL NIL NIL 
13. 9762 GUHANATHAN  55/M 9400 57 38 5 9500 59 36 5 14 14 10.6 10.8 25 24 NIL NIL NIL NIL NIL NIL 
14. 9964 CHINNAPPA  56/M 9900 60 34 6 9200 60 36 4 18 15 11.0 11.1 34 33 NIL NIL NIL NIL NIL NIL 
15. 106 PONNAMMAL 39/F 7800 55 38 7 7700 54 42 4 15 14 9.0 9.3 34 33 NIL NIL NIL NIL NIL NIL 
16. 208 KANDHASAMY 45/M 9800 55 39 6 9800 55 41 4 13 12 10.2 10.1 37 36 NIL NIL NIL NIL NIL NIL 
17. 378 GOMATHY 47/F 9500 60 36 4 9800 60 35 5 14 13 10.6 10.0 29 28 NIL NIL NIL NIL NIL NIL 
18. 562 VENKATESAN 55/M 8600 55 39 6 8700 56 38 6 15 14 10.5 10.1 29 30 NIL NIL NIL NIL NIL NIL 
19. 893 KARTHIKEYAN 53/M 8000 55 39 6 8000 57 37 6 14 15 11.0 10.1 35 37 NIL NIL NIL NIL NIL NIL 
20. 1165 RAMASAMY 58/M 9200 61 36 3 9300 64 35 3 15 13 9.0 9.9 28 29 NIL NIL NIL NIL NIL NIL 
Sl. 
No. 
O.P. 
No. Name 
Age/ 
Sex 
                                                                 4.3.8   HAEMATOLOGICAL REPORT URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) BL.UREA BT AT 
TC 
CU/mm 
DC TC 
CU/mm 
DC BT       AT     Hb(Gm) 
BT AT Alb Sug Dep Alb Sug Dep 
P L E P L E 1 hr 1hr BT AT 
21. 5648 JEYALAKHSMI  43/F 9800 55 32 13 9500 57 33 6 15 14 9.0 9.3 28 34 NIL NIL NIL NIL NIL NIL 
22. 7579 SIVALINGAM 62/M 7600 48 46 6 7800 55 43 5 14 13 10.2 10.1 34 33 NIL NIL NIL NIL NIL NIL 
23. 9238 SOKKALINGAM 54/M 9500 59 36 5 9430 65 30 5 13 24 10.6 10.6 33 35 NIL NIL OPC NIL NIL NIL 
24. 9275 ARUN 30/M 9200 53 40 7 9200 53 42 5 14 12 10.8 10.8 25 24 NIL NIL NIL NIL NIL NIL 
25. 403 RUBY 65/F 7600 63 32 5 8000 52 44 4 16 15 12.0 12.4 30 28 NIL NIL OPC NIL NIL NIL 
26. 436 SULOKSHANA 45/F 9700 57 36 7 9100 60 36 4 15 14 12.0 12.7 23 22 NIL NIL OPC NIL NIL NIL 
27. 437 RAMASAMY 50/M 8700 59 35 6 8800 58 56 6 14 13 13.0 13.3 34 33 NIL NIL NIL NIL NIL NIL 
28. 1101 SASIKALA 50/F 9800 63 31 6 9400 62 33 5 14 14 10.0 10.4 33 35 NIL NIL NIL NIL NIL NIL 
29. 1102 RAMACHANDRAN 55/M 8600 64 32 4 8500 52 44 4 12 11 9.0 9.3 29 30 NIL NIL NIL NIL NIL NIL 
30. 1214 JEYAGOPAL 48/M 9600 62 33 5 9900 58 34 5 12 12 12.0 12.3 29 28 NIL NIL NIL NIL NIL NIL 
31. 1273 RANI 50/F 6100 64 31 5 6300 51 44 5 12 14 11.0 11.6 23 22 NIL NIL NIL NIL NIL NIL 
32. 1340 KUMAR 45/M 7200 59 36 5 9800 59 37 4 11 12 13.0 13.6 34 33 NIL NIL NIL NIL NIL NIL 
33. 1806 PRATHAP 54/M 9200 52 39 9 9200 58 38 4 16 15 11.0 11.4 29 30 NIL NIL NIL NIL NIL NIL 
34. 2405 ALAMELU  48/F 7800 55 38 7 7900 54 42 4 15 14 9.0 9.3 30 28 NIL NIL NIL NIL NIL NIL 
35. 3768 RAJESWARI  45/F 8600 55 39 6 9800 55 41 4 13 12 10.2 10.1 23 22 NIL NIL NIL NIL NIL NIL 
36. 4145 RAJENDRAN 53/M 9700 60 36 4 9800 62 35 5 14 13 10.6 10.0 34 33 NIL NIL NIL NIL NIL NIL 
37. 5451  SUGANTHI 45/F 8600 55 39 6 8700 56 38 6    15 14 10.8 10.1 29 30 NIL NIL OPC NIL NIL NIL 
38. 6210 DEVI 35/F 8700 55 39 6 8000 57 37 6    14 15 11.0 10.1 35 37 NIL NIL OPC NIL NIL NIL 
39. 
7170 
 
PRAKASH 
 
40/M 9200 61 36 3 9300 62 35 3 15 13 9.0 9.9 28 29 NIL NIL NIL NIL NIL NIL 
40. 7177 PRIYA 45/F 8700 59 35 6 8800 53 56 6 14 13 13.0 13.8 34 32 NIL NIL OPC NIL NIL NIL 
  
 
 
 
 
 
 
 
 
Sl. 
No. 
I.P. No. Name Age/ Sex 
                                                                 4.3.8   HAEMATOLOGICAL REPORT URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) BL.UREA BT AT 
TC 
CU/mm 
DC TC 
CU/mm 
DC BT       AT     Hb(Gm) 
BT AT Alb Sug Dep Alb Sug Dep 
P L E P L E 1 hr 1hr BT AT 
41. 1339/4958 ELLAMMAL 55/F 9200 54 32 13 9500 57 33 6 15 14 9.0 9.3 23 22 NIL NIL NIL NIL NIL NIL 
42. 1446/8001 GNANAMBAL 65/F 7600 48 46 6 7800 52 43 5 14 13 10.2 10.1 34 33 NIL NIL NIL NIL NIL NIL 
43. 54/1611 SARAVANAN 43/M 9700 59 36 5 9430 65 30 5 13 24 10.6 10.6 33 35 NIL NIL OPC NIL NIL NIL 
44. 70/1920 GEETHALAKHSMI 55/F 9100 52 40 7 9200 53 42 5 14 12 10.6 10.8 25 24 NIL NIL NIL NIL NIL NIL 
45. 83/2084 PERUMAL 62/M 7600 63 32 5 8000 52 44 4 16 15 12.0 12.4 30 28 NIL NIL OPC NIL NIL NIL 
46. 256/7740 MAHADEVAN 52/M 9400 57 36 7 9100 60 36 4 15 14 12.0 12.7 23 22 NIL NIL OPC NIL NIL NIL 
47. 357/1231 SABEERHUSSAIN 56/M 8600 52 35 6 8800 58 56 6 14 13 13.0 13.7 34 33 NIL NIL NIL NIL NIL NIL 
48. 446/4154 DEVAKI 58/F 9800 63 31 6 9400 62 33 5 14 14 10.0 10.3 33 35 NIL NIL NIL NIL NIL NIL 
49. 487/4920 CHANDRA 50/F 9800 64 32 4 8500 52 44 4 12 11 9.0 9.3 29 30 NIL NIL NIL NIL NIL NIL 
50. 536/6242 MOORTHY 58/M 9900 65 33 5 9800 62 34 5 12 12 12.0 12.2 30 28 NIL NIL NIL NIL NIL NIL 
GENERAL HAEMATOLOGICAL INVESTIGATION 
Sl. 
No. 
O.P. 
No. Name 
Age/ 
Sex 
HAEMATOLOGICAL REPORT URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm)          Hb(Gm) B.L SUGAR BT AT 
TC 
CU/m
m 
DC TC 
CU/m
m 
DC BT AT 
BT AT ALB SUG DEP ALB SUG DEP 
P L E P L E 1 hr 1hr   
1. 7518 KALIMUTHU 57/M 8800 57 40 4 9000 57 39 4 19 18 11.0 11.4  83 103 NIL NIL NIL NIL NIL NIL 
2. 7540 RENGARAJAN 66/M 9800 62 33 5 9900 62 34 5 12 12 12.0 12.3 143 113 NIL NIL NIL NIL NIL NIL 
3. 138 GNANASELVAM 65/F 8700 64 31 5 6300 51 44 5 12 14 11.0 11.6 117 123 NIL NIL NIL NIL NIL NIL 
4. 5424 VISWANATHAN 37/M 10000 59 36 5 9800 59 37 4 11 12 13.0 13.6 136 128 NIL NIL OCC NIL NIL NIL 
  5. 5462 SAKILA 30/F 9800 52 39 9 9200 58 38 4 16 15 11.0 11.4 110 103 NIL NIL NIL NIL NIL NIL 
6. 5504 RAO 64/M 8400 63 32 5 8000 52 44 4 16 15 12.0 12.4 96 105 NIL NIL NIL NIL NIL NIL 
7. 6207 LENIN 62/M 7800 57 36 7 9100 60 36 4 15 14 12.0 12.7 98 107 NIL NIL NIL NIL NIL NIL 
8. 7165 SARADHA 45/F 8400 59 35 6 8800 58 56 6 14 13 9.8 13.7 136 128 NIL NIL  OCC NIL NIL NIL 
9. 7259 KARPAGAMPAL 49/F 10400 63 31 6 9400 62 33 5 14 14 10.0 10.4 112 115 NIL NIL NIL NIL NIL NIL 
10. 7837 AMSA 50/F 7600 48 46 6 7800 50 45 5 14 12 12.0 12.0 92 102 NIL NIL NIL NIL NIL NIL 
11. 7695 PUSHPA 47/F 9000 49 45 6 9200 50 45 5 19 18 13.0 13.6   98 107 NIL NIL OCC NIL NIL NIL 
12. 7932 KATHIRESAN 38/M 7400 53 41 6 7600 52 40 8 17 16 10.7 11.0 114 112 NIL NIL NIL NIL NIL NIL 
13. 8432 MURUGESAN 45/M 9400 57 38 5 9500 59 36 5 14 14 10.6 10.8   96 99 NIL NIL NIL NIL NIL NIL 
14. 9254 SAIRA BAANU 52/F 10100 60 34 6 9200 60 36 4 18 15 11.0 11.1 107 115 NIL NIL OCC NIL NIL NIL 
15. 803 ASHA 53/F 7800 55 38 7 7900 54 42 4 15 14 9.0 9.3 105 117 NIL NIL NIL NIL NIL NIL 
16. 836 SELVARAJ 52/M 9800 55 39 6 9800 55 41 4 13 12 10.2 10.1 121 127 NIL NIL NIL NIL NIL NIL 
17. 1469 SEKAR 48/M 9700 60 36 4 9800 60 35 5 14 13 10.6 10.0 103 119 NIL NIL NIL NIL NIL NIL 
18. 2852 NIRMALA 32/F 8600 55 39 6 8700 56 38 6 15 14 10.8 10.1 89 96 NIL NIL NIL NIL NIL NIL 
19. 4589 RAMESH 35/M 8000 59 39 6 8000 57 37 6 14 15 11.0 10.1 95 108 NIL NIL NIL NIL NIL NIL 
20. 6238 PARIMALA 39/F 7800 61 36 3 9300 64 32 3 15 13 10.2 10.8 93 99 NIL NIL NIL NIL NIL NIL 
 Sl. 
No. 
O.P. 
No. Name 
Age/ 
Sex 
                                                                    HAEMATOLOGICAL REPORT URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) BL.SUGAR BT AT 
TC 
CU/mm 
DC TC 
CU/mm 
DC BT       AT     Hb(Gm) 
BT AT Alb Sug Dep Alb Sug Dep 
P L E P L E 1 hr 1hr BT AT 
21. 7215 GANAPATHI 69/M 9400 61 32 13 9800 57 36 6 15 14 9.0 9.3    89 95 NIL NIL NIL NIL NIL NIL 
22. 2755 LATHA   33/F 7600 48 46 6 7800 52 43 5 14 13 10.2 10.1   104 112 NIL NIL NIL NIL NIL NIL 
23. 3952 SOUNDHAR   60/M 9700 59 36 5 9430 65 30 5 13 24 10.6 10.6   106 131 NIL NIL OPC NIL NIL NIL 
24. 4660 ELUMALAI 49/M 9200 53 40 7 9200 53 42 5 14 12 10.8 10.8    99 107 NIL NIL NIL NIL NIL NIL 
25. 8016 MUTHUSELVAKUMAR 32/M 7600 63 32 5 8000 52 44 4 16 15 12.0 12.4   94 99 NIL NIL OPC NIL NIL NIL 
26. 9436 RAJA 35/M 9400 65 36 7 9100 60 36 4 15 14 12.0 12.7 121 117 NIL NIL OPC NIL NIL NIL 
27. 9455 SATHYA   40/F 8700 59 35 6 8800 58 39 6 14 13 13.0 13.7 130 108 NIL NIL NIL NIL NIL NIL 
28. 9611 SAKTHIVEL 59/M 9800 63 31 6 9400 62 33 5 14 14 10.0 10.4 132 112 NIL NIL NIL NIL NIL NIL 
29. 1675 KAMALA 35/F 9800 64 32 4 8500 52 44 4 12 11 9.0 9.3 107 98 NIL NIL NIL NIL NIL NIL 
30. 1678 RAJESWARI 42/F 9600 62 33 5 9900 62 34 5 12 12 12.0 12.3 110 116 NIL NIL NIL NIL NIL NIL 
31. 1851 MARI 36/F 6100 64 31 5 6300 51 44 5 12 14 11.0 11.6 115 109 NIL NIL NIL NIL NIL NIL 
32. 1849 PUSHPA 50/F 9800 59 36 5 9800 59 37 4 11 12 13.0 13.6 102 108 NIL NIL NIL NIL NIL NIL 
33. 2243 SANKAR 28/M 9200 57 39 9 9200 58 38 4 16 15 11.0 11.4 134 128 NIL NIL NIL NIL NIL NIL 
34. 2406 LAKSHMI 35/F 7800 55 38 7 7900 54 42 4 15 14 9.0 9.3 86 97 NIL NIL NIL NIL NIL NIL 
35. 8107 SELVARAJ 50/M 9800 55 39 6 9600 55 41 4 13 12 10.2 10.1 89 104 NIL NIL NIL NIL NIL NIL 
36. 8865 KANNAN 46/F 9700 60 36 4 9800 60 35 5 14 13 10.6 10.0 88 95 NIL NIL NIL NIL NIL NIL 
37. 9265 MUNIRAJ 49/M 8600 55 39 6 8700 56 38 6     15 14 10.8 10.1 85 98 NIL NIL OPC NIL NIL NIL 
38. 9368 KASTHURI 51/F 8000 59 39 6 7900 57 34 6     13 17 11.0 11.5 99 107 NIL NIL OPC NIL NIL NIL 
39. 
9621 
 
MATHIVANAN 49/M 9200 61 36 3 9300 62 35 3 15 13 9.0 9.9 97 113 NIL NIL NIL NIL NIL NIL 
40. 9981 VAELLAMMAL 42/F 8700 59 35 6 8700 58 56 6 14 13 12.8 13.5 104 108 NIL NIL OPC NIL NIL NIL 
Sl. 
No. 
I.P. No. Name Age/ Sex 
                                                                    HAEMATOLOGICAL REPORT URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT ESR (mm) BL.SUGAR BT AT 
TC 
CU/mm 
DC TC 
CU/mm 
DC BT       AT     Hb(Gm) 
BT AT Alb Sug Dep Alb Sug Dep 
P L E P L E 1 hr 1hr BT AT 
41. 1077/7053 RAJALAKHSMI 52/F 9400 56 32 13 8900 62 36 6 15 14 9.0 9.3 98 103 NIL NIL NIL NIL NIL NIL 
42. 1128/8173 SELVI   37/F 7600 48 46 6 7800 52 43 5 14 13 9.2 10.2 96 88 NIL NIL NIL NIL NIL NIL 
43. 1220/1115 MOHAMMADBAEG   50/M 9700 55 36 5 9450 65 30 5 13 24 10.6 10.6 117 102 NIL NIL OPC NIL NIL NIL 
44. 1231/1419 KAASI 59/M 9200 53 40 7 9200 59 42 5 14 12 10.6 10.8 121 101 NIL NIL NIL NIL NIL NIL 
45. 1317/4312 DHANALAKHSMI 53/F 7600 63 32 5 8000 52 44 4 16 15 12.0 12.4 108 114 NIL NIL OPC NIL NIL NIL 
46. 1399/6626 RAMESH 35/M 9400 58 36 7 9200 60 36 4 15 14 12.0 12.7 98 103 NIL NIL OPC NIL NIL NIL 
47. 1419/7245 SAROJA   43/F 8700 59 35 6 8800 58 39 6 14 13 13.0 13.8 89 94 NIL NIL NIL NIL NIL NIL 
48. 74/1979 PADMAVATHI 65/F 9800 63 31 6 9400 60 33 5 14 14 10.0 10.4 132 105 NIL NIL NIL NIL NIL NIL 
49. 320/9361 MARY 50/F 9800 64 32 4 8500 52 44 4 12 11 9.0 9.3 127 111 NIL NIL NIL NIL NIL NIL 
50. 349/925 PAMIATH 55/F 9600 57 33 5 9800 58 34 5 12 12 12.0 12.5 124 106 NIL NIL OPC NIL NIL NIL 

